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Introduction 
Cyclic dinucleotides (CDNs) are highly versatile signaling molecules that control various important 
biological processes in bacteria. The best-studied example is cyclic di-GMP (c-di-GMP). Known since the 
late 1980s, it is now recognized as a near-ubiquitous second messenger that coordinates diverse aspects 
of bacterial growth and behavior, including motility, virulence, biofilm formation and cell cycle 
progression. The roles of the prototypical second messengers cyclic AMP (cAMP) and cyclic GMP 
(cGMP) have been studied for more than 50 years, whereas recognition of the cyclic dinucleotides 
(CDNs), which are larger signaling molecules, has lagged behind. The first CDN was discovered in 1987, 
when Moshe Benziman reported “an unusual cyclic nucleotide activator” that was able to stimulate 
cellulose synthase from Komagataeibacter xylinus (formerly known as Gluconacetobacter xylinus), and 
identified this compound as bis-(3′-5′)-cyclic diguanylic acid (c-di-GMP) [1]. More than 20 years later, c-
di-AMP was discovered as a factor that is involved in DNA repair in Bacillus subtilis [2] (Box 1). Moreover, 
versions of c-GMP–AMP (cGAMP) that have different chemical linkages were first discovered in bacteria 
[3] and later in mammalian cells [4], and they were shown to have prominent roles in virulence and the 
innate immune response, respectively. Despite their chemical similarities, different CDNs seem to have 
distinct evolutionary origins, and the enzymes that are involved in their synthesis and breakdown are 
structurally unrelated [2,5,6]. The idea that different CDNs evolved in parallel emphasizes the potency 
and versatility of this macrocyclic ring with two purine moieties, which is the structural component of 
these biomolecules, as a key carrier of cellular information.  
The discovery of CDNs has provided novel entry points for the study of important biological processes 
and cell behavior, including how bacteria coordinate their own growth and replication cycle, how they 
adapt to surfaces by forming multicellular consortia known as biofilms, or how pathogenic bacteria 
control their virulence and persistence. This was possible by first identifying the enzymes that are 
involved in the synthesis and degradation of CDNs [7,8], followed by the characterization of specific 
effectors and target molecules (see below). The field of CDN research is now rapidly expanding, and 
aspects of the signaling pathways that are involved are being explored at the atomic, molecular and 
cellular levels. In the past years, we have learned that CDNs are wide- spread and immensely versatile 
signaling molecules that control bacterial cellular processes at several levels, are well integrated with 
other global regulatory pathways, such as phosphorylation networks [9] and quorum sensing pathways 
[10], and crosstalk with other small signaling molecules, including cGMP, cAMP and guanosine 
tetraphosphate (ppGpp) [11-13]. So far, in bacteria, c-di-GMP is not only the most widespread CDN but 
also the most intensely studied and best-understood member of this family of second messengers.  
 
 
Box 1 | CDNs beyond c-di-GMP  
 
The cyclic dinucleotide (CDN) cyclic di-AMP (c-di-AMP) was discovered as a ligand that was bound to the amino-
terminal domain of the DNA damage-sensing protein DisA of Bacillus subtilis [2]. Biochemical studies identified 
this domain as diadenylyl cyclase (DAC), which is the founding member of a family of enzymes that converts ATP 
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into c-di-AMP. Specific phosphodiesterases (PDEs) that contain DHH-DHHA1 or HD domains hydrolyze c-di-AMP 
into 5’-phosphoadenylyl-(3’-5’)-adenosine (pApA) or AMP [14-16]. C-di-AMP is essential in various different 
bacteria, and dysregulation of c-di-AMP signaling causes abnormal phenotypes [17,18]. A recent report related the 
essential nature of c-di-AMP in listeria monocytogenes to increased level of guanosine tetraphosphate (ppGpp), 
which is a global second messenger that has been linked to carbon metabolism and nutrient starvation. Depletion of 
c-di-AMP in rich media led to an accumulation of ppGpp and altered GTP concentrations, thereby inactivating the 
pleiotropic transcriptional regulator CodY [19]. In Gram-positive bacteria, c-di-AMP is associated with an increased 
list of cellular functions. These functions include cell wall homeostasis [18,20-23], DNA integrity [18,24-26], 
potassium homeostasis [27-30] and osmoprotection [31,32], gene expression [33,34], biofilm formation [35,36], 
sporulation [37], metabolism [38], antibiotic resistance [39], and, similar to c-di-GMP, cell-mediated adaptive 
immune response (see below). 
cGMP-AMP (cGAMP) is of special interest because it is produced by bacteria and metazoans [3,40]. Bacterial cGAMP 
exhibits 3’-3’ linkage and is synthesized by the dinucleotide synthase DncV, which was originally identified in Vibrio 
cholerae [3]. Structural studies have revealed that, in the first nucleotidyl transfer reaction, DncV preferably 
recognizes ATP and GTP as acceptor and donor nucleotides, respectively [41]. cGAMP is required for host 
colonization by V. cholerae and for exoelectrogenesis in different members of the Deltaproteobacteria [42,43]. 
Mammalian cGAMP (2’-3’ linkage) has a prominent role in vertebrate innate immunity pathway that is responsible 
for the surveillance of cytoplasmic DNA [44].  cGAMP is synthesized by cGAMP synthase (cGAS), which is activated 
by binding to cytoplasmic DNA [45,46]. In turn, cGAMP binds to and activates the host receptor stimulator of 
interferon genes (STING), which then recruits TANK-binding kinase 1 (TBK1) to phosphorylate interferon 
regulatory factor 3 (IRF3), ultimately leading to the production of type I interferon (IFN). Evolutionary studies have 
recently revealed that the function of the cGAS-STING axis is conserved in sea anemones, which diverged from the 
human lineage more than 500 million years ago. As cGAS in sea anemones produces a bacteria-like 3’-3’-linked CDN 
that is recognized by its own STING protein, it was proposed that 2’-3’linked cGAMP recently evolved in vertebrates 
and that during evolution the protein components of this innate immunity pathway remained structurally 
conserved, whereas chemical changes in the second messenger were driving functional innovation [47]. 
Recent evidence suggests that c-di-GMP and c-di-AMP, which are secreted by bacteria or released through cell lysis, 
are also sensed by STING, thereby converging with the cGAS-cGAMP cytosolic DNA-surveillance pathway [48-50]. 
Interestingly, bacteria seem to have evolved strategies to decrease the production of IFN by avoiding the activation 
of STING. Group B Streptococcus was recently shown to express an ectonucleotidase, CdnP, which hydrolyses 
extracellular bacterial c-di-AMP to attenuate the cGAS-STING axis [51]. 
 
 
 
Makers and breakers 
The c-di-GMP monomer exhibits two-fold symmetry, with two GMP moieties that are fused by a 5′-3′ 
macrocyclic ring (Figure 1A). High-resolution structures of c-di-GMP, in solution or bound to protein, 
indicate that the ligand exists either as an elongated monomer or as a condensed intercalated dimer 
[3,52]. At physiological concentrations, c-di-GMP is a monomer in solution[4,53], which suggests that 
intercalated dimers form through the successive binding of two monomers to specific effector proteins. 
Cellular levels of c-di-GMP are regulated in response to internal and environmental cues. This is achieved 
through the activity of two antagonistic enzyme families: diguanylate cyclases (DGCs) and c-di-GMP-
specific phosphodiesterases (PDEs) (Figure 1A), with equivalent enzymes being responsible for the 
metabolism of c-di-AMP (Box 1). DGCs and PDEs are found in members of all major bacterial phyla, 
thus representing two of the largest known families of signaling proteins in the bacterial kingdom 
[2,5,6,54]. The synthesis of c-di-GMP is catalyzed by DGCs through the cooperative action of their two 
catalytic GGDEF domains, which arrange in an antiparallel manner with one GTP molecule bound to 
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each protomer. Pioneering structural and mechanistic studies on PleD, which is a DGC from Caulobacter 
crescentus, proposed modes of substrate binding, catalytic mechanism, enzyme activation and product 
inhibition for this class of enzymes [5,9,55-57]. A mechanism was proposed whereby two GTP molecules 
are positioned in an antiparallel manner to enable their condensation into c-di-GMP [3,52] (Figure 1B). 
The requirement for dimerization conveys a simple mechanism to control the activity of DGCs by using 
an accessory domain that forms homodimers in a signal-dependent manner. In the case of PleD or the 
DGC WspR in Pseudomonas aeruginosa, this is facilitated by an amino-terminal receiver domain that 
dimerizes following phosphorylation [5,11-13,55,58] (Figure 1B). Recently, an alternative mechanism for 
the activation of DGCs was proposed for DgcZ from Escherichia coli, which contains a catalytic GGDEF 
domain that is fused to an N-terminal zinc-binding (CZB) domain. DgcZ is a constitutive dimer and its 
activity is allosterically regulated by the CZB domain [59] (Figure 1C). When zinc is present, the GGDEF 
domains of DgcZ, although facing each other, are not positioned in a catalytically competent 
conformation. In the absence of zinc, DgcZ may be activated through the repositioning of the GGDEF 
domains to enable the formation of phosphodiester bonds between substrate molecules (Figure 1B).  
The arrangement of the catalytic GGDEF domains was also implicated in the feedback inhibition of c-di-
GMP synthesis. Many of these enzymes are subject to non-competitive product inhibition through the 
binding of c-di-GMP to the allosteric I-site on the surface of the GGDEF domain [5,57]. In PleD and WspR, 
an intercalated c-di-GMP dimer binds to the I-site and a secondary binding site, thereby immobilizing 
the GGDEF domains in a non-catalytic state [55,58] (Figure 1B). Product inhibition of DGCs may establish 
precise cellular threshold concentrations of c-di-GMP or contribute to the reduction of stochastic 
perturbations and increased stability of c-di-GMP signaling networks by maintaining c-di-GMP levels in 
defined concentration windows [57]. Although a functional connection between the I-site and product 
inhibition has been clearly established, the binding of c-di-GMP to some GGDEF domains may also have 
other roles, such as in protein–protein interactions [60] (see below).  
Structurally and mechanistically distinct c-di-GMP-specific PDEs that contain an EAL domain or an HD-
GYP domain have been described. EAL-type PDEs hydrolyze c-di-GMP in the presence of Mg2+ or Mn2+ 
to yield the linear 5′-phosphoguanylyl-(3′-5′)-guanosine (pGpG) dinucleotide [8]. EAL domain-
containing proteins are active as dimers [61,62] but, in contrast to DGCs, for which the fusion of two GTP 
molecules requires a dimeric arrangement of the enzyme, this quaternary arrangement does not seem to 
be required for PDE catalysis. Instead, recent structural studies have implied a regulatory role for EAL 
domain dimerization. Based on crystal structures, a clam-shell-like opening and closing mechanism of 
the EAL dimer was proposed to regulate the activity of PDEs [62,63]. The evolutionarily conserved 
dimerization interface is formed by two helices, with one of them, α5, directly connecting through the 
β5–α5 loop (loop 6) to two central Asp residues that coordinate the metal ions in the active site [61,62,64] 
(Figure 1D). Structural and biophysical studies revealed that the α5–loop 6 region undergoes substantial 
rearrangements during the clam-like opening and closing movements of the EAL dimer. These findings 
indicate that this part of the protein may function as a ‘hinge joint’ to couple EAL conformation to 
catalytic activity through the positioning of metal ions in the active site [62,63]. 
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Figure 1 | Components of the c-di-GMP signaling network. (A) Principles of cyclic di-GMP (c-di-GMP) signaling. The c-
di-GMP monomer exhibits two-fold symmetry, with two GMP moieties that are fused by a 5′-3′ macrocyclic ring. The 
synthesis of c-di-GMP is catalyzed by diguanylate cyclases (DGCs) through the cooperative action of their two catalytic 
GGDEF domains (orange). Specific phosphodiesterases (PDEs) that contain EAL or HD-GYP domains (blue) hydrolyze c-
di-GMP into 5′-phosphoguanylyl-(3′-5′)-guanosine (pGpG) or GMP, respectively. DGCs are subject to product inhibition 
through the binding of c-di-GMP to an allosteric I-site. Product inhibition of PDEs is accomplished through the competitive 
binding of pGpG to the active site of the enzyme. Through binding to effector molecules, c-di-GMP regulates diverse 
cellular processes, including motility, adherence, biofilm formation, virulence, development and cell cycle progression. 
(B) Schematic of DGC activation. The upper panel shows the phosphorylation-dependent activation of PleD from 
Caulobacter crescentus. The amino-terminal receiver domains and GGDEF domains that are bound to GTP are shown. The 
phosphorylation-induced dimerization of receiver domains leads to the activation of GGDEF domains. The GTP molecules 
that are bound by each protomer are positioned in an antiparallel manner to enable the formation of two intermolecular 
phosphodiester bonds. Binding of c-di-GMP to the I-site and to a secondary binding site on the surface of the GGDEF 
domain immobilizes the enzyme in a catalytically inactive state. The lower panel shows the metal-dependent activation 
mechanism of DgcZ from Escherichia coli, which contains a catalytic GGDEF domain that is fused to an N-terminal zinc-
binding (CZB) domain. DgcZ is a constitutive dimer. In the presence of zinc, the GGDEF domains of DgcZ are not 
positioned in a catalytically competent conformation. In the absence of zinc, DgcZ may be activated through the 
repositioning of the GGDEF domains to enable the formation of phosphodiester bonds between the GTP molecules that 
are bound to each DgcZ protomer. (C) Structure of the DgcZ dimer from E. coli (RCSB Protein Data Bank (PDB) entry 
4H54) [59]. GGDEF-domains (orange) and zinc-binding CZB domains (grey) are highlighted. Zinc metal ions are depicted 
as red spheres. The binding of c-di-GMP (magenta) to antipodal inhibitory I-sites (IP and IP′ from each protomer, 
respectively) and the binding of the GTP analogue GTPαS (green) to active sites (A and A′ from each protomer, 
respectively) are shown. (D) Overlay of the EAL domains of the phosphodiesterase PdeL in the tight, substrate-bound 
conformation (blue; PDB entry 4LJ3) and the relaxed, substrate-free (apo) conformation (grey; PDB entry 4LYK) [62]. The 
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inset shows a zoomed-in view of the active site of PdeL and the conserved loop 6 region. The loop 6 conformations in the 
relaxed, apo (yellow) and tight c-di-GMP-bound (orange) dimer are indicated. Yellow spheres (Mg2+) and magenta spheres 
(Ca2+) indicate the positions of catalytic ions in the relaxed and tight protein conformations, respectively. The conserved 
double-aspartic acid motif (D262, D263) is highlighted. The figure also shows the anchoring glutamate (E235), which 
determines the structural arrangement of loop 6 through interaction with D263 or the conserved T270, respectively. (E) 
Activation of the membrane-bound BcsA–BcsB cellulose synthase complex by c-di-GMP. The structure of the Rhodobacter 
sphaeroides BcsA subunit (green), its carboxy-terminal PilZ-domain (magenta) and the BcsB subunit (grey; PDB entry 4P02) 
are shown [65]. The binding of c-di-GMP to the C-terminal PilZ domain of BcsA releases autoinhibition of its 
glycosyltransferase activity to activate the complex. A dimer of c-di-GMP bound to the PilZ domain is indicated.  
 
 
Consistent with this, accessory domains that are known to control PDE activity communicate with the 
catalytic core by modulating the conformation of the EAL dimerization interface [63]. The observation 
that substrate binding induces EAL dimerization and also determines the conformation of the α5–loop 6 
region suggested allosteric coupling between EAL domains and the associated regulatory domains, with 
the α5–loop 6 region acting as a central communication platform [62-64]. Interestingly, EAL domain-
containing proteins that have adopted roles as c-di-GMP effectors seem to use similar c-di-GMP-
mediated dimerization and α5–loop 6 remodeling to regulate cellular processes [66] (see below). A 
second, unrelated family of c-di-GMP-specific phosphodiesterases contains conserved HD-GYP domains 
[67]. Recently, the first crystal structure of an active HD-GYP-containing PDE was solved and indicated 
that a novel trinuclear iron-binding site is involved in catalysis [68]. Whereas EAL-based enzymes 
generally convert c-di-GMP into the linear product pGpG, HD-GYP hydrolyses c-di-GMP in a one-step 
reaction to yield two molecules of GMP [68]. Thus, for bacteria that lack HD-GYP domain-containing 
proteins it remained unclear how pGpG is further catabolized into GMP. This puzzle was solved recently 
by studies that showed that the oligoribonuclease Orn, which is a ribonuclease that hydrolyses RNAs 
that are 2–5 nucleotides in length, is the primary enzyme that is capable of degrading pGpG [69,70].  
Despite detailed knowledge on the structure and function of DGCs and PDEs, it has remained 
challenging to assign physiological roles to individual enzymes under laboratory conditions [71]. Genetic 
studies often fail to reveal clear phenotypes. Thus far, only a few specific input signals have been 
identified for these enzymes, including oxygen [72], light [61], nitric oxide [73], metals [59], nutrients 
[74,75] or surface contact [76], which may be owing to the limited physiological conditions that are 
assayed in the laboratory. Evidence for this was provided by a recent study of PDEs in E. coli. Despite a 
total of 13 PDEs being encoded in the genome of this organism, only PdeH is able to decrease c-di-GMP 
levels and license motility in growing E. coli cells [77,78] (see below). The observations that most PDEs 
are readily expressed and that a large proportion of these enzymes can be genetically activated to 
substitute for PdeH in motility control implied that most of these enzymes simply lack the appropriate 
stimuli under laboratory conditions [79].  
DGCs and PDEs also engage in downstream signaling cascades through direct interactions with their 
effector molecules, thereby spatially controlling cellular processes [60,72,80]. In such supramolecular 
complexes, these proteins not only regulate the synthesis and degradation of c-di-GMP but can also act 
as ‘c-di-GMP sensors’ to control the activity of interacting proteins [80]. 
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Box 2 | 1st aim of this thesis 
 
Out of the 13 putatively active PDEs in E. coli K-12 we still lack knowledge of the exact physiological functions of 
most of these PDEs. In fact – under laboratory conditions – only the PDE PdeH seems to license motility in E. coli by 
reducing c-di-GMP levels below the threshold required to activate the flagellar brake protein YcgR. This raised 
questions regarding expression and activity of the other PDEs. Several possibilities could account for the observation 
that none of the other proteins are involved in motility control: (i) The remaining PDEs are not expressed. (ii) The 
input signals activating their enzyme activity are absent under the conditions tested. (iii) Some PDEs might be 
spatially confined to signal within microdomains without affecting the global c-di-GMP pool. Genetically studying 
the contribution of DGCs and PDEs to c-di-GMP-responsive output systems is a challenging endeavor, since under 
laboratory conditions most DGCs and PDEs are present in their inactive state, sue to missing input signals. In this 
work we aim to answer, whether E. coli PDEs are restricted to a confined output target or – whether activated – 
could in principle contribute to a number of c-di-GMP-responsive output system. 
 
 
 
C-di-GMP effectors 
Although the coordinated control of makers and breakers explains how c-di-GMP levels are controlled 
in time and space, c-di-GMP pathways ultimately rely on the respective effectors that bind to c-di-GMP 
and on their downstream targets, which are the cellular components that are regulated by specific c-di-
GMP effectors. Given the global influence of c-di-GMP on bacterial cell physiology and the sheer 
abundance of DGCs and PDEs in some bacteria, it can be assumed that numerous such effectors and 
cellular targets exist. Several families of effector proteins and RNAs have been identified and are 
structurally and functionally well characterized [81]. These include mRNA riboswitches [82], 
transcriptional regulators [83-85], proteins that contain PilZ domains [78,86,87], and proteins that contain 
degenerate GGDEF and EAL domains [88]. The field has recently come full circle; the discovery of c-di-
GMP goes back to the observation that c-di-GMP activates the membrane-bound BcsA–BcsB cellulose 
synthase complex in K. xylinus, thereby increasing the production of this exopolysaccharide matrix 
component [1]. The availability of the structure of the BcsA–BcsB complex revealed an elegant 
mechanism, whereby the binding of c-di-GMP to the carboxy-terminal PilZ domain of BcsA releases 
autoinhibition of its glycosyltransferase activity to activate the complex [65] (Figure 1E). This example 
illustrates how c-di-GMP effectors, such as proteins that contain PilZ domains or the newly discovered 
YajQ protein family [89], can act as versatile adaptors that link c-di-GMP signal input to the activity of 
enzymes complexes or transcription factors.  
The discovery that c-di-GMP binds to a range of transcription factors, including members of the response 
regulator or cAMP-responsive protein (Crp) families, in a way that was not predictable from their protein 
sequence, argued for a more versatile nature of ligand–effector interactions [83,90,91]. This is supported 
by the identification and characterization of a range of novel c-di-GMP effectors, an endeavor that was 
greatly aided by the introduction of innovative high-throughput methods and biochemical techniques 
(Box 3). One of the most exciting recent discoveries was the finding that ATPases bind to c-di-GMP. The 
first example is FleQ, which is a bacterial enhancer-binding protein (bEBP) from P. aeruginosa. Whereas 
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other members of this family of transcription factors are normally activated by phosphorylation, the 
activity of FleQ is controlled by c-di-GMP [84]. Structural studies have revealed that c-di-GMP interacts 
with the AAA+ ATPase domain of FleQ at a site that is distinct from the ATP-binding pocket. The binding 
of c-di-GMP obstructs the ATPase activity of FleQ, thereby altering its quaternary structure and its 
transcriptional activity [91]. In other bacteria, specific homologues of FleQ have also been identified as c-
di-GMP effectors [92,93]. Similarly, c-di-GMP specifically binds to MshE, which is an AAA+ ATPase that 
is involved in the assembly of mannose-sensitive haemagglutinin pili (MSHA pili) in Vibrio cholerae [94-
96]. The observation that HxrA, which is an MshE homologue and type 2 secretion (T2S) ATPase from P. 
aeruginosa, also specifically binds to c-di-GMP opened up the exciting possibility that this protein 
secretion pathway, which uses a pilus-like extrusion mechanism, might also be controlled directly by c-
di-GMP [94]. The idea that c-di-GMP globally controls bacterial protein secretion is reinforced by some 
recent observations that indicate that this second messenger also controls type VI secretion systems 
(T6SSs) [97], as well as T3SSs [98]. Although the exact role of c-di-GMP in T6SSs remains unclear, its effect 
on T3SSs seems to be direct and again mediated through a central ATPase, as it was shown that the 
flagellar export ATPase FliI from a range of distantly related bacteria specifically binds to c-di-GMP [98]. 
The binding of c-di-GMP to FliI, and to its homologues HrcN and ClpB2 from the T3SS and T6SS, 
respectively, inhibits ATPase activity, which suggests that it directly interferes with flagellar export and 
T3S-mediated protein secretion. The authors of this study proposed that the mechanism of c-di-GMP 
binding might be widely conserved among the rotary export ATPases, which makes c-di-GMP central to 
the function of many of these secretion proteins [98]. It will be interesting to compare the c-di-GMP 
binding mode of the individual members of this family once structural information is available. Finally, 
sensor histidine kinases, which are the central components of phosphorylation pathways in bacteria, 
have also been identified as targets of c-di-GMP. The histidine kinase cell cycle kinase A (CckA) from C. 
crescentus was shown to bind to c-di-GMP through its catalytic and ATPase domains, which leads to a 
shift in the kinase–phosphatase activity of this bifunctional enzyme [9] (see below). The discovery that 
several ATPases act as regulatory hubs for c-di-GMP may reflect the global role of c-di-GMP in 
monitoring bacterial cell physiology. ATPases often function as central regulatory switches that govern 
key cellular processes and c-di-GMP seems to control the activity of some of these essential enzymes. 
 
 
Box 3 | Toolkit for the analysis of CDN and CDN-binding proteins 
 
Several tools and biomarkers were established for the in vitro and in vivo analysis of cyclic di-GMP (c-di-GMP). This 
includes sensitive high-performance liquid chromatography-coupled tandem mass spectrometry (HPLC-MS/MS) to 
accurately determine the concentration of second messengers in cell extracts [99,100], fluorescence-based reporters 
that are fused to c-di-GMP-dependent promoters or riboswitches [101-104], and a c-di-GMP concentration in 
individual live cells [105,106]. In the past five years, novel approaches were developed to identify and characterize 
cyclic dinucleotide (CDN) effector proteins on a global scale. This included affinity pull-down assays followed by 
mass spectrometry analysis. Trivalent chemical scaffolds with a CDN-binding, a biotin-sorting and a crosslinking 
moiety were used as capture compounds in combination with streptavidin-coated beads [107,108]. A similar 
approach used c-di-GMP-coated sepharose beads for affinity pull-down assays [109]. The advantage of these 
methods is that potential binding proteins can directly be isolated from cell extracts without the need for time-
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consuming fractionation or biochemical purification. Moreover, once specific binding proteins have been identified, 
such pull-down methods can also be used for diagnostic purposes in combination with specific antibodies [110]. 
Both methods were successfully applied for different bacteria, including Pseudomonas aeruginosa, Salmonella enterica 
subsp. enterica serovar Typhimurium, Caulobacter crescentus, Listeria monocytogenes, Streptomyces venezuelae or 
Bdellovibrio bacteriovorus [38,85,107,111]. A more indirect approach involves the screening of the complete genome-
scale ORF library (ORFeome) and the subsequent testing of cell lysates with a high-throughput binding assay 
[94,112]. Differential radial capillary action of ligand assay (DRaCALA) was developed to directly mix proteins with 
labelled nucleotides (such as radiolabeled nucleotides) on a nitrocellulose membrane. After washing the membrane, 
free ligands will difuse away, whereas ligands that are specifically bound to proteins will be immobilized at the 
contact site [112]. The application of these techniques, as well as more conventional approaches, such as isothermal 
titration calorimetry (ITC) or microscale thermophoresis (MST), has led to the identification of numerous novel 
effector proteins [27,94,98,111]. 
 
 
Box 4 | 2nd aim of this thesis 
 
In silico analyses have identified several conserved families of c-di-GMP-binding proteins based on consensus 
motifs. Apart from the known c-di-GMP-binding proteins such as PilZ, degenerate GGDEF and EAL-domain 
proteins, a substantial number of non-canonical c-di-GMP-binding proteins have been experimentally identified and 
characterized so far. The structures of some of these proteins show a high degree of variability regarding the binding 
of c-di-GMP to them. This makes it challenging – if not impossible – to apply in silico approached to predict and 
identify novel non-canonical c-di-GMP-binding proteins. The first aim of this work was to develop a novel approach 
to experimentally identify novel c-di-GMP binding proteins. The method was based on a biochemical approach, 
which applies a molecule comprised of a covalent link between c-di-GMP, a cross-linking and a sorting moiety. This 
allowed to capture c-di-GMP-binding proteins out of cell extracts, covalently cross-link the captured proteins, sort 
them by affinity pull-down and identify them via state-of-the-art mass-spectrometry. 
 
 
 
Physiological roles of c-di-GMP 
Development and morphogenesis 
Several bacteria use c-di-GMP to control morphogenesis and developmental transitions. This includes C. 
crescentus, which is an aquatic organism that has an inherently asymmetric life cycle [113] (Figure 2). C. 
crescentus produces two specialized progeny cells during each division cycle — a motile swarmer cell and 
a sessile stalked cell. Dividing C. crescentus cells are highly polarized, with a stalk and adhesive holdfast 
exposed at one cell pole and a flagellum, pili and chemotaxis apparatus assembled at the opposite pole. 
The surface-attached stalked cell progeny reinitiates chromosome replication (S phase) and cell division 
(G2 phase) immediately, whereas the new swarmer cell is motile but blocks replication for an extended 
period called G1 phase. Replication and division resume when the swarmer cell differentiates into a 
stalked cell, a process during which it ejects its flagellum, retracts its pili and replaces them with a holdfast 
and a stalk [113] (Figure 2).  
Recent studies identified c-di-GMP as a major driver of pole morphogenesis and cell cycle control in C. 
crescentus [9,114,115]. Mutants that were unable to synthesize c-di-GMP lost all polar appendages and 
showed marked cell morphology aberrations [115]. 
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Figure 2 | Role of c-di-GMP in C. crescentus pole morphogenesis and cell cycle progression. A schematic of the cell cycle 
of Caulobacter crescentus is shown in the middle of the figure and individual panels highlight stage-specific processes at 
the stalked and flagellated poles. Motile, flagellated swarmer cells have a replication arrest (G1 phase) before 
differentiating into a sessile stalked cell and entering S phase and subsequently dividing. Dividing C. crescentus cells are 
highly polarized, with a stalk and adhesive holdfast exposed at one cell pole and a flagellum, pili and chemotaxis 
apparatus assembled at the opposite pole. The replication status of the circular chromosome is indicated schematically, 
with swarmer cells being replication silent, whereas chromosome replication initiates in stalked cells. Bacteria use cyclic 
di-GMP (c-di-GMP) to control pole morphogenesis and developmental transitions. This is achieved through the 
asymmetric, cell type-specific distribution of c-di-GMP. Levels of c-di-GMP oscillate during the cell cycle ofC. crescentus, 
with trough values in the motile swarmer cell, a peak during the swarmer-to-stalked cell transition and intermediate 
concentrations during cell division. Changes in c-di-GMP concentration are controlled by the opposing action of the 
diguanylate cyclase (DGC) PleD and the phosphodiesterase (PDE) PdeA. The subcellular localization of PleD, PdeA, the 
flagellar placement protein TipF, and the sensor histidine kinases PleC, DivJ and CckA are marked at individual stages of 
the cell cycle. (A) Flagellar assembly. Following binding to c-di-GMP, TipF binds to its polar receptor TipN (not shown) 
to localize to the cell pole, where it recruits the flagellar components PflI and FliG to initiate flagellar assembly. (B) Low 
levels of c-di-GMP at the flagellated pole of dividing cells and in swarmer cells promote the degradation of TipF by the 
ClpXP protease and promote the kinase activity of cell cycle kinase A (CckA). CckA activates CtrA through the 
phosphotransferase ChpT. Phosphorylated CtrA inhibits replication initiation by binding to the C. crescentus origin of 
replication (Cori). PdeA and as-yet-unidentified PDEs contribute to the decrease in the concentration of c-di-GMP at this 
stage of the cell cycle. PleC histidine kinase inhibits the phosphorylation of PleD in swarmer cells, and thus contributes to 
the decrease in the levels of c-di-GMP (see the central panel). (C) During differentiation into stalked cells, CtrA is 
inactivated and chromosome replication is initiated. PdeA and CtrA are degraded by the ClpXP protease. The ClpXP 
protease adaptor PopA binds to c-di-GMP and delivers CtrA to the protease. PleD and as-yet-unidentified DGCs 
contribute to the increase in c-di-GMP levels following entry into S phase and in the predivisional cell. The histidine kinase 
DivJ promotes the phosphorylation of PleD in stalked cells and thus contributes to the increase in c-di-GMP levels. (D) 
The inactivation of CtrA by the CckA phosphatase during the swarmer-to-stalked cell transition and at the stalked pole of 
the dividing cell. The binding of c-di-GMP to the catalytic domain of the histidine kinase CckA causes a switch from its 
default kinase activity to its S phase-specific phosphatase activity. This reverses the phosphate flux through the CckA– 
ChpT–CtrA cascade and leads to the inactivation of CtrA.  
 
 
Levels of c-di-GMP oscillate during the cell cycle of C. crescentus, with trough values in the motile 
swarmer cell, a peak during the swarmer-to-stalked cell transition and intermediate concentrations 
during division [105,115] (Figure 2). The increase in the concentration of c-di-GMP during the swarmer-
to-stalked cell transition is mainly promoted by PleD, which is a DGC that is activated by 
phosphorylation when cells enter S phase [115,116]. The activity of PleD is confined to the stalked cell by 
two antagonistic histidine kinases, PleC and DivJ, which are positioned at opposite poles of dividing cells 
and differentially segregate into swarmer cell and stalked cell progenies (Figure 2). Whereas PleC 
functions as a phosphatase that keeps the levels of phosphorylated PleD low in swarmer cells, DivJ 
functions as a kinase to drive the phosphorylation of PleD in stalked cells [116]. In addition, counteracting 
PDEs are thought to keep c-di-GMP levels low in the motile swarmer cell. One of these PDEs, PdeA, 
localizes to the flagellated pole before division and later partitions into the new swarmer cell, in which it 
promotes motility by keeping c-di-GMP levels low. PdeA is removed by specific proteolysis during the 
swarmer-to-stalked cell transition, which coincides with the activation of PleD, thereby contributing to 
the sharp increase in c-di-GMP at this stage of the cell cycle [114].  
But how does the oscillation of c-di-GMP instigate the exact timing of cell cycle events in C. crescentus? 
One example is illustrated by the TipF–TipN pathway, which regulates flagellar polarity. Following the 
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binding of c-di-GMP, TipF localizes to the pole opposite to the stalk, where it binds to its polar receptor, 
the birth scar protein TipN [117] (Figure 2A). TipF then recruits flagellar proteins to this subcellular site 
to initiate flagellar assembly in the pre-divisional cell. TipF is stable when bound to c-di-GMP but is 
rapidly degraded when c-di-GMP levels decrease in the swarmer cell (Figure 2B). The removal of TipF 
was proposed to reset the flagellar polarization state and avoid incorrect positioning of the flagellar 
motor at the incipient stalked cell pole [117]. Recent studies also linked oscillations of c-di-GMP to the 
G1–S phase transition and control of chromosome replication [9]. The transcription factor cell cycle 
transcriptional regulator A (CtrA) is phosphorylated and active in swarmer cells (G1 phase) in which it 
binds to the C. crescentus origin of replication (Cori) to block replication initiation [113] (Figure 2B). 
During differentiation into stalked cells, CtrA is inactivated and replication is initiated. The activity of 
CtrA is controlled by the bifunctional cell cycle histidine kinase CckA, which phosphorylates and thus 
activates CtrA through the phosphotransferase protein ChpT. CckA exhibits kinase activity in the 
swarmer cell but adopts marked phosphatase activity during the G1–S transition, thereby reversing the 
phosphate flux through the CckA–ChpT–CtrA cascade and inactivating CtrA. Concurrent with its 
dephosphorylation, CtrA is degraded by the ClpXP protease [113] (Figure 2C). Both the 
dephosphorylation and degradation of CtrA are controlled by the increase in c-di-GMP during the G1–
S phase transition. The degradation of CtrA is mediated by the ClpXP protease adaptor PopA, which 
binds to c-di-GMP and delivers CtrA to the protease [88,118,119], whereas the dephosphorylation of CtrA 
results from c-di-GMP directly interfering with the CckA kinase–phosphatase switch (Figure 2D). 
Biochemical and structural studies have shown that c-di-GMP binds to the catalytic and ATP-binding 
domain of CckA, thereby inhibiting its default kinase activity and stimulating its phosphatase activity 
[9,120]. By controlling a key cell cycle kinase to drive the G1–S phase transition in C. crescentus, c-di-GMP 
has adopted a role similar to cyclins in eukaryotes, which drive the cell cycle by regulating the activity 
of cyclin-dependent kinases [121]. Moreover, c-di-GMP spatially controls the activity of CckA during 
division to promote the asymmetric replication of future daughter cells. In predivisional cells, CckA 
localizes to opposite cell poles, adopting kinase and phosphatase activity at the flagellated and stalked 
pole, respectively (Figure 2). This leads to a gradient of phosphorylated CtrA in the cell and to the 
asymmetric initiation of replication, with Cori at the stalked cell pole being activated before cell division 
is completed, whereas the Cori at the flagellated pole remains inactive [122,123]. The asymmetric 
distribution of c-di-GMP was proposed to control the differential activity of CckA at opposite poles. 
Although the bulk of dividing cells experience high levels of c-di-GMP, a microenvironment that has low 
levels of c-di-GMP was proposed to promote the kinase activity of CckA at the flagellated pole [9] (Figure 
2). The authors of this study proposed that this mechanism could shield CckA molecules that are 
sequestered to the flagellated pole from the cellular pool of c-di-GMP. How such a microenvironment 
with low c-di-GMP levels is organized and which PDEs are involved in this spatial control remain to be 
shown. 
The asymmetric distribution of c-di-GMP during cell division was also observed in other bacteria, which 
argues that this might represent a general principle to control cell behavior and/or reproduction [105]. 
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For example, during the cell cycle of P. aeruginosa, c-di-GMP levels decrease a short period after cell 
division in the daughter cell that inherits the polar flagellum. This pattern is caused by the asymmetric 
distribution of Pch, which is a PDE that localizes to the chemotaxis machinery at the flagellated cell pole 
during division [106]. Similar to the G1 phase of the cell cycle of C. crescentus, a decrease in c-di-GMP at 
this stage of the cell cycle of P. aeruginosa may promote diversity in the swimming behavior, which, in 
turn, could help P. aeruginosa to adapt to new environments. In addition to contributing to cell polarity 
and the determination of cell fate in unicellular bacteria, c-di-GMP also controls complex multicellular 
behavior in bacteria. For example, streptomycetes undergo an elaborate life cycle with two distinct 
filamentous cell forms. Germinating spores develop into vegetative hyphae, which grow into a substrate 
to scavenge nutrients. Following nutrient depletion, aerial hyphae are formed, which eventually 
differentiate into long chains of spores [124]. Recently, c-di-GMP was found to have a key role in the 
transition from vegetative mycelial growth to the formation of a reproductive aerial mycelium [85]. The 
deletion of genes that encode proteins that are involved in the metabolism of c-di-GMP had a notable 
effect on colony morphology and development [124]. Moreover, increasing internal levels of c-di-GMP 
blocked development, whereas decreasing levels of c-di-GMP caused premature spore production by 
bypassing the formation of aerial hyphae [85]. Premature sporulation is also observed in mutants that 
lack BldD, the master regulator of Streptomyces development that represses a global regulon of 
approximately 170 sporulation genes [124]. Recently, a direct connection between these two key 
components of developmental control was identified when BldD was shown to be a c-di-GMP effector 
protein that represses its target genes in a manner that is dependent on c-di-GMP binding [85]. Thus, a 
decrease in cytoplasmic levels of c-di-GMP may cause the disassembly of the BldD dimer and its 
inactivation, and thus the induction of sporulation genes. Other studies in Myxococcus xanthus [92,125], 
Bdellovibrio bacteriovorus [126] and cyanobacteria [127] further highlight the broad effect of c-di-GMP on 
development and morphogenesis in bacteria.  
 
 
Motile-sessile transition and biofilm formation 
Controlling the motile–sessile transition of bacteria is a universal feature of c-di-GMP. Generally, low 
levels of c-di-GMP are associated with the motility of individual cells, whereas increased concentrations 
of c-di-GMP promote surface attachment and the formation of biofilms. However, rather than being a 
simple on–off switch, complex regulatory steps seem to be involved in a multistage process that leads to 
surface colonization [128].  In line with the idea that motility is one of the primary processes that is 
targeted by c-di-GMP, the assembly and activity of the bacterial flagellar motor is highly regulated by 
this second messenger. This includes the regulation of flagellar gene expression [83,84], motor assembly 
[98,117] and motor function [78,129]. Although controlling flagellar gene expression is likely to be part 
of a long-term adaptation strategy, tuning motor activity might be important for bacteria to rapidly 
change their behavior during the colonization of a surface. 
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Figure 3 | Role of c-di-GMP in biofilm formation and dispersal. Bacterial surface attachment, biofilm formation and 
dispersal are indicated schematically in thecentral panel. (A) Cyclic di-GMP (c-di-GMP)-mediated control of flagellar 
motility in Escherichia coli. In its c-di-GMP-bound form, the c-di-GMP effector YcgR interacts with and curbs the flagellar 
motor, which leads to the obstruction of motor function. PdeH inactivates YcgR by keeping c-di-GMP levels low and 
thereby enabling motor function.(B) c-di-GMP-dependent production of the biofilm matrix components amyloid curli 
fibers and cellulose in E. coli. The global DgcE and PdeH module controls the overall levels of c-di-GMP, and increased 
levels of the second messenger are sensed by the local DgcM and PdeR module to activate the transcription factor MlrA. 
This transcription factor induces the expression of the global transcription factor CsgD, which then activates the expression 
of curli components and DgcC. In turn, DgcC stimulates the synthesis of c-di-GMP, which allosterically activates the 
production of cellulose by binding to the BcsA–BcsB complex. (C) c-di-GMP-mediated synthesis of the alternative 
exopolysaccharide poly-β-1,6-N-acetyl-glucosamine (PGA) in E. coli. The biogenesis and secretion of PGA require the Pga 
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complex, which comprises the two transmembrane proteins PgaA and PgaB, and the two inner membrane components 
PgaC and PgaD. The carbon storage regulator (Csr) global regulatory system represses the pga genes, which encode 
components of the PGA synthesis machinery (PgaA, PgaB, PgaC (represented by single letter ‘C’ in this panel) and PgaD 
(represented by single letter ‘D’ in this panel)), and dgcT and dgcZ, which encode two diguanylate cyclases (DGCs) that 
are responsible for the allosteric activation of PgaC and PgaD. The histidine kinase BarA is stimulated by short-chain fatty 
acids and activates the expression of two small RNAs, CsrB and CsrC, through the phosphorylation of the response 
regulator UvrY. In turn, CsrB and CsrC antagonize the translation inhibitor CsrA and thus enable the expression of pga, 
dgcT and dgcZ. Intracellular levels of c-di-GMP increase through the action of DgcT and DgcZ. The binding of c-di-GMP 
to PgaC and PgaD allosterically activates the Pga complex. (D) Biofilm dispersal mechanism in Pseudomonas fluorescens 
Pf01. The LapA surface protein mediates surface adhesion and contributes to the stabilization of biofilms in P. fluorescens. 
Under conditions of phosphate starvation, LapA is degraded by the periplasmic protease LapG, which results in biofilm 
dispersal. If enough phosphate is available, LapG is sequestered by its partner LapD in its c-di-GMP-bound conformation. 
When phosphate becomes limited, the phosphodiesterase (PDE) RapA is expressed through the Pst–PhoR–PhoB 
phosphate control system, which leads to a decrease in the levels of c-di-GMP, a conformational change in apo-LapD and 
the release of the LapG protease, which cleaves the LapA adhesin. pGpG, 5′-phosphoguanylyl-(3′-5′)-guanosine.  
 
 
For example, in E. coli and Salmonella enterica subsp. enterica serovar Typhimurium, increased levels of c-
di-GMP result in the obstruction of motor function by the c-di-GMP effector protein YcgR, which, in its 
c-di-GMP-bound form, interacts with the flagellar rotor–stator interface [78,130,131] (Figure 3A). To 
block the activity of YcgR and promote swimming, these bacteria co-express the PDE PdeH and flagellar 
genes. A similar mechanism was proposed to tune motility in B. subtilis, in which PdeH controls motility 
by preventing flagellar obstruction by the YcgR homologue DgrA [132]. YcgR homologues also control 
flagellar function in pseudomonads [133,134]. Intriguingly, in P. aeruginosa, the YcgR homologue FlgZ 
controls swarming motility by specifically interacting with the MotC–MotD flagellar stator, which is 
required for surface-associated motility [133]. YcgR in E. coli exhibits high binding affinity for c-di-GMP, 
which suggests that small spikes in the level of c-di-GMP are sufficient to adjust the flagellar motor and 
to initiate surface attachment. Consecutive steps of surface colonization may involve an incremental 
increase in the level of c-di-GMP and the sequential activation of distinct cellular processes, such as 
surface motility or the production of adhesins and components of the biofilm matrix. This could be 
accomplished through the successive involvement of DGCs that have distinct levels of feedback 
inhibition [57] and through the activation of c-di-GMP receptors that have gradually decreased affinities 
[135]. For example, in P. aeruginosa, different DGCs, PDEs and effector proteins are required at discrete 
stages of biofilm formation [128].  
On contact with a surface, bacteria rapidly change their behavior, expose adhesins, activate surface 
organelles and produce an extracellular matrix to protect developing microcolonies. This adaptation is 
coordinated by c-di-GMP at the transcriptional (see, for example, Ref. [136]), translational (see, for 
example, Ref. [137]) and post-translational levels (see, for example, Ref. [110]). For example, c-di-GMP 
regulates type IV pili (T4P), which are the prototypical surface adherence and motility organelles, in 
various bacteria, including M. xanthus [138], V. cholerae [95], P. aeruginosa [139], C. crescentus [115] or 
Clostridium difficile [140] (see below). Similarly, in E. coli, the production of the two principal biofilm 
matrix components — curli fibers and cellulose — is regulated by c-di-GMP [141]. During biofilm 
formation, c-di-GMP levels increase as a result of σS (also known as RpoS)-induced expression of DgcE 
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(formerly known as YegE) [77] and other DGCs, and the consecutive downregulation of the PDE PdeH 
(formerly known as YhjH) [77], which acts as a gatekeeper for motility and is part of the large flagellar 
regulon [78,142].  
 
 
Box 5 | 3rd aim of this thesis 
 
In response to environmental changes, bacteria frequently switch their lifestyle from a motile single-cell to a 
community-based surface attached lifestyle. This is achieved through downstream effectors, which bind c-di-GMP 
to elicit the corresponding cellular function. As c-di-GMP acts primarily on the post-translational level and many 
effector proteins have binding affinities in the low to mid nanomolar range, c-di-GMP is able to stage a rapid and 
hypersensitive response. Given that many bacterial species harbor a whole array of DGCs and PDEs, this raises the 
problem of network robustness. How is a deterministic cellular response ensured and buffered against stochastic 
noise in expression and activity of DGCs and PDEs? 
In this work, we studied PdeL from E. coli, a protein with dual role as transcription factor and c-di-GMP specific 
phosphodiesterase. We ask, whether PdeL acts as a buffer for c-di-GMP noise to facilitate rapid and robust lifestyle 
transitions in E. coli. 
 
 
Increased global levels of c-di-GMP induce a local control module that consists of DgcM and the trigger 
enzyme PdeR (Box 6), which form a DGC–PDE pair that directly interacts with and stimulates the 
transcription factor MlrA (Figure 3B); this activates the expression of the central curli regulator CsgD. 
Interestingly, PdeR and DgcM do not primarily exhibit a catalytic role but rather sense the global increase 
in c-di-GMP and function as co-activators for MlrA [80]. CsgD then induces the transcription of curli 
genes and dgcC, which encodes the primary DGC that stimulates the synthesis of c-di-GMP, which, in 
turn, allosterically activates the production of cellulose by binding to the BcsA–BcsB complex [65] (Figure 
1E, 3B). This is a key example of how different levels of the c-di-GMP signaling network are 
interconnected to gradually activate and coordinate a cellular response, which, in this case, tunes the 
expression of matrix components. An alternative exopolysaccharide, poly-β-1,6-N-acetylglucosamine 
(PGA), can promote surface adherence and biofilm formation in E. coli. The biogenesis and secretion of 
PGA require the PGA complex (comprising PgaA, PgaB, PgaC and PgaD) and its allosteric activation by 
c-di-GMP. Both the pgaABCD operon and the genes that encode the two DGCs, DgcT and DgcZ, are 
controlled by the carbon storage regulator (Csr) system, a global regulatory system that mediates 
virulence and biofilm formation in E. coli [143]. Recent findings indicate that c-di-GMP activates the PGA 
complex by binding directly to both PgaC and PgaD, which are the two inner membrane components of 
the PGA complex, to stimulate their glycosyltransferase activity [110] (Figure 3C).  
Although the processes that drive biofilm formation are relatively well understood, the mechanisms that 
underlie biofilm dispersal have remained understudied. Given the prominent role of c-di-GMP in biofilm 
formation, careful control of the levels of this second messenger must also be linked to active biofilm 
dispersal [144]. A potential escape mechanism was identified in Pseudomonas fluorescens, in which the 
LapA surface protein mediates surface adhesion and the stabilization of biofilms [145]. At high c-di-GMP 
levels, c-di-GMP binds to LapD to help sequester the LapG protease in the periplasm. When c-di-GMP 
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levels decrease following the induction of the PDE RapA, LapD is inactivated, thereby releasing the 
protease to cleave the LapA adhesin and weaken the biofilm (Figure 3D).  
As biofilms contribute to acute and chronic infections, it is not surprising that the c-di-GMP network is 
under selective pressure in human patients. Slow-growing autoaggregative P. aeruginosa isolates from 
the respiratory tracts of patients with cystic fibrosis were shown to have mutations that lead to marked 
activation of some of the major DGCs [146,147]. The observation that such variants effectively persisted 
in animal models and in the presence of subinhibitory concentration of antibiotics, despite decreased 
growth rates in vitro, indicated that they may have an important role in persistence during antimicrobial 
chemotherapy [146]. 
 
 
Box 6 | Moonlighting enzymes 
 
The term moonlighting originates from proteins, which, apart from their primary, have a secondary (unrelated) 
function [148,149]. Up to date many moonlighting enzymes have been described such as in C. crescentus, where the 
essential metabolic enzyme CtpS is an integral cytoskeletal component contributing to the crescentoid shape. In this 
particular case the enzyme activity does not affect cell-shaping, since mutations in the active site residues still 
retained its ability to form cytoskeletal filaments [150]. Moonlighting enzymes are also represented in transcription 
factors. A prominent example is the metabolic enzyme and transcription factor PutA, which is present throughout 
many bacterial species including E. coli. PutA catalyzes the first step in the proline degradation pathway, namely 
the irreversible conversion of L-proline to (S)-1-pyrroline-5-carboxylate. In its reduced and proline-bound state, 
PutA localizes to the membrane where it functions as an enzyme, whereas oxidation and absence of proline leads to 
translocation of PutA to the DNA to repress expression of the put operon [151,152]. This mechanism allows PutA to 
entirely shut off its expression once proline is depleted, to which PutA itself contributes. 
In both examples the two functions are mutually exclusive and the enzymatic activity is functionally uncoupled 
from transcription or generation of cytoskeletal elements in the case of CtpS. However, in the previously described 
example, of c-di-GMP-dependent csgD expression this is not the case. The primary role of the PDE PdeR is not to 
deplete the cellular c-di-GMP pool but rather to translate the c-di-GMP status of the cell into further downstream 
signaling. Thus both functions of PdeR are functionally coupled, since the authors showed that abolished c-di-GMP 
binding of PdeR fully abrogated c-di-GMP-dependent csgD transcription [80]. This functional coupling defines a 
special class of moonlighting enzymes, namely ‘trigger enzymes’. 
 
 
Role of c-di-GMP in bacterial virulence 
The virulence of animal and plant pathogens has been shown to be modulated by c-di-GMP [54]. 
Processes that are controlled by c-di-GMP include host cell adherence, the secretion of virulence factors, 
cytotoxicity, invasion, resistance to oxidative stress and the modulation of the immune response of the 
host. Importantly, recent findings have linked c-di-GMP to the most prominent secretion systems for 
virulence factors, including T2SSs, T3SSs and T6SSs [94,97,98]. This opens up the possibility that c-di-
GMP interferes with these processes on a more global scale. Studies in C. difficile have highlighted the 
importance of c-di-GMP in virulence. In contrast to most gram-positive bacteria, C. difficile encodes 
numerous enzymes that are involved in the turnover of c-di-GMP [153]. During the course of infection, 
C. difficile undergoes a c-di-GMP-mediated switch from a motile to a surface-adherent state, whereby 
cells adhere to the intestinal mucosa through T4P and other adhesins [154]. This transition is mediated 
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by a total of 16 c-di-GMP-responsive riboswitches, 12 of which are off switches (type I) and four are on 
switches (type II) [155]. Through these regulatory elements, c-di-GMP controls the expression of flagella, 
pili, adhesion factors and other virulence factors, including the toxins TcdA (also known as ToxA) and 
TcdB, which are the main virulence factors of C. difficile [140,155-158] (Figure 4). For example, a collagen-
binding protein (CBP) and its specific protease are inversely controlled by type I and type II riboswitches, 
respectively [155]. Expression of the protease at low c-di-GMP concentrations effectively prevents host 
cell adherence, whereas expression of the CBP at high c-di-GMP concentrations promotes attachment to 
host tissue. Thus, c-di-GMP-mediated riboswitches control C. difficile host colonization by coordinating 
motility, toxin production, surface adhesion and biofilm formation.  
 
 
 
Figure 4 | Role of c-di-GMP in the virulence of Clostridium difficile. Cyclic di-GMP (c-di-GMP)-mediated riboswitches 
control host colonization by Clostridium difficile. Type I riboswitches and type II riboswitches control the expression of 
factors that are involved in motility, surface attachment and virulence, including the toxins TcdA and TcdB. Type I 
riboswitches (off switches) inhibit translation following the binding of c-di-GMP, whereas type II riboswitches (on 
switches) promote the translation of target genes when bound to c-di-GMP. Increasing levels of c-di-GMP stimulate the 
expression of adhesion factors, such as type IV pili and collagen-binding proteins (CBP), and inhibit the expression of 
flagellar genes and the CBP protease to promote host colonization. When the concentration of c-di-GMP is low, cells 
express motility and anti-adhesion genes. In addition, the gene that encodes the sigma factor SigD is co-regulated with 
flagellar genes, leading to the expression of the SigD-dependent toxins TcdA and TcdB, which are the main virulence 
factors of C. difficile.  
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The prominent role of c-di-GMP in virulence is exemplified by the outbreak of E. coli O104:H4 in 
Germany in 2011, which caused an unusually high incidence of haemolytic uraemic syndrome (HUS) 
[159]. The genome of the causative strain showed characteristics of both enterohaemorrhagic E. coli 
(EHEC) and enteroaggregative E. coli (EAEC), and revealed the presence of a highly-expressed DGC 
(encoded by dgcX), which is prevalent in EAEC O104:H4 strains [160]. This indicated that the outbreak 
strain and EAEC in general produce high levels of c-di-GMP and are likely to form biofilms in the host. 
The observation that dgcX is inserted at the attB locus, the integration site for phage λ, and is flanked by 
prophage elements, suggested that the gene was acquired by horizontal gene transfer. The analysis of E. 
coli O104:H4 also emphasized the key importance of adaptation and regulatory flexibility of the c-di-
GMP network. Although marked adherence, together with the expression of Shiga toxin, is a key 
virulence factor of E. coli O104:H4, this strain produces curli but is cellulose negative. The authors of this 
study speculated that the marked pro-inflammatory effect of curli, together with the absence of cellulose 
(which normally counteracts this effect), may facilitate entry into the bloodstream and kidneys, in which 
this pathogen can cause life-threatening HUS [160].  
Given their widespread abundance in bacteria and their importance in bacterial virulence, it is not 
surprising that bacterial CDNs are sensed by the immune system of the host. Recent evidence suggests 
a prominent role for c-di-GMP and c-di-AMP as pathogen- associated molecular patterns (PAMPs), 
which are specifically recognized by the innate immune system of the host (Box 1).  
 
 
 
Conclusion and outlook 
This introduction summarized some of the recent findings that describe the mechanistic and functional 
aspects of c-di-GMP signaling in bacteria. Although c-di-AMP was discovered more recently, the field is 
rapidly advancing and exposing a physiological complexity that is comparable to the c-di-GMP network 
(Box 1). It is possible that additional CDNs still await discovery, providing even greater signaling 
diversity by varying either the nucleotide composition or linkage chemistry. However, why are CDNs 
so prevalent in the control of important biological processes in bacteria? One major advantage of second 
messenger-based networks over other information-transfer systems that are based on protein–protein 
interactions might be the ease with which they are able to evolve. For example, the recruitment of 
additional cellular processes into an existing c-di-GMP network seems relatively straight-forward, 
considering that c-di-GMP often binds to the surface of pre-existing protein domains with only a few 
amino acids that contribute to ligand affinity and specificity (Figure 5A). Simple recruitment of 
additional effectors, together with the rapid expansion of makers and breakers by gene duplication, 
might thus have predisposed CDN-based regulatory networks for the coordination of global metabolic 
and behavioral transitions in bacteria.  
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CDN-based second messengers also provide various advantages in signal transduction. On the one hand, 
their rapid cellular diffusion stages an instantaneous and global internal response. On the other hand, 
CDNs may act in a highly specific manner either through temporal or spatial control [161,162]. For 
example, the combination of DGCs or PDEs that have distinct inhibition constants and substrate 
affinities, respectively, together with effector proteins or RNAs of matching c-di-GMP affinities would 
permit cells to regulate different processes in a highly specific manner (Figure 5B). 
 
 
 
 
Figure 5 | General concepts of c-di-GMP signaling modules. (A) Evolutionary diagram of the incorporation of a new 
cellular process into an existing cyclic dinucleotide (CDN) network. Minor modifications to the surface of a specific protein 
can mediate the specific binding of cyclic di-GMP (c-di-GMP; rendering it an effector protein (E)), which, in turn, can 
modulate the activity and stability of the protein (E2) or its interaction with a partner (E–E′). (B), (C) The network 
architecture that is involved in pathway-specific signaling. c-di-GMP-dependent processes can be specifically regulated 
by temporal (part B) or spatial (part C) separation. Temporal regulation can depend on effector proteins with different 
ligand-binding affinities (Kd) and on diguanylate cyclases (DGCs) and/or phosphodiesterase (PDEs) with specific 
inhibition (Ki) and activation constants (Km), respectively. This mode of regulation establishes precise cellular thresholds 
of c-di-GMP levels, thereby activating specific downstream effectors and pathways. Spatially separated signaling relies on 
some form of compartmentalization. For example, a specific DGC–PDE module (DGC1–PDE1 or DGC2–PDE2) interacts 
with its specific effector (E1 or E2, respectively). To avoid unwanted crosstalk between individual DGC–PDE modules and 
other effectors and cellular pathways, spatially confined modules need to be effectively separated. This can occur through 
the action of the module-specific PDE (PDE1 or PDE2) or by a general cellular PDE that prevents the leakage of c-di-GMP 
into other compartments. (D) c-di-GMP can control the same biological process at different levels. For example, c-di-GMP 
can control gene expression (transcription and translation) or the activity of one of the resulting proteins. Expression and 
allosteric control can be mediated by the same module, comprising a DGC and PDE, or can be modulated independently 
by different DGC and PDE modules. c-di-GMP molecules are indicated as blue circles or as a spatial gradient in part C.  
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Alternatively, the spatial organization of DGCs and/or PDEs that interact directly with their respective 
targets, together with effective mechanisms that isolate individual signaling modules from each other, 
would permit parallel CDN signaling modules with highly specific readouts (Figure 5C). CDNs, such as 
c-di-GMP, control the expression, activity, stability, localization and interaction of specific proteins (see, 
for example, Refs. [85,110,117,163]). Moreover, c-di-GMP can control the same biological process at 
different levels, including transcriptional and translational control or allosteric control (Figure 5D; see, 
for example, Ref. [94]). Such a multilayered signaling architecture can impose tight control over strictly 
unidirectional cellular processes, such as cell cycle progression, or processes that have considerable 
metabolic cost, such as the motile–sessile switch. It also enables bacteria to rapidly sample the 
environment and adjust their behavior without the need for de novo protein synthesis. In addition, the 
c-di-GMP network could function to integrate two distinct processes but, at the same time, uncouple 
them if necessary through the use of distinct DGC–PDE modules (Figure 5D). An example of such a 
process is illustrated by the production of curli and cellulose in E. coli (see above). Finally, this signaling 
network could be used to define activity windows for specific cellular processes; for example, by the 
sequential control of gene expression (module 1) and inactivation of a downstream effector (module 2), 
which is either turned off by c-di-GMP or subject to c-di-GMP-mediated degradation.  
Despite the advances in the field of CDN research, important questions remain to be addressed in the 
future. For example, are there additional CDNs to be included in this emerging signaling paradigm? 
Which cellular activities do specific CDN networks control and how extensively do these compounds 
interfere with basic cellular processes in bacteria? What are the important environmental input signals 
that control these regulatory systems? What is the exact architecture of CDN networks and how do they 
contribute to the highly dynamic behavior of bacterial cells? Finally, how are CDN-based networks 
integrated with other signaling networks, such as quorum sensing pathways, phosphorylation cascades 
or ppGpp-dependent pathways? It is safe to predict that this field of research will continue to provide 
exciting novel insights into bacterial signaling, growth and behavior. Future steps should include the 
development of tools to quantitatively describe CDN network dynamics. This will provide the basis for 
the mathematical description of these systems and eventually afford the predictive power to 
experimentally test and refine important network parameters. Moreover, the field has now advanced 
sufficiently to re-evaluate the therapeutic potential of CDNs. For example, agonists of the host receptor 
stimulator of interferon genes (STING) are currently being explored as candidate stimulants for 
anticancer immune activity [164]. Given that STING has been shown to bind to c-di-GMP and c-di-AMP 
(Box 1), similar approaches could be assessed as strategies for the treatment of bacterial infections 
[165,166]. 
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Abstract 
The second messenger cyclic di-GMP is a near-ubiquitous signaling molecule that globally alters bacterial 
cell physiology to promote biofilm formation and community behavior. Much progress was made in 
recent years towards the identification and characterization of diguanylate cyclases and 
phosphodiesterases, enzymes involved in the synthesis and degradation of this signaling compound. In 
contrast, our knowledge of the nature and mechanistic details of c-di-GMP effector proteins lags behind, 
primarily because effective tools for their specific enrichment and rapid analysis are missing. In this 
report, we demonstrate that a novel tri-functional c-di-GMP-specific Capture Compound (cdG-CC) can 
be effectively used to identify and validate c-di-GMP binding proteins. The cdG-CC was able to 
specifically and efficiently pull down bona fide c-di-GMP effector proteins. Furthermore, in combination 
with mass spectrometry (CCMS), this technology robustly identified a substantial fraction of the known 
c-di-GMP signaling components directly from cell extracts of different model organisms. Finally, we 
applied the CCMS technique to profile c-di-GMP binding proteins of Pseudomonas aeruginosa and 
Salmonella enterica serovar typhimurium. Our studies establish CCMS as a powerful and versatile tool to 
identify and analyze components of the cellular c-di-GMP pathway in a wide range of different 
organisms.   
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Technical note 
Cyclic di-GMP is a ubiquitous second messenger regulating growth and behavior of a wide range of 
gram-positive and gram-negative bacteria. In particular, c-di-GMP mediates the switch between single 
cell behavior and a community lifestyle called biofilm, which is often associated with chronic infections 
of bacterial pathogens [167]. Major components of the regulatory network are the GGDEF, EAL, and HD-
GYP domains that are widespread in bacteria and catalyze c-di-GMP synthesis and degradation, 
respectively [168]. The list of cellular processes controlled by c-di-GMP is ever-increasing and includes 
the biosynthesis and secretion of surface adhesins and exopolysaccharide (EPS) matrix components, 
different forms of cellular motility, long-term survival and response to environmental stress, synthesis 
of secondary metabolites, regulated proteolysis and cell cycle progression, delivery of anti-bacterial 
toxins, intracellular growth and the production of virulence factors in a range of animal and plant 
pathogens [82,168,169]. Despite of this wide variety of cellular functions that are modulated by c-di-GMP, 
the list of effector proteins has remained relatively sparse [82,168,169]. These include PilZ, small switch-
like domains that undergo conformational change upon binding c-di-GMP. In addition, several members 
of the CRP/FNR and response regulator superfamilies of transcription regulators were shown to 
specifically bind c-di-GMP. Finally, a subgroup of GGDEF and EAL domains was recognized as c-di-
GMP effector proteins adopting their novel functionality through the combined loss of catalytic activity 
and exploitation of their allosteric and active site binding pockets, respectively. While most known 
effector proteins were discovered through an “educated guess” approach that was based on their 
functional linkage to c-di-GMP mediated cellular processes, unbiased screening for novel effectors was 
hampered primarily by the lack of reliable and effective biochemical tools for their enrichment and 
isolation. Only one global recent study used a chemical proteomics approach to identify c-di-GMP 
binding proteins in P. aeruginosa [109]. Here we introduce a novel tri-functional capture molecule (cdG-
CC) as an effective tool to identify specific c-di-GMP binding proteins directly from a complex mixture 
of macromolecules. The compound is based on a chemical scaffold harboring specificity, reactivity, and 
sorting properties (Figure 1A) [170,171]. C-di-GMP provides the selectivity for capturing proteins. Upon 
UV irradiation, the photo-reactivity group forms a highly reactive nitrene [172] that interacts with 
proteins bound by the selectivity function, thereby forming an irreversible covalent crosslink. Biotin as 
sorting function then allows for the efficient and facile isolation of the captured proteins by binding of 
the compound to streptavidin coated magnetic beads.  
These results encouraged us to probe if the capture compound can be applied for the selective enrichment 
of c-di-GMP binding proteins from a more complex mixture of proteins. To test this, we captured soluble 
c-di-GMP binding proteins from cell extracts and probed immunoblots with PopA specific antibodies. 
PopA is a GGDEF effector protein that regulates cell cycle progression in C. crescentus in response to a 
cellular upshift of c-di-GMP during the G1-S phase transition [88,114]. 
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Figure 1 | The cdG-CC can specifically pull down bona fide c-di-GMP binding proteins from purified and from crude 
cell extracts. (A) Chemical structure of cdG-CC. (B) Immunoblot of purified and captured DgrA (wt), DgrA W75A and 
DgrA RR11AA. In all capture experiments 10 µM cdG-CC was present, in competition experiments the proteins were 
preincubated with a 100x excess of c-di-GMP (cdG) or GTP. All proteins were His-tagged and detected using anti-His 
antibodies. (C) Immunoblot of PopA. PopA (wt) or the PopA I-site mutant R357G was expressed in NA1000 ∆popA (lanes 
marked with ‘proteins’; note that this I-site mutant is less abundant in the cell). PopA was captured in the presence of 3 
µM cdG-CC. Addition of 1 mM c-di-GMP but not 1 mM GTP prevented the binding to the cdG-CC. In contrast the PopA 
I-site mutant could not be captured at all. PopA was detected using anti-PopA antibodies. 
 
 
To bind c-di-GMP PopA utilizes a conserved and well-defined binding pocket, which, in related catalytic 
GGDEF domains, is used as an allosteric I-site for product inhibition of the diguanylate cyclase (DGC) 
activity [55,57]. As shown in Figure 1C, PopA with a known Kd for c-di-GMP of 2.5 µM, was readily 
captured from C. crescentus cell lysates using 3 µM cdG-CC and a total of 400 µg soluble protein. Pull 
down of PopA was inhibited in the presence of a large excess of c-di-GMP (1 mM), while GTP did not 
interfere with cdG-CC binding (Figure 1C), arguing that the cdG-CC interaction with PopA is highly 
specific. Likewise, no PopA was bound to the cdG-CC when using a strain expressing a PopA mutant 
that lacks the highly conserved Arg residue of the canonical RxxD I-site binding motif (R357G) [88] 
(Figure 1C). This indicated that the cdG-CC can enrich c-di-GMP binding proteins directly from whole 
cell extracts in a highly specific manner and that this compound is suited for a global isolation procedure 
of c-di-GMP binding proteins. Therefore, we combined capture experiments with the analysis of isolated 
proteins by LC–MS/MS (CCMS, [170,171]). When applying 10, 5 or 2.5 µM cdG-CC with 400 µg of soluble 
C. crescentus proteins, nine of eleven proteins predicted to contain either a PilZ, GGDEF or EAL domain 
(Table 1A & Table S1A) were significantly enriched as compared to the competition control based on 
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the spectral counts of the identified peptides. In addition to the analysis of soluble proteins we also aimed 
at evaluating the efficiency of CCMS for the enrichment of c-di-GMP binding proteins from membrane 
fractions. Although the numbers of spectral counts were lower as compared to proteins from the soluble 
fraction, three of the five integral membrane proteins predicted to bind c- di-GMP were identified when 
400 µg DDM solubilized membrane proteins and 10 µM cdG-CC were used for CCMS (Table 1A & Table 
S1A). Only four of the known components of the C. crescentus c-di-GMP network were not identified by 
CCMS. Two of these are integral membrane proteins with several predicted membrane-spanning 
domains in their N-terminal regions (CC0740, CC0896). It is possible that they were not solubilized by 
the detergent used or not detected by LC–MS/MS. Another possibility is that they are not expressed, as 
it might be the case for the not captured soluble proteins CC3094 and CC3148.  
 
 
 
 
 
To expand these studies to a different organism, we attempted to identify known c-di-GMP binding 
proteins from P. aeruginosa PA01. With 42 GGDEF and EAL domain proteins, eight PilZ domain proteins, 
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two HD-GYP domain proteins, and the transcriptional regulator FleQ that was shown to bind c-di-GMP 
[173], the complexity of the c-di-GMP signaling network in this organism is much higher than in C. 
crescentus. Using 10 µM, 7.5 µM, 5 µM, 2.5 µM and 1.25 µM cdG-CC and 350 µg of soluble protein extract, 
11 of these proteins were unambiguously identified by CCMS (Table 1B & Table S1B). This includes 
four PilZ domain proteins, four GGDEF, two composite GGDEF-EAL domain proteins and FleQ. The 
fraction of potential c-di-GMP binders from P. aeruginosa isolated by CCMS is substantially lower (11 of 
33 predicted soluble proteins) as compared to C. crescentus but is comparable to a recent study using 
sepharose-coupled c-di-GMP to pull down c-di-GMP binding proteins [109]. That study identified 14 of 
the soluble and three of the membrane anchored proteins known or predicted to bind c-di-GMP. Six of 
these proteins were identified in both studies, including the PilZ domain proteins PA0012, PA2989, 
PA3353, and PA4908, the GGEEF domain protein PA3702 and FleQ. In addition to known or predicted 
c-di-GMP binding proteins we identified 54 novel putative c-di-GMP binding proteins in at least two of 
five independent CCMS experiments performed with 7.5 µM cdG-CC (Table S3). The identified proteins 
were classified according to their annotated function (www.pseudomonas.com) [174] (Figure S1). The 
largest group of identified proteins is of unknown function (30.4%). The others are annotated as being 
involved in amino acid biosynthesis and metabolism (16.1%), energy metabolism (12.5%), nucleotide 
biosynthesis and metabolism (8.9%), chemotaxis (7.1%), polysaccharide biosynthesis (3.6%) and some 
additional pathways. Düvel et al. [109] have reported 140 novel putative c-di-GMP binding proteins. 
Interestingly, only five proteins (PA1458, PA3348, PA3801, PA4310, and PA4489) were identified in both 
approaches indicating that the different compounds used for the experiments might be specific for a 
certain subset of proteins. Alternatively, it is possible that one or both methods generate a set of false 
positives e.g. by pulling out intact protein complexes containing only one specific effector. Clearly, target 
validation with alternative techniques is required to confirm bona fide c-di-GMP binding proteins.  
 
 
Figure 2 | Volcanoplot based visualization of 
proteins significantly enriched by CCMS of S. 
typhimurium. Following capturing, LC-MS/MS 
analysis and label-free quantification, log2-
intensity ratio of all detected peptide features 
between capturing and competition 
experiment were calculated and plotted versus 
values derived from significance analysis. 
Proteins within the significance thresholds for 
q-values <0.05 and intensity ratios >2-fold are 
indicated in a box. Experiments in triplicate 
were performed in the presence of 7.5 µM cdG-
CC and with 1 mM c-di-GMP added to the 
competition reactions. 
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To expand our analysis, we included S. typhimurium in our cdG-CC based CCMS experiments. This 
organism was chosen to perform an unbiased CCMS experiment because its c-di-GMP network appears 
to be of lower complexity as compared to other bacterial species [175]. In contrast to the CCMS 
experiments with C. crescentus and P. aeruginosa, in which spectral counts were extracted for known c-di-
GMP binders, we tested whether CCMS is capable to enrich for c-di-GMP binding proteins upon MS1 
label-free quantification. CCMS experiments were performed in triplicates with 350 µg soluble whole 
cell proteins using 7.5 µM cdG-CC and competition controls with an excess of c-di-GMP (1 mM) (Table 
S2A). Following mass spectrometry analysis and label-free quantification (Table S2B) significant 
differences in protein enrichment between cdG-CC experiments and control samples with competing c-
di-GMP were visualized in a volcanoplot. The graph shows a significant enrichment (>2 fold) of 36 
proteins as compared to the control with a q-value <0.05 (Table S2C & Figure 2). Among the enriched 
proteins is the PilZ domain protein YcgR (Fig. 2) [176]. Many of the identified components that were not 
previously associated with the c-di-GMP network were metabolic proteins and proteins involved in fatty 
acid and LPS biosynthesis (Figure 2). Such proteins might be of interest in the light of switching between 
a virulent planktonic and a surface attached persistent lifestyle. However, since some of these proteins 
might be allosterically regulated by other nucleotides, they first need to be validated regarding a specific 
c-di-GMP binding. Similarly, other potential non-specific binders might be highly abundant proteins, 
such as five tRNA-related proteins or the chaperone GroEL (Table S2C).  
In this study, we demonstrate that the novel c-di-GMP specific Capture Compound is a powerful tool to 
validate known c-di-GMP effectors and to identify novel c-di-GMP binding proteins. Through the use of 
a photo-reactivity group that forms a covalent bond between the cdG-CC and captured proteins stringent 
wash conditions can be applied to increase the specificity. Moreover, this feature allows capturing of low 
affinity binders and low abundant proteins and reduces the probability to pull-out entire protein 
complexes. Our CCMS experiments with S. enterica and P. aeruginosa identified a broad range of putative 
c-di-GMP binding proteins belonging to different classes and biological pathways that will give further 
insights into the complex c-di-GMP signaling network in these organisms. 
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Materials & Methods 
Bacterial strains and growth conditions 
C. crescentus NA1000 was grown in peptone yeast extract (PYE). Strain UJ2827 (NA1000 ∆popA) 
containing either plasmid pAD38 expressing wild-type popA or plasmid pAD39 expressing popA (R357G) 
[88] was grown in PYE containing 2.5 mg/ml tetracycline. P. aeruginosa PA01 and S. typhimurium SL1344 
were grown in LB. 
 
Protein expression and purification 
His-tagged DgrA wild-type and mutants DgrAW75A and DgrARR11AA were expressed in E. coli 
BL21DE3 (Novagen) from plasmids pET42b::dgrA, pET42b::dgrA (W75A) or pET42b::dgrA (RR11AA) and 
purified as described [177]. The proteins were dialyzed against PBS containing 1 mM DTT. 
 
Protein analysis and c-di-GMP production 
Proteins were separated by SDS-PAGE and detected by immunoblot analysis. His-tagged DgrA was 
visualized using anti-His antibodies (Qiagen) and horseradish conjugated rabbit anti-mouse antibodies 
(Dako). PopA was visualized using anti-PopA antibodies [88] and horseradish conjugated swine anti 
rabbit antibodies (Dako). Protein concentrations were determined either with Bradford assays or by 
measuring absorption at 280 nM with a NanoDrop device (Thermo Scientific). C-di-GMP was 
synthesized and purified as described in [178]. 
 
Extract preparation for CCMS experiments 
C. crescentus cells were grown in PYE and P. aeruginosa and S. thyphimurium in LB to mid logarithmic 
phase and pelleted by centrifugation for 20 min at 5’000 x g. The pellet was resuspended in lysis buffer 
(6.7 mM MES, 6.7 mM HEPES, 200 mM NaCl, 6.7 mM KAc, pH 7.5 and, for P. aeruginosa and S. 
typhimurium, 10 mM b-mercaptoethanol) and protease inhibitor (complete mini, EDTA-free, Roche) as 
well as DNaseI (Roche) was added. Cells were lysed by passing it 3 x at 20’000 psi through a French 
pressure cell. After centrifugation at 100’000 x g for 1 h the supernatant was used directly for CCMS 
experiments of soluble proteins. The lysates of P. aeruginosa and S. typhimurium were additionally passed 
through a PD10 (GE healthcare) to remove nucleotides. 
After centrifugation at 100’000 g the pellet was washed once in lysis buffer and resuspended in the same 
buffer before n-dodecyl-b-D-maltopyranoside (DDM, Anatrace) was added to a final concentration of 1 
%, and incubated for 1 hour at 4°C with gentle agitation on a rotary wheel. After centrifugation at 
100’000x g for 1 hour the supernatant was used directly for CCMS experiments of membrane proteins. 
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Capturing of c-di-GMP binding proteins 
The capture experiments were essentially carried out as described for other Capture Compounds 
[179,180] but were optimized for the cdG-CC using known c-di-GMP proteins as positive controls. All 
experiments were performed in 200 µL 12-tube PCR strips (Thermo Scientific). 400 µg of the soluble 
protein fractions (350 µg for P. aeruginosa and S. typhimurium) were mixed with the indicated amounts of 
cdG-CC (Caprotec Bioanalytics GmbH, Berlin) and with 20 µL 5x capture buffer (100 mM HEPES, 250 
mM KAc, 50 mM MgAc, 50 % glycerol, pH 7.5). The volume was adjusted with H2O to 100 µL and 
incubated for 2 h at 4°C in the dark on a rotary wheel. The reaction was then UV irradiated for 4 min 
using a caproBox (Caprotec Bioanalytics GmbH, Berlin). 50 µL magnetic streptavidin beads (Dynabeads 
MyOne Streptavidin C1, Invitrogen) and 25 µL 5x wash buffer (250 mM Tris pH 7.5, 5 M NaCl, 0.1 % n-
octyl-b-glucopyranoside (b-OG)) were added and the mixture was incubated for 45 min at 4°C on a rotary 
wheel. The beads were then collected with a magnet (caproMag, Caprotec Bioanalytics GmbH, Berlin) 
and washed 6 times with 200 µL 1x wash buffer. For immunoblot analysis the beads were resuspended 
in 25 µL sample buffer and loaded on a SDS polyacrylamide gel. For LC-MS/MS analyses the beads were 
prepared directly for digestion (see below). In control experiments run in parallel, c-di-GMP or GTP was 
added to protein extracts up to a final concentration of 1 mM and incubated for 30 min at 4°C on a rotary 
wheel before the cdG-CC was added.  
Capturing of membrane proteins was performed with the following modifications: The capture mixture 
was incubated overnight at 4°C instead of 2 h; b-OG was replaced in the wash buffers with 0.1 % DDM 
for the first six washing steps; the magnetic beads were treated by two additional washing steps with 
buffer containing 0.05 % DDM and by one additional washing step with buffer containing 0.025 % DDM. 
Capture experiments with purified proteins were performed in the presence of 0.5 µM protein and were 
incubated with the cdG-CC for one hour. Control experiments were carried out in the presence of a 100-
fold excess of c-di-GMP or GTP as compared to the cdG-CC concentration. 
 
Tryptic digest of proteins for MS analysis 
Magnetic beads with captured soluble proteins were washed 1x with 200 µL H2O, 6 times with 80 % 
acetonitrile and 2 times with H2O and then resuspended in 20 µL 100 mM ammonium bicarbonate. 0.5 
µL 200 mM TCEP (sulfhydryl reductant tris[2-carboxyethyl]-phosphine) was added and the beads were 
incubated for 1 h at 60°C. After addition of 0.5 µL 400 mM iodoacetamide and incubation for 30 min at 
25°C in the dark, 0.5 µL 500 mM N-acetyl cysteine was added and the beads were further incubated for 
10 min at 25°C. Finally, 1 µg porcine trypsin (Promega) was added and the solution incubated for 16 h at 
37°C.  
Membrane proteins coupled to streptavidin coated magnetic beads were treated as follows. The beads 
were washed 3 times with 100 mM ammonium bicarbonate containing 2M urea. The beads were then 
resuspended in 20 µl 100 mM ammonium bicarbonate, 8 M urea. TCEP, iodoacetamide and N-acetyl 
cysteine were added to the same amounts as indicated for the soluble proteins and the beads were 
incubated as outlined for soluble proteins. 1 µg of endoproteinase Lys-C (Wako) was added and the 
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solution was incubated for 16 h at 37°C. Following the addition of 80 µl 100 mM ammonium bicarbonate, 
1 µg porcine trypsin was added and incubated for 6 h at 37°C. 
For soluble and membrane proteins the beads were removed and the peptides were purified using C18 
Microspin columns (Harvard Apparatus) and dried in a speed vac. 
 
LC-MS/MS analysis 
LC-MS/MS analyses were performed on a dual pressure LTQ-Orbitrap Velos mass spectrometer, which 
was connected to an electrospray ion source (both Thermo Scientific). Peptide separation was carried out 
using an easy nano-LC systems (Thermo Scientific) equipped with a RP-HPLC column (75 µm x 15 cm) 
packed with C18 resin (Magic C18 AQ 3 µm; Michrom BioResources) using a linear gradient from 96 % 
solvent A (0.15 % formic acid, 2 % acetonitrile) and 4 % solvent B (98 % acetonitrile, 0.15 % formic acid) 
to 35 % solvent B over 40 minutes at a flow rate of 0.3 µL/min. The data acquisition mode was set to 
obtain one high resolution MS scan in the FT part of the mass spectrometer at a resolution of 60,000 
FWHM followed by MS/MS scans in the linear ion trap of the 20 most intense ions. To increase the 
efficiency of MS/MS attempts, the charged state screening modus was enabled to exclude unassigned 
and singly charges ions.  
Collusion induced dissociation was triggered when the precursor exceeded 100 ion counts. The dynamic 
exclusion duration was set to 15 sec. The ion accumulation time was set to 300 ms (MS) and 50 ms 
(MS/MS). 
 
Database search and label-free quantification 
Mass spectrometry raw spectra were converted into mascot generic files (mgf) and searched with 
MASCOT version 2.3. C. crescentus and S. typhimurium uniprot/tremble databases were downloaded via 
the European Bioinformatics Institute (EBI, http://www.ebi.ac.uk/) and P. aeruginosa NCBI-database was 
downloaded via the NCBI homepage (http://www.ncbi.nlm.nih.gov/). 
In silico trypsin digestion was performed after lysine and arginine (unless followed by proline) tolerating 
two missed cleavages in fully tryptic peptides. Database search parameters were set to allow oxidized 
methionines (+15.99491 Da) as variable modifications and carboxyamidomethylation (+57.021464 Da) of 
cysteine residues as fixed modification. For MASCOT searches using high-resolution scans the precursor 
mass tolerance was set to 15 ppm. and the fragment mass tolerance was set to 0.6 Da. The protein FDR 
was set to 1 %. 
Mascot searches of C. crescentus and P. aeruginosa CCMS experiments were imported into Scaffold 
(Proteomesoftware, Version 3), which was used to extract spectral count. 
For label-free quantification the files were imported into Progenesis LC-MS software (Nonlinear 
Dynamics, Version 4.0). Data in .mgf format were exported directly from Progenesis LC-MS and MS/MS 
spectra were searched using the MASCOT against a decoy database of the predicted proteome from S. 
typhimurium. Search parameters were the same as described above. Results from the database search 
were imported into Progenesis LC-MS, mapping peptide identifications to MS1 features. The peak areas 
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of all MS1 features annotated with the same peptide sequence were summed, per LC-MS run. Next, 
peptide area ratios between samples with cdG-CC and competing cdG as well as accompanying q-values 
(i.e. p-values adjusted for multiple testing) were calculated using an in-house developed R script 
(available upon request) employing the Limma package [181] of BioConductor. As ribosomal proteins 
are common contaminations using enrichment matrices, those proteins were not considered for 
quantitative analysis. 
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Abstract 
Intracellular levels of the bacterial second messenger cyclic di-GMP (c-di-GMP) are controlled by 
antagonistic activities of diguanylate cyclases and phosphodiesterases. The phosphodiesterase PdeH was 
identified as a key regulator of motility in Escherichia coli, while deletions of any of the other 12 genes 
encoding potential phosphodiesterases did not interfere with motility. To analyze the roles of E. coli 
phosphodiesterases, we demonstrated that most of these proteins are expressed under laboratory 
conditions. We next isolated suppressor mutations in six phosphodiesterase genes, which reinstate 
motility in the absence of PdeH by reducing cellular levels of c-di-GMP. Expression of all mutant alleles 
also led to a reduction of biofilm formation. Thus, all of these proteins are bona fide phosphodiesterases 
that are capable of interfering with different c-di-GMP-responsive output systems by affecting the global 
c-di-GMP pool. This argues that E. coli possesses several phosphodiesterases that are inactive under 
laboratory conditions because they lack appropriate input signals. Finally, one of these 
phosphodiesterases, PdeL, was studied in more detail. We demonstrated that this protein acts as a 
transcription factor to control its own expression. Motile suppressor alleles led to a strong increase of 
PdeL activity and elevated pdeL transcription, suggesting that enzymatic activity and transcriptional 
control are coupled. In agreement with this, we showed that overall cellular levels of c-di-GMP control 
pdeL transcription and that this control depends on PdeL itself. We thus propose that PdeL acts both as 
an enzyme and as a c-di-GMP sensor to couple transcriptional activity to the c-di-GMP status of the cell.  
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Importance 
Most bacteria possess multiple diguanylate cyclases and phosphodiesterases. Genetic studies have 
proposed that these enzymes show signaling specificity by contributing to distinct cellular processes 
without much cross talk. Thus, spatial separation of individual c-di-GMP signaling units was postulated. 
However, since most cyclases and phosphodiesterases harbor N-terminal signal input domains, it is 
equally possible that most of these enzymes lack their activating signals under laboratory conditions, 
thereby simulating signaling specificity on a genetic level. We demonstrate that a subset of E. coli 
phosphodiesterases can be activated genetically to affect the global c-di-GMP pool and thus influence 
different c-di-GMP-dependent processes. Although this does not exclude spatial confinement of 
individual phosphodiesterases, this study emphasizes the importance of environmental signals for 
activation of phosphodiesterases.  
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Introduction 
The second messenger cyclic di-GMP (c-di-GMP) is a nearly ubiquitous small signaling molecule which 
greatly affects bacterial growth and behavior. In particular, c-di-GMP controls important cellular and 
behavioral processes in a wide range of bacteria, including motility and chemotaxis, surface colonization 
and the formation of communities, virulence and persistence, and cell cycle progression (for reviews, see 
references [7,54,161]). The key enzymes involved in c-di-GMP metabolism are diguanylate cyclases 
(DGCs) [8] and phosphodiesterases (PDEs) [182]. Together, DGCs and PDEs constitute one of the largest 
families of bacterial signaling proteins, with tens of thousands of members currently deposited in the 
protein databases. Contributing to an explanation for this enormous multiplicity and diversity is the 
observation that most bacteria contain multiple representatives, often a few tens, of these proteins [7]. 
For example, the genomes of Escherichia coli K-12 strains contain genes encoding a total of 29 proteins 
harboring a GGDEF and/or EAL domain, the catalytic units of DGC and PDE enzyme activities, 
respectively [183]. Moreover, throughout evolution, many of the formerly catalytic members of this 
family seem to have adopted novel functionalities as c-di-GMP effector proteins [88,117,184-186] or as 
protein interaction platforms that have lost the connection to their original effector altogether [162].  
This caused some confusion in the field in the early years and raised the question of why bacteria evolved 
multiple DGCs and PDEs to control a small signaling molecule that likely shows rapid diffusion within 
bacterial cells, thereby providing limited options for signaling specificity. One possible explanation for 
this phenomenon is that individual representatives are expressed under specific environmental 
conditions or are specialized for specific cellular tasks which normally are kept separate from each other 
in either time or space [54]. In the case of temporal sequestration, one would expect that only a subset of 
these enzymes is expressed at any given time or environmental situation. The other possibility is that 
cells express and display multiple members of this enzyme family to be able to rapidly respond to a 
diverse range of signaling inputs. In this case, one would expect that most or possibly all enzymes are 
expressed at any given time but that the majority of them are not active due to the absence of an input 
signal. In the past few years, the amount of information about biochemical and structural characteristics 
of DGCs and PDEs has increased rapidly [5,58,61,187]. Despite such rapid progress, in vivo results often 
remain controversial. Considering that specific components of this signaling network might not be 
expressed or might not receive the appropriate stimuli to be active, genetic studies relying solely on 
mutant phenotypes will not give conclusive answers.  
Here we address these questions by analyzing the expression and activities of multiple PDEs in E. coli K-
12. This organism has a total of 16 EAL domain proteins, only 3 of which show obvious degeneration of 
consensus amino acid motifs required for catalytic activity (Figure 1A & B). Among the other 13 proteins, 
only 7 have been characterized in detail and identified as PDEs [72,80,188-192]. The functions of the other 
members of this family that potentially are able to catalyze c-di-GMP hydrolysis remain unclear. To 
identify additional candidate PDEs, we made use of a genetic approach by sequentially isolating 
activating gain-of-function mutations in specific members of the EAL domain proteins. Our analysis is 
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based on some recent reports demonstrating that PdeH (YhjH), a highly active PDE that globally controls 
c-di-GMP levels in E. coli, is primarily responsible for motility control in this organism [78,188,193]. The 
pdeH gene is coregulated with flagellar genes, and mutants lacking PdeH show increased c-di-GMP levels 
and poor motility. PdeH licenses flagellar motility in the exponential and early postexponential phases 
by keeping c-di-GMP levels low. Upon entry into stationary phase, c-di-GMP levels increase partially 
due to FlhDC-dependent downregulation of pdeH [142], leading to activation of the c-di-GMP effector 
protein YcgR, which interacts with the flagellar motor to curb its activity [78,130]. Thus, in growing E. 
coli cells, PdeH has a central role in maintaining cell motility by keeping the cellular concentration of c-
di- GMP below a threshold level that is able to activate YcgR. The observation that pdeH mutants showed 
poor motility also suggested that under these conditions, no other PDE was expressed or active (enough) 
to functionally substitute for this PDE. We thus hypothesized that mutations activating any of the other 
PDEs would be able to restore the motility of the pdeH mutant. If so, this would then allow us to identify 
silent PDEs by genetically uncoupling their activities from the unknown signals that are normally 
required for their activation. We present genetic and biochemical evidence that a large fraction of the 
remaining potential PDEs can indeed be activated genetically to substitute for the function of PdeH. This 
argues in favor of the idea that these proteins are bona fide PDEs that are able to interfere with the general 
cellular pool of c-di-GMP and that, under laboratory conditions, these proteins lack the appropriate 
signal(s) to become active.  
Please note that throughout this report we use the systematic nomenclature for E. coli DGCs and PDEs 
that was recently proposed by Hengge et al. [77]. To make it easier for the expert reader to adopt the new 
nomenclature, the corresponding traditional designations are listed in Figure 1A and are highlighted in 
parentheses in the text.  
		50 | 
Results 
Expression of PDEs in growing E. coli cells 
High levels of c-di- GMP generally obstruct flagellar motility in various microbes [78,130,142]. As a 
consequence, PDEs play key roles in regulating cell motility [106,114]. In E. coli, the PDE PdeH appears 
to be the sole contributor to the maintenance of cell motility under laboratory conditions [78]. This is 
surprising since the genomes of E. coli K-12 strains encode more than a dozen additional potential PDEs 
[77]. One possibility is that most of these components are not expressed during growth under these 
conditions. Previous studies used microarrays and b-galactosidase reporter assays to demonstrate that, 
with the exception of pdeF (yfgF) and pdeG (ycgG), all genes encoding potential PDEs are actively 
transcribed [194,195]. To confirm this and to demonstrate that active transcription indeed results in the 
production of PDEs, chromosomal 3xFlag-tagged constructs were engineered for all potential pde genes 
in the E. coli strain MG1655. These were introduced into the wild type and a pdeH mutant background, 
and protein levels were monitored in exponentially growing cells (OD600 of 0.5 to 0.8). As shown in Figure 
1C, most PDEs were readily detected. The only exceptions were PdeF and PdeG, the latter of which was 
present at low levels in the wild-type background but absent in the pdeH strain. This confirmed previous 
results and indicated that these proteins failed to contribute to cell motility as a result of a lack of 
expression under these conditions. Rather, most of these PDEs may be present in the cell at high enough 
concentrations but may not interfere with motility control because of a lack of enzyme activity. 
 
 
Motile suppressor mutants of a pdeH mutant identify activating mutations in alternative PDEs 
A pdeH mutant is unable to swim effectively toward higher nutrient concentrations in motility plates. To 
isolate spontaneous motile suppressor mutants, the pdeH mutant was inoculated onto the center of 
motility plates and incubated for an extended period, until visible “flares” were arising and spreading 
on the plates (Figure 2A). It was shown previously that mutations in the gene encoding the motility 
regulator YcgR can restore motility under these conditions [78]. Likewise, mutations in several genes 
encoding DGCs required for YcgR activation alleviate the motility block. We reasoned that activating 
mutations in “alternative” PDEs could also restore motility by countering high levels of c-di-GMP in the 
pdeH mutant. In order to enrich for such rare pde gain-of-function mutations, we first designed a tailored 
screening strain that reduced the likelihood of isolating mutations in known components of c-di-GMP-
mediated motility control. To reduce the frequency of loss-of-function mutations in ycgR, a second 
chromosomal copy of ycgR was introduced into the pdeH screening strain. In addition, the screening 
strain was equipped with a plasmid carrying a copy of wspR, the gene encoding the diguanylate cyclase 
WspR from Pseudomonas fluorescens. Expression of wspR from the Plac promoter maintains a threshold 
level of c-di-GMP that prevents motility even if one of the four active native DGCs is inactivated.  
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Figure 1 | Conservation of c-di-GMP-specific phosphodiesterases. (A) ClustalW alignment of PdeL with endogenous 
and exogenous phosphodiesterases and noncatalytic EAL domains. Regions containing residues involved in substrate 
binding (open triangles) and catalysis (closed triangle) are highlighted. Amino acid numbering refers to the numbering 
for PdeL. The double-aspartic-acid motif (DD) is displayed in purple, in analogy to panel B. (B) Atomic organization of 
the catalytic site of a PdeL monomer. The two essential metals are displayed as gray spheres. Conserved residues involved 
in metal coordination or catalysis are displayed in red. The double-aspartic-acid motif (Asp262 and Asp263; shown in 
purple) is involved in metal ion coordination as well as coordination of the catalytic water (small blue spheres). The same 
is true for the glutamic acid at position E141, which is part of the conserved E(A/V)L motif. (C) Immunoblot analysis of 
PDEs in E. coli wild-type and pdeH mutant strains. PDEs were tagged at their C-termini with a 3xFlag-tag and were 
analyzed with an anti-Flag antibody. Cells were grown in tryptone broth (TB) at 37°C and harvested at an OD600 of 0.5-0.8. 
Note that in both strain backgrounds, all pde genes were expressed, with the exception of pdeF. PdeG levels were low in 
the wild type, and the protein seemed to be absent in the ∆pdeH mutant.  
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With this strain, a continuous genetic forward screen was set up. First, activating mutations in one of the 
pde genes were isolated from a pool of spontaneous suppressor mutants. A kanamycin resistance cassette 
was introduced next to the corresponding pde gene on the chromosome. Suppressor mutations linked to 
this marker were then identified by cotransduction into a clean pdeH background and by subsequent 
sequencing of the neighboring DNA regions. Second, the pde gene for which motility suppressor mutants 
were isolated was deleted from the chromosome. With the resulting mutant strain, a new round of 
selection for motile suppressor mutants was initiated to isolate mutations in one of the remaining pde 
genes. Successive rounds of selection resulted in the isolation of a total of 16 suppressor mutations in six 
individual PDEs (Figure 2B & C). Closer examination revealed gene fusion events in both pdeB and pdeC. 
In the case of pdeB, a 5,846-bp deletion between two direct repeats (TTGATGTCATT) resulted in an in-
frame fusion of pdeB with its upstream gene, acrB, encoding a subunit of the Acr multidrug efflux pump. 
The resulting protein was fused at amino acid 205 of AcrB and position 168 of PdeB, giving rise to a 
fusion protein of a size similar to that of PdeB. As shown in Figure 3A, the overall level of the resulting 
fusion protein was strongly increased compared to that of the PdeB wild type. This increase likely 
resulted from the direct coupling of the truncated pdeB gene with the promoter of the acr operon. We 
reasoned that motility suppression results either from strong overexpression or from uncoupling of the 
respective catalytic domain of PdeB from its N-terminal regulatory region. Similarly, an IS element (ins 
mobile element) inserted into the promoter region of pdeC (28 bp upstream of the putative transcriptional 
start site of pdeC). As in the case of PdeB, this resulted in a strong upregulation of the overall level of 
PdeC (Figure 3B), indicating a suppression mechanism similar to that described above. Mutations 
resulting in single amino acid substitutions were identified in pdeL, pdeA, pdeI, and pdeN, arguing that 
the encoded proteins can be activated genetically (Fig. 2C). While substitutions in the pdeA-, pdeI-, and 
pdeN-encoded proteins localized to the EAL domain, to transmembrane regions, or to uncharacterized 
regions of the protein neighboring the EAL domain, mutations in the pdeL-encoded protein localized 
exclusively within the catalytic domain. This is in line with the observation that the soluble PdeL protein 
lacks a potential signal input domain and instead harbors a LuxR-type DNA binding domain. Levels of 
PdeA, PdeI, and PdeN proteins harboring suppressor mutations were unaltered compared to that of the 
wild type. Also, the cellular concentrations of these enzymes were similar in strains with different levels 
of c-di-GMP (Figure 3C-E & 4). In contrast, levels of several PDEs were different in E. coli wild-type, 
pdeH, and csrA mutant strains, indicating that their expression might be regulated by c-di-GMP itself 
(Figure 3B & F). In line with this, a subset of the isolated PdeL suppressors revealed higher PdeL protein 
levels in all genetic backgrounds tested (Figure 3F). This was not due to increased protein stability, as 
suppressor variants and wild-type PdeL showed very similar stabilities upon translation inhibition 
(Figure S1). Together with the finding that all mutations in PdeL mapped to the catalytic domain, this 
suggested that pdeL expression is autoregulated and possibly controlled by the overall cellular level of c-
di-GMP. Together, these results indicate that E. coli possesses several PDEs that under normal conditions 
do not contribute to motility control but can be activated genetically to substitute for the role of the 
primary cellular PDE, PdeH. 
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Figure 2 | Isolation of alleles activating E. coli phosphodiesterases. (A) Selection for motile suppressor mutants of a non-
motile pdeH mutant strain on a low- percentage agar plate. Independent suppressors were recovered from motile flares 
(arrows) after incubation on motility plates for several days at 37°C. (B) Mutations in pdeL restore the motility of a pdeH 
mutant. Mutant alleles of pdeL are indicated. Motility was examined as described for panel a. wt, wild type. (C) Graphical 
representation of isolated pde suppressor variants. Vertical black bars represent transmembrane helices, c-di-GMP-specific 
phosphodiesterase do- mains (EAL) are depicted in blue, the LuxR-like DNA binding domain of PdeL is shown in yellow 
(HTH), and the degenerate cyclase domain (xGGDEF) of PdeA is shown in red. The positions of single amino acid 
substitutions are marked with black triangles.  
 
 
Pde suppressor alleles restore motility by reducing intracellular c-di-GMP levels 
High levels of c-di-GMP interfere with flagellar motility via the YcgR effector protein. To demonstrate 
that the pde suppressor alleles do indeed reinstate the flagellar motor behavior of a pdeH mutant by 
reducing levels of c-di-GMP, both single-cell trajectories and c-di-GMP concentrations were recorded for 
a selection of the isolated mutants. Dark-field microscopy tracking and subsequent computational 
analysis of the recorded trajectories determined the behavior of swimming bacteria. Measured 
trajectories of an exponentially growing pdeH strain revealed swimming velocities of 3.4 to 6.1 µm/s 
(median, 4.1 µm/s), whereas a pdeH
 
strain displayed velocities of 6.0 to 12.2 µm/s (median, 8.9 µm/s) 
(Figure 4). Importantly, swimming velocities of all motile suppressor mutants were significantly higher 
than that of their isogenic pdeH strain and were similar to velocities measured for the wild type. To 
complement these single cell measurements, cellular c-di-GMP concentrations in cell populations of the 
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same strains were quantified using LC-MS/MS technology [99]. In accordance with earlier observations 
[78], levels of c-di-GMP were increased 10-fold in the pdeH mutant (3.5 µM) compared to the wild type 
(0.31 µM). Importantly, all strains harboring mutations in PDEs showed a significant reduction of the 
intracellular c-di-GMP pool compared to their isogenic pdeH mutant strain. While the reduction of c-di-
GMP was moderate in some suppressor mutants, c-di-GMP levels were reduced to levels comparable to 
that of the wild type or, for one mutant, even below the detection limit (Figure 4). Importantly, we 
observed a strong overall correlation between the reduction of the intracellular c-di-GMP levels and the 
measured swimming velocities (Figure 4).  
Together, these findings support the notion that the pde suppressor alleles increase the level and/or 
enzymatic activity of their respective PDE products, lowering the cellular concentration of c-di-GMP in 
the original pdeH mutant and thereby restoring flagellar motor function.  
 
 
 
Figure 3 | Expression of mutant phosphodiesterases in E. coli. Immunoblot analysis was performed on the wild type 
and on strains with suppressor variants for detection of PdeB (A), PdeC (B), PdeN (C), PdeA (D), PdeI (E), and PdeL (F) 
carrying 3xFlag-tags at their C-termini. Proteins were analyzed in the following strains grown to exponential phase: wild 
type, ∆pdeH mutant (AB607), and csrA- mutant (AB958). Suppressor variants of PdeB (A) and PdeC (B) showed strongly 
increased protein levels indicating derepression of their expression. In contrast, suppressor variants of PdeN, PdeA, and 
PdeI showed unaltered protein levels in all strain backgrounds tested. Of the 10 PdeL suppressor variants isolated, three 
were analyzed (G299S, F206S, and F249L). All variants showed increased protein levels in all genetic backgrounds tested. 
Note that protein levels of PdeC and PdeL differed in different genetic backgrounds.  
 
 
Pde suppressor alleles reduce poly-GlcNAc levels and cellulose-dependent attachment 
The observation that the pde suppressor alleles restored motility in a pdeH background by reducing the 
intracellular c-di-GMP concentration prompted us to test if this represents a general cellular response 
that can also interfere with other c-di-GMP-mediated processes. We have shown previously that poly-
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GlcNAc (PGA)-dependent biofilm formation is regulated posttranslationally by c-di-GMP [110]. The pga 
operon encoding the poly-GlcNAc biosynthesis machinery is controlled by the carbon storage regulator 
CsrA. Inactivation of csrA leads to derepression of the pga genes and two genes encoding DGCs: dgcT 
(ycdT) and dgcZ (ydeH) [196,197]. As a consequence, a csrA- mutant strain not only shows constitutive 
expression of PGA components but also displays a strong increase of the c-di-GMP level (5.35 µM) 
compared to that of the wild type (0.31 µM) (Figure 5A). A mutant lacking both CsrA and DgcZ produces 
significantly less c-di-GMP and shows strongly reduced PGA-dependent attachment [110] (Figure 5A). 
To assay the effect of the pde suppressor mutations on PGA-mediated attachment, mutant alleles were 
introduced into a csrA- single mutant and a csrA- dgcZ double mutant. As shown in Figure 5A, only pdeC 
and two of the pdeL alleles were able to effectively reduce attachment in the high-c-di-GMP background 
(csrA- mutant). Apparently, in accordance with the capacity of restoring motility, only the most active 
PDE variants are able to reduce the level of c-di-GMP in this strain to a concentration range below the 
activation constant (Kact) of the PGA biosynthesis machinery (62 nM) [110]. In contrast, when biofilm 
formation was assayed in the low-c-di-GMP background (csrA- dgcZ), all pde alleles showed a significant 
reduction of biofilm formation. The only suppressor allele that was not able to reduce PGA-dependent 
biofilm formation was PdeI (G412S) (Figure 5B). However, because motile suppressor mutants were 
isolated at 37°C and biofilm as- says were routinely carried out at 30°C, we tested if pdeI expression was 
temperature controlled. As shown in Figure 5C, PdeI protein levels were indeed strongly temperature 
dependent, with the highest concentration reached at 42°C (Figure 5C). In line with this observation, the 
pdeI (G412S) allele significantly reduced attachment of the csrA- dgcZ mutant at 37°C (Figure 5C).  
While E. coli forms poly-GlcNAc biofilms in the host and at higher temperatures [198-200], it can form 
cellulose-based biofilms in the environment and at lower temperatures. Like that of poly- GlcNAc, 
production of cellulose is also stimulated by c-di-GMP [1]. Many lab-adapted E. coli strains, including E. 
coli K-12 MG1655, are deficient in cellulose production. This is due to a single point mutation in the bcsQ 
gene, encoding cellulose synthase. Restoration of the bcsQ wild-type sequence results in proficient 
cellulose production [201]. Introduction of a bcsQ wild-type allele into the cellulose-deficient strain 
MG1655 increased attachment about 2-fold. Deletion of pdeH in a bcsQ
 
background increased attachment 
about 4-fold compared to that of the isogenic bcsQ
 
strain (Figure 5D). Deletion of pdeH in the cellulose-
deficient MG1655 strain also led to a 4-fold increase in attachment compared to that of the wild type, 
arguing that other c-di-GMP-dependent systems contribute to biofilm formation in this strain. 
Importantly, when the three pdeL suppressor alleles (encoding G299S, F206S, and F249L mutations) were 
introduced into the bcsQ
 
pdeH background, cellulose- dependent attachment was strongly reduced, 
similar to the pattern observed for poly-GlcNAc-dependent biofilm formation (Figure 5D). 
These results strongly suggest that genetically activated variants of several PDEs have a profound effect 
on the cellular c-di-GMP concentration, which eventually becomes manifested in different c-di-GMP-
responsive output systems. 
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Figure 4 | Swimming velocities of E. coli wild-type and phosphodiesterase mutant strains. Velocities of individual cells 
of the E. coli wild type (white), the pdeH mutant (gray), and motile suppressor mutants of the pdeH mutant (green) were 
scored. For statistical analysis, the Kruskal-Wallis rank sum test was applied. Swimming velocities of at least 76 single 
cells are shown as box plots. Boxes show the lower and upper quartiles. Black horizontal lines represent the median 
velocities. Dashed lines show extreme values, whereas small black squares represent individual outliers. Comparisons of 
motile suppressor mutants with the parental ∆pdeH strain all showed statistically significant differences (P < 0.05). Motile 
suppressor mutants showed swimming velocities restored to the levels observed for the wild type. Black bars represent 
intracellular c-di-GMP concentrations as measured by LC-MS/MS. A mutant lacking PdeH displayed a 10-fold-increased 
cellular c-di-GMP concentration (3.5 µM) compared to that of the wild type (0.31 µM). Motile suppressor mutants showed 
reduced intracellular c-di-GMP concentrations compared to their parental strain (∆pdeH).  
 
 
PdeL suppressors show increased enzymatic activity 
To gain further insight into the suppression mechanisms that caused reduced levels of c-di-GMP, we 
investigated the specific in vitro activity of mutant phosphodiesterases. We chose three representative 
suppressor mutants of PdeL, since this is the only soluble cytoplasmic enzyme and because it was 
previously shown to be an active c-di-GMP-specific phosphodiesterase [62,188]. We overexpressed and 
purified PdeL wild-type and G299S, F206S, and F249L mutant proteins that carried a StrepII tag at the C-
terminus. To determine their activities, we developed a novel enzyme-coupled phosphate sensor-based 
assay that allows for sensitive real-time determination of c-di-GMP-specific phosphodiesterase activity 
(see the legend to Figure 6 and Materials and Methods for details). PDE activity was determined at an 
enzyme concentration of 500 nM, with substrate concentrations ranging from 100 nM to 0.5 µM. While 
wild-type PdeL had a specific PDE activity (kcat/KM) of 0.14 M-1 s-1, all three PdeL variants showed 
significantly increased turnover rates, ranging from 0.21 to 0.26 M-1 s-1
 
(Figure 6A).  
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Figure 5 | Surface attachment of E. coli wild-type and phosphodiesterase mutant strains. (A) Relative surface attachment 
of E. coli csrA- and csrA- ∆dgcZ mutant strains harboring individual pde suppressor mutations, as indicated. Levels of c-di-
GMP (cdG) in both mutant backgrounds are indicated (n.d., not detectable). A schematic of the regulatory network of PGA 
and cellulose-dependent biofilm control is shown beside the graph. Gray bars and white bars indicate relative levels of 
biofilm formation in the csrA- and csrA- ∆dgcZ strain backgrounds, respectively. Biofilm formation was examined at 30°C 
(B) and 37°C (C) for strains carrying wild-type pdeI and the pdeI (G412S) suppressor allele. Temperature-dependent 
expression of pdeI as measured by immunoblot analysis is shown in the inset of panel c. (D) Relative attachment of pdeL 
suppressor alleles (G299S, F206S, and F249L) in a cellulose-producing bcsQ+ ∆pdeH background. Black bars indicate strains 
harboring a single nucleotide polymorphism (SNP) in the bcsQ gene, and gray bars represent a “repaired” bcsQ gene 
(bcsQ+). Attachment is shown relative to that of the cellulose-deficient lab-adapted strain E. coli K-12 MG1655 of Blattner 
et al. [202]. The assay was performed at room temperature. 
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PdeL suppressors enhance pdeL transcription 
Strikingly, strains expressing pdeL (G299S), pdeL (F206S), and pdeL (F249L) showed significantly higher 
PdeL protein levels than that of the isogenic pdeL wild-type strain (Figure 3F). The observation that PdeL 
harbors an N-terminal LuxR-type DNA binding domain fused to its catalytic EAL domain led us to 
investigate whether pdeL expression is subject to autoregulation. To test this, we constructed a 
chromosomal reporter, fusing the entire intergenic region upstream of pdeL and downstream of betT to 
the lacZ gene. The fusion was engineered in the lacZ locus of the chromosome, leaving the original pdeL 
locus intact (Figure 6B, inset). b-galactosidase activity was then determined to compare pdeL promoter 
strengths in pdeH strains harboring the pdeL alleles encoding the G299S, F206S, and F249L substitutions. 
All strains expressing activated mutant forms showed similar, about 5-fold increases of pdeL transcription 
compared to that in their isogenic strain (Figure 6B). This suggested that pdeL transcription is 
autoregulated and that PdeL enzyme activity is coupled to the transcription of its own gene. 
 
 
PdeL directly regulates its own expression in a c-di-GMP-dependent manner 
Promoter activity of pdeL could be linked directly to the enzymatic activity of PdeL, possibly through its 
DNA binding domain. Alternatively, the enzymatic activity of PdeL might influence pdeL transcription 
indirectly by modulating the cellular level of c-di-GMP. To distinguish between these two possibilities, 
we compared pdeL promoter activities in strains expressing a wild-type copy of PdeL but harboring 
distinct c-di- GMP concentrations. To this end, we used the MG1655 wild-type strain, the pdeH mutant 
strain, and a strain [referred to as the dgc(4) strain] lacking four DGCs: DgcE (yegE), DgcN (yfiN), DgcO 
(yddV), and DgcQ (yedQ) [78]. While wild-type MG1655 harbored intermediate cellular levels of c-di-
GMP (0.31 µM), the pdeH mutant showed high levels (> 3 µM), and the dgc(4) mutant had very low levels 
of c-di-GMP as measured by LC- MS/MS (65 nM) (Figure 6C). Similar to that in strains harboring PdeL 
suppressors, pdeL promoter activity was increased in a strain lacking the four DGCs.  
In contrast, a strain lacking PdeH showed strongly reduced pdeL transcription. Together, these 
observations argued that pdeL transcription is controlled negatively by c-di-GMP and that the pdeL 
promoter is highly active when the cellular c-di-GMP concentration is very low. In principle, there are 
two possibilities to explain this regulatory behavior. Internal c-di-GMP levels could be sensed through 
an unknown transcription factor that modulates pdeL promoter strength accordingly. In this case, the role 
of PdeL and its enzyme activity in autoregulation would be entirely indirect, through the modulation of 
the cellular c-di-GMP pool. Alternatively, the role of PdeL could be more direct in that it not only is 
involved in c-di-GMP homeostasis but also acts as a sensor for the prevailing c-di-GMP concentration 
and, in response, directly regulates pdeL promoter strength, involving its DNA binding domain. To 
distinguish between these two possibilities, we performed electrophoretic mobility shift assays (EMSAs) 
to test for binding of purified PdeL to its own promoter region. Due to the exceptional size of the region 
be- tween pdeL and its upstream gene betT (874 bp), binding of PdeL to this region had to be tested by 
using a series of Cy3-labeled DNA probes of various lengths. 
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Figure 6 | Enzyme activities and autoregulation of PdeL suppressor variants. (A) Specific phosphodiesterase activities of 
purified wild-type PdeL and mutant PdeL variants. The specific activities (kcat/KM [µM
-1
 
sec-1]) of PDEs were determined 
using an enzyme-coupled phosphate sensor assay (see Materials and Methods). In our assay, we applied an enzyme 
concentration of 100 nM and substrate concentrations ranging from 100 nM to 5 µM. All three PdeL mutants showed an 
increased turnover rate compared to that of the wild type (0.15 µM-1
 
sec-1). (B) Relative b-galactosidase activities of pdeH 
mutant strains carrying translational PpdeL-lacZ fusions at the native lacZ locus. A schematic of the reporter strain is shown 
at the top. The presence of pdeL suppressor alleles increased pdeL promoter activity about 5-fold. (C) The inset shows a 
partial alignment of the HTH domain sequence of E. coli PdeL and NarL. Lysine 192 of NarL (black arrow) is involved in 
DNA binding. EMSAs were performed with purified PdeL-StrepII (left panel) and PdeL (K60A)-StrepII (right panel) by 
using oligonucleotide 4991-7, containing the minimal PdeL binding region. (D) c-di-GMP regulates pdeL transcription in 
a PdeL-dependent manner. The promoter activity of pdeL was determined for the wild type, a strain exhibiting low levels 
of c-di-GMP [∆dgc(4)], and a strain with high levels of c-di-GMP (∆pdeH). c-di-GMP levels of the respective strains are 
shown as green diamonds. The graph includes the pdeL promoter activity of a strain harboring the pdeL (K60A) allele. (E) 
Model of c-di-GMP-dependent pdeL transcription control. Enzymatic activity is depicted with a dashed arrow. c-di-GMP 
negatively regulates pdeL transcription through an unknown mechanism. The enhanced enzymatic activity of PdeL 
suppressor variants (PdeLmut) lowers the cellular levels of c-di-GMP and leads to pdeL transcription stimulation.  
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This analysis yielded a minimal PdeL binding region of 24 bp, located 679 nucleotides upstream of pdeL, 
harboring an imperfect palindromic sequence (5’-TTC AAT AAG TTT AGT CTT ATT TAA) (Figure 6C).  
To corroborate these results, we aimed to construct a DNA binding-deficient mutant of PdeL which 
harbors an N-terminal LuxR-like helix-turn-helix (HTH) domain. Based on structural information of the 
LuxR-like domain of the response regulator NarL [203], we identified a conserved lysine at position 60 
of PdeL, which in NarL interacts with DNA (Figure 6C, inset). As shown in Figure 6C, purified PdeL 
(K60A) failed to bind to the PdeL box as indicated above. Next, we determined pdeL promoter activity as 
a function of c-di-GMP levels in strains lacking PdeL. As shown in Figure 6D, pdeL promoter activity 
was strongly reduced in the absence of PdeL, irrespective of the cellular concentration of c-di- GMP. 
Similarly, when the pdeL gene was replaced in the chromo- some with a pdeL allele encoding the K60A 
mutation, pdeL promoter activity was abolished (Figure 6D). Taken together, these experiments strongly 
argue that PdeL is an enzyme and a transcription factor stimulating its own expression in response to 
the prevailing c-di-GMP regimen in the cell. 
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Discussion 
A large variety of cellular processes in bacteria are dependent on c-di-GMP and are tuned during growth 
or behavioral processes by accurately regulated cellular levels of this second messenger. This requires 
tight and coordinated control of the enzymes producing or degrading c-di-GMP. Many of these enzymes 
contain N-terminal signal input domains to sense and integrate environmental cues. While some of these 
signals have been identified and include oxygen, NO, redox, light, and the availability of nutrients 
[59,61,72,204-206], the vast majority of input signals are unknown. It is thus not surprising that under 
controlled laboratory conditions, only a subset of these enzymes shows activity and contributes to known 
c-di-GMP-dependent cellular processes. We showed previously that from a total of 25 potential enzymes 
involved in c-di-GMP turnover, only four DGCs, DgcO (YddV), DgcQ (YedQ), DgcN (YfiN), and DgcE 
(YegE), and one PDE, PdeH (YhjH), contribute to the regulation of E. coli motility [78]. A major player of 
this regulation is PdeH (YhjH), a soluble PDE that lacks a signal input domain and is coregulated with 
other flagellar genes to license cell motility and planktonic cell behavior [193]. In contrast, deletions of 
any of the remaining 12 candidate PDEs encoded in the genomes of E. coli K-12 strains showed no effect 
on motility control (A. Boehm and U. Jenal, unpublished results). Several possibilities exist to explain 
this observation. Some of these proteins might not be expressed under laboratory conditions. If present, 
they might be sequestered to control specific cellular processes, or they might simply lack catalytic 
activity. Finally, they might require an appropriate stimulus to become operative.  
Here we showed that most potential pde genes are expressed in E. coli, resulting in readily detectable 
protein levels. This indicated that these PDEs are present in an inactive state. This was corroborated by 
our findings that several of these components could be activated genetically to interfere with motility 
and biofilm control by lowering the overall levels of c-di-GMP in the cell. These experiments support the 
view that bacteria are equipped with an arsenal of sensors that allows bacteria to rapidly integrate a 
range of environmental signals to modulate the general c-di-GMP pool and thus to optimally adapt to 
their variable environments. This does not exclude the possibility that bacteria also tune the levels of 
these enzymes by altering transcriptional or translational control or as a result of differential protein 
stability. Also, bacteria likely express distinct sets of such sensory components for specific growth phases 
or environmental niches. This view is supported by the observation that in E. coli, several DGCs and 
PDEs are regulated by the stationary-phase sigma factor, sS
 
[194]. Similarly, we found that pdeI (yliE) 
expression is strongly temperature controlled and present at high concentrations only at temperatures 
well above 30°C. This argues that PdeI is part of an enzyme cocktail that is used primarily in the host 
environment. Finally, we were unable to isolate activating mutations in several of the remaining PDEs, 
including PdeK (YhjK), PdeR (YciR), PdeO (DosP), and PdeD (YoaD), despite applying strong selective 
pressure. It is possible that activating mutations in the relevant genes can be isolated in principle and 
that our genetic screen was not saturated. Likewise, the activities of some of these enzymes might simply 
be too weak, even in an activated state, to counter the relatively high cellular c-di-GMP levels of the pdeH 
mutant strain. Alternatively, some of these components might be part of a specific spatial or structural 
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organization that confines them to acting in a functionally restricted manner. This was recently proposed 
for PdeR (YciR). This enzyme was shown to form a signaling complex together with the diguanylate 
cyclase DgcM (YdaM) and the transcription factor MlrA. In this complex, PdeR seems to act both as an 
enzyme and as a local trigger of the transcriptional activity of MlrA, which drives the expression of CsgD, 
a central biofilm regulator activating the genes for cellulose matrix and curli fibers [80]. While the 
mechanistic details of the PdeR transcription complex need to be worked out, this regulatory 
arrangement is consistent with a (locally) limited catalytic function of PdeR, thus offering a plausible 
explanation for why it was not picked up in our motility screen. Similarly, PdeO (DosP) was recently 
shown to be part of an RNA degradation complex, in which it seems to locally control RNA turnover in 
response to oxygen availability [72].  
In this study, we used suppression analysis to identify PDE variants in E. coli that can substitute for the 
major PDE PdeH (YhjH). Using this genetic trick allowed us to bypass the requirement of individual 
input signals that are normally required to unleash the putative PDE activity. The fact that it is possible 
to isolate activating mutations in PDEs strongly argues that these enzymes exist in two distinct forms, an 
active and an inactive conformation, and that their activities are tightly controlled, possibly by switching 
between these two states. The nature of the mutations that lead to enhanced catalytic PDE activity thus 
reveals details about the specific mechanisms which these enzymes employ to control their own activity. 
In principle, several mechanisms to activate a PDE are conceivable. (i) Because PDEs are generally active 
as dimers [61,62], an increase of the protein concentration by overexpression will shift the equilibrium 
toward the active dimeric state. Consistent with this, overexpression of PDEs (or DGCs) can indeed affect 
the global c-di-GMP pool of bacterial cells, regardless of their activation state [194,204]. (ii) Signal input 
domains might obstruct the substrate binding site of the catalytic domain or stabilize the enzyme in an 
inactive conformation. In this case, enzyme activation could result from a functional uncoupling of the 
two domains. (iii) Mutations within the enzymatic EAL domain may directly enhance specific catalytic 
PDE activity or change the equilibrium between putative inactive and active conformations toward the 
latter. In agreement with such a mechanism, we isolated several suppressor alleles encoding single amino 
acid changes within the EAL domain in PdeL and PdeN. These mutations likely represent true activating 
mutations.  
Of the PDEs that were able to substitute for PdeH activity, PdeL is the best-characterized enzyme. In our 
study, we isolated 10 mutations affecting eight individual amino acid residues. Three of these were 
analyzed in detail and were shown to result in enhanced catalytic activity in vitro as well as enhanced 
pdeL expression. In principle, both properties could contribute to the observed suppression phenotype. 
At low substrate concentrations, i.e., below the observed KM of about 1 µM, the cellular turnover of c-di-
GMP (catalyzed by PdeL) would be increased by a factor of about 10 for the suppressor mutants, as a 
consequence of a 2-fold increase in specific PDE activity and a 5-fold increase in expression. The increase 
in specific PDE activity of PdeL mutants is intriguing and warrants a closer analysis. Figure 7 shows the 
locations of all identified mutations that map to the two known wild-type PdeL EAL crystal structures 
[62]. It is striking that none of the mutated sites are part of the active site that is located at the C-terminal 
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end of the central b-barrel. This enforces the notion that it is not trivial to optimize the catalytic properties 
of an enzyme through a directed- evolution approach. Rather, the increase in activity may be due to 
subtle second- or higher-shell effects that are difficult to predict. Alternatively, the mutations may change 
the thermodynamic equilibrium between (at least) two global conformational states with distinct 
catalytic activities.  
 
Figure 7 | Model for PdeL phosphodiesterase 
activation by suppressor mutations. (A) Two distinct 
EAL dimer structures are shown as obtained recently 
by X-ray crystallography [62]. The sites of suppressor 
mutations are shown in grey. Structure of the canonical 
“open” PdeL EAL dimer as determined in the presence 
of magnesium (green sphere) (PDB code 4LYK) is 
shown in orange (protomer A = opaque) and red 
(protomer B). Structure of the “closed” PdeL EAL 
dimer as determined in the presence of c-di-GMP/Ca2+
 
(PDB code 4LJ3) is shown in green (protomer A) and 
light green (protomer B = opaque). Protomer A of open 
dimer was aligned to protomer A of closed dimer to 
illustrate the large conformational movement between 
the two crystalized dimer species (indicated by black 
arrow). (B) Comparison of the PdeL EAL monomer 
structures of the “open” and “closed” dimers. Colors 
are the same as those shown in panel A (green with 
loop 6 in pink, “open” dimer; orange with magenta 
loop, “closed” dimer). In addition to the mutation sites 
(dark gray residues), the substrate c-di-GMP, the 
calcium ions M1 and M2 (yellow), magnesium ion M1 
(bright green), and highly conserved metal-
coordinating aspartates 262 and 263 at the end of b-
strand 5 are highlighted. The latter precedes loop 6 and 
has been implicated in catalysis regulation [62].  
 
 
We favor the second scenario, since it was recently shown that the EAL domain of PdeL exhibits exquisite 
inherent regulatory properties [62]. The domain can adopt two states that differ drastically in their 
catalytic activity: a virtually inactive monomeric state and a catalytically competent dimeric state. 
Coupling of a quaternary state to the precise geometry of the active site, and thus to catalytic activity, 
appears to be mediated by the b5-a5 loop (loop 6) that constitutes a major part of the dimerization 
interface (Figure 7), as also observed in other EAL structures [207]. Intriguingly, it was also shown that 
the EAL domain of PdeL can adopt two distinct dimer conformations, both involving similar 
dimerization interfaces (formed mainly by loop 6 and helices a5 and a6) but showing drastically different 
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relative monomer arrangements (“open” (Figure 7A) and “closed” (Figure 7B) dimers) [62]. It has not 
yet been studied whether both kinds of dimers also exist in solution and, if so, what their relative catalytic 
activities and the equilibrium constant between them would be.  
In light of this structural information, we propose that the fully characterized suppressor mutations 
(G299S, F206S, and F249L) shift the thermodynamic equilibrium of PdeL from an inactive or lowly active 
state (EAL domain monomer or dimer of low activity) toward the active state (highly active dimer). 
Structurally, the shift of the equilibrium would be due to different effects of the suppressor mutations on 
the two alternative dimerization interfaces (Figure 7A & B). Indeed, amino acid 299 is part of 
dimerization helix a6, though the added side chain would not project directly toward the interface. The 
two phenylalanines, residues 206 and 249, are part of the hydrophobic core that is formed by the packing 
of helices a4 and a5 onto the central b-barrel. Upon mutation at these sites, the two helices may well shift 
relative to the b-barrel, causing a perturbation of that part of the interface, which is formed by the N-
terminus of a5 and the preceding a5-b5 loop (loop 6). Reassuringly, suppressor mutations F207W/F and 
L261Q map to the same hydrophobic core, and an increase of activity due to a similar mechanism is 
predicted. Residues T266 and T270 are part of loop 6 (Figure 7C), the part of the structure that changes 
most between the two PdeL conformations. Thus, differential stabilization of the possibly more active 
conformation (or destabilization of the inactive conformation) is conceivable.  
Our findings suggest that in addition to its enzymatic function, PdeL can also be a transcription factor 
and a sensor for c-di-GMP. We showed that increased activities of PdeL variants containing suppressor 
mutations result in increased levels of the respective proteins. The observation that the stability of these 
activated mutant variants was unaltered, together with the finding that the activity of the pdeL promoter 
was increased in the suppressor strains, strongly argued that PdeL exhibits autoregulation. Transcription 
of pdeL could respond directly to PdeL activity or conformation or could be controlled indirectly through 
cellular levels of c-di-GMP, which drop as a consequence of increased PdeL activity. The finding that the 
pdeL promoter is strongly upregulated in cells harboring low levels of c-di-GMP but inhibited at high c-
di-GMP concentrations strongly argued for the latter. Finally, the observation that c-di-GMP-mediated 
regulation of pdeL promoter strength strictly depended on PdeL itself and on its intact DNA binding 
domain suggested that PdeL is able to sense cellular levels of c-di-GMP and, in response, tune its own 
expression. Considering the domain architecture of PdeL, it seems plausible that the EAL domain is 
involved in sensing c-di-GMP concentrations, while the LuxR-type DNA binding domain is likely 
required for transcriptional autoregulation. While the exact mechanism and physiological significance of 
this feedback control remain to be elucidated, it is notable that a similar mechanism was described 
recently, in which PdeR plays a role both as an enzyme and as a sensor for c-di-GMP [80]. This example 
illustrates that an active phosphodiesterase can adopt additional functions to control gene expression in 
response to substrate availability. Thus, PdeL and PdeR are conceptually very similar in that both 
proteins “measure” c-di-GMP via an unknown mechanism and in turn regulate gene expression. But 
while PdeR engages in a signaling complex together with an independent transcription factor, PdeL 
apparently has evolved more independence by recruiting and directly coupling a DNA binding domain 
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to its catalytic domain. Proteins coupling metabolite availability to gene expression control are common 
in bacteria and were termed trigger enzymes [149]. It will be interesting to clarify the regulatory details 
and similarities of these systems and to analyze how widespread this phenomenon is among 
phosphodiesterases. 
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Materials & Methods 
Bacterial strains, plasmids, and growth conditions 
The bacterial strains and plasmids used in this study are listed in Table S1 in the supplemental material. 
E. coli K-12 MG1655, obtained from Blattner et al. [202], and its derivatives were grown as indicated in 
the relevant sections. When needed, antibiotics were included at the following concentrations: 30 µg/ml 
chloramphenicol for plasmids, 20 µg/ml chloramphenicol for chromosomal chloramphenicol resistance 
cassettes, 12.5 µg/ml tetracycline, 50 µg/ml kanamycin, 100 µg/ml ampicillin for plasmids, and 30 µg/ml 
ampicillin for chromosomal ampicillin resistance cassettes. 
 
DNA work 
(i) PCR amplification. Each PCR mixture contained the following: 1x polymerase buffer (NEB), a mix 
containing a 0.1 mM concentration of each deoxynucleoside triphosphate (dNTP), 0.3 µM forward 
primer, 0.3 µM reverse primer, 10-20 pg template DNA, and 0.7 µL Taq polymerase (NEB). For colony 
PCR, a single colony was picked up with a pipette tip and resuspended in the PCR mixture.  
(ii) Gel electrophoresis. Five microliters of PCR product was mixed with DNA loading dye, loaded into 
a 1 % agarose gel supplemented with a 1:20,000 dilution of RedSafe DNA stain (iNtRON), and separated 
using 1x Tris-borate-EDTA (TBE) buffer. DNA was analyzed under UV light.  
(iii) Sequencing. Linear DNA was purified using NucleoSpin extract II (Macherey-Nagel). Sequencing 
reactions were carried out by Microsynth AG (Balgach, Switzerland). The sequences obtained were 
assembled and analyzed using 4Peaks (mekentosj).  
(iv) Plasmid preparation. Plasmid DNA was purified using a Gen-Elute plasmid miniprep kit (Sigma) 
according to the commercial protocol.  
(v) TSS transformation. Transcription start site (TSS) transformation of plasmid DNA was carried out 
as previously described [209].  
(vi) Electroporation. For electroporation of purified linear DNA with a Bio-Rad GenPulser cuvette (1 
mm diameter), the following electroporation settings were applied: 400 W, 1.75 kV, and 25 µF.  
 
P1 phage lysate preparation and transduction 
P1 phage lysate preparations and transductions were carried out essentially as described by Miller [210]. 
 
l-RED recombineering 
(i) Chromosomal gene deletions and modifications. Gene deletions were carried out essentially as 
described by Datsenko and Wanner [211], with the use of a comprehensive mutant library (Keio 
collection [[212]]) and P1-mediated transduction. Chromosomal 3xFlag-tags were constructed according 
to the published method of Uzzau et al. ([213]). For unmodified strains, AB330 was used (Table S1), 
whereas pKD46 was used for construction of 3xFlag-tagged versions of the motile suppressor mutants. 
Kanamycin resistance markers used for selection during strain construction were removed by site-
		68 | 
specific recombination using pCP20, generating a short, “Frt” scar sequence which replaced the deleted 
gene or cotransduced kanamycin resistance marker [211]. 
(ii) Construction of lacZ promoter fusions. The construction of chromosomal lacZ promoter fusions was 
constructed via l-RED-mediated recombination essentially as described above. AB989 (Table S1) was 
used as a template for construction of the reporter fusion. AB989 contains Prha-ccdB and a flanking 
kanamycin resistance cassette which is inserted upstream of the native lacZ locus. The donor PCR 
fragment harboring the promoter of interest was designed to site-specifically excise Prha-ccdB and 
integrate upstream of the lacZ open reading frame (ORF), generating a merodiploid translational fusion. 
Selection of successful integration events was achieved through growth at 30°C on minimal medium 
plates provided with 0.2 % rhamnose supplemented with 0.5 µg/ml biotin. The fusion was transduced 
into strains of interest via P1 transduction. 
 
Immunoblotting 
Cells were grown with shaking in tryptone broth (TB) at 37°C until an optical density at 600 nm (OD600) 
of 0.5-0.8. An equivalent of 1 mL of cells at an OD600 of 1.0 was pelleted and resuspended in 100 µL SDS 
Laemmli buffer. For detection of 3xFlag-tagged PdeA and its derivatives, the cells were resuspended in 
30 µL SDS loading dye. Cells were lysed by boiling the sample at 98°C for 15 min. Eight microliters of 
the total cell extract was loaded onto a 12.5 % SDS-polyacrylamide gel, and proteins were transferred by 
use of a Bio-Rad wet blot system. Proteins were detected with a 1:10,000 dilution of mouse anti-Flag 
monoclonal antibody (Sigma) and a 1:10,000 dilution of horseradish peroxidase (HRP)-conjugated rabbit 
anti-mouse secondary antibody (DakoCytomation, Denmark). Proteins were visualized by use of an 
enhanced chemiluminescence (ECL) detection reagent (PerkinElmer Life Sciences) on a photo film (Fuji) 
or gel imager (GE ImageQuant LAS 4000). 
 
Suppressor screen 
The strains used for the genetic forward screen of individual PDEs are listed in Table S1 in the 
supplemental material. Each strain was transformed with pwspR. For each screen, 300 TB swarm plates 
supplemented with tetracycline were prepared, among which 100 were supplemented with 5 µM 
isopropyl-b-D-thiogalactopyranoside (IPTG) and 100 were supplemented with 20 µM IPTG. Single 
colonies of the screening strain harboring pwspR were applied to screening plates. The screening plates 
were incubated at 37°C. Over the course of a week, all plates displaying motile suppressor mutants 
showed visible flares spreading from the center of inoculation. The motile suppressor mutants were 
isolated and pooled in a liquid LB culture. A pool lysate was prepared and transduced into AB607 
(∆pdeH). Transductants were picked up and placed on TB swarm plates supplemented with kanamycin 
and 20 mM sodium citrate. After incubation at 37°C for 3 to 4 h, the motile suppressor mutants that 
appeared were restreaked, and the ORF of the PDE of interest was sequenced. 
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Video tracking 
Bacterial swimming speed measurements were carried out essentially as described by Boehm et al. ([78]). 
Briefly, bacteria were grown in TB at 37°C to an OD600 of 0.5-0.8. Cells were diluted 1:100 into fresh TB 
and applied to a coverslip that was attached to a glass slide with two-sided adhesive tape. Two videos 
of 30 sec each were recorded at 15 fps with a video microscope and dark-field optics at a magnification 
of 40x. The acquired videos were imported into ImageJ 1.43 (NIH), and trajectories were calculated with 
the “2D particle tracker” plug-in. Velocities and statistical data were computed via a custom-made R 
script. 
 
C-di-GMP measurements 
C-di-GMP measurements were performed according to the published procedure of Spangler et al. ([99]). 
Briefly, E. coli cells were grown in 5 mL TB at 37°C until an OD600 of 0.5-0.8. The culture was pelleted and 
washed in 300 µL ice-cold distilled H2O. After washing, the cell pellet was resuspended in 300 µL ice-
cold extraction solvent (acetonitrile/methanol/distilled H2O, 40/20/20 [vol/vol/vol]). After incubating on 
ice for 15 min, the samples were boiled at 100°C for 15 min. After pelleting, the supernatant was 
transferred to a safe-lock tube, and the extraction procedure was repeated twice with 200 µL extraction 
solvent. Biological triplicates were performed for each tested bacterial strain. Measurements were 
performed in collaboration with the group of Volkhard Kaever (Institute of Pharmacology, Hannover, 
Germany) via high-pressure liquid chromatography–tandem mass spectrometry (HPLC-MS/MS). 
Measured values were mathematically converted into intracellular c-di-GMP concentrations (µM) per 
CFU.  
 
Attachment assay 
Attachment assays were carried out as described by Boehm et al. ([214]). Briefly, 5 µL of a shaking 
overnight culture grown in TB at 37°C was used to inoculate 200 µL TB provided in a 96-well microtiter 
plate (Falcon, NJ). The plate was incubated statically at 30°C for 24 h. For quantification of cellulose-
dependent attachment, cells were incubated statically in TB at room temperature for 24 h. After recording 
of the OD600 of the total biomass, the planktonic phase of the culture was discarded and the wells were 
washed with deionized water from a hose. The total attached biomass was stained with 300 µL 0.3% 
crystal violet (0.3 % [vol/vol] in distilled H2O, 5 % [vol/vol] 2-propanol, 5 % [vol/vol] methanol) for 20 
min. Subsequently, the plate was washed, and the remaining crystal violet-stained biomass was 
dissolved in 20 % acetic acid for 20 min and quantified by measuring the OD600. Attachment was 
normalized to the initially measured total biomass.  
 
Protein purification 
(i) Strep II purification. C-terminally Strep II-tagged wild-type and mutant variants of pdeL were cloned 
into a pET28a vector (Novagen) between the NcoI and NotI restriction sites. Proteins were overexpressed 
from plasmids in BL21-AI cells grown at 30°C in 2 L of LB medium. At an OD600 of 0.6, the culture was 
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induced with 0.1 % L-arabinose. Cells were harvested at 4 h post induction by centrifugation at 3,500 
rpm for 30 min at 4°C. The cell pellet was resuspended in 8 mL buffer A (100 mM Tris-HCl, pH 8.0, 250 
mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 1 mM dithiothreitol [DTT]) including a tablet of Complete mini 
EDTA-free protease inhibitor (Roche) and a spatula tip of DNase I (Roche). Cells were lysed in a French 
press and the lysate cleared at 4°C in a table-top centrifuge for 40 min at full speed. The cleared 
supernatant was loaded onto 1 mL Strep-Tactin Superflow Plus resin (Qiagen). The supernatant was 
reloaded another two times before washing with a total of 60 ml buffer A. Protein was eluted as 500 µL 
aliquots with a total of 10 mL elution buffer A containing 2.5 mM D-desthiobiotin. Fractions with the 
highest protein concentrations were pooled.  
(ii) Heparin purification. A 1 mL HiTrap heparin HP column (GE Healthcare) was washed with 10 mL 
distilled H2O followed by equilibration with 10 mL buffer A. The eluate from the StrepII purification was 
loaded three times. After loading, the column was washed with 10 ml buffer A followed by a washing 
step with 10 mL buffer B (100 mM Tris-HCl, pH 8.0, 300 mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 1 mM 
DTT). The protein was eluted in 500 µL fractions with a total of 10 mL buffer C (100 mM Tris-HCl, pH 
8.0, 1 M NaCl, 5 mM MgCl2, 0.5 mM EDTA, 1 mM DTT). The fractions containing the highest protein 
concentrations were pooled and dialyzed overnight against 1.5 L of dialysis buffer (100 mM Tris-HCl, 
pH 8.0, 250 mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 1 mM DTT). The final protein concentration was 
recorded at 280 nm, and the content of copurified nucleotides was determined through the 260/280 nm 
ratio. 
 
C-di-GMP hydrolysis assay and data fitting (phosphate sensor assay) 
PdeL-catalyzed conversion of c-di-GMP to the linear pGpG dinucleotide was measured indirectly by a 
novel alkaline phosphatase (AP) phosphate sensor online assay. In this assay, the terminal phosphate of 
the pGpG product is cleaved by the coupling enzyme AP (20 U/µL; 5 U in assay mixture; Roche), and the 
phosphate concentration is determined from the fluorescence increase through binding of phosphate to 
the phosphate sensor (0.5 µM in assay mixture; Life Technologies).  
Dialysis buffer was used as the assay buffer. The assay was performed at a protein concentration of 100 
nM and substrate concentrations ranging from 100 nM to 5 M, in a final volume of 300 µL in a 5-mm by 
5-mm cuvette (Hellma Analytics). Progress curves were recorded with a Jasco FP-6500 fluorescence 
spectrophotometer at 20°C. The instrument set- tings were as follows: bandwidth (excitation), 5 nm; 
bandwidth (emission), 5 nm; excitation wavelength, 430 nm; emission wavelength, 468 nm; response, 1 
s; sensitivity, low; and data pitch, 2 s.  
The measured progress curves of fluorescence increases were fitted to the following scheme: 
 
(i) 
 
 
 
c-di-GMP+PDE KD 	PDE← →⎯⎯ c-di-GMPiPDE KD 	PDE← →⎯⎯ PDE+pGpG
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(ii) 
 
 
 
(iii) 
 
 
 
 
with the measured relative fluorescence units (RFU) originating from the uncomplexed (RFU1) and 
complexed (RFU2) sensors, as follows:  
 
 
 
By a sufficiently large concentration of AP, it was ensured that reaction 2 was not rate limiting. The 
equilibrium dissociation constant for PS (Kd PS) was obtained by phosphate titration in the absence of 
enzymes. Fitting of the data with this kinetic model was done with a custom-built Python script using 
NumPy and SciPy libraries. The corresponding differential equations were integrated with the 
assumption that product formation is the rate-determining step. The kinetic parameters of the PDE (Kd 
PDE and kcat) as well as the scaling parameters (sc and gain) were refined globally for each series of 
experiments measured with various substrate concentrations. An observed slight background increase 
with time was taken into account by addition of a linear term with locally refined parameters. Fitted 
progress curves as well as individual Km and kcat values are documented in Figure S2 and Table S2 in 
the supplemental material.  
 
Electrophoretic mobility shift assay (EMSA) 
Cy3-labeled DNA probes were generated via either oligonucleotide annealing or PCR, using E. coli 
MG1655 as the template. Oligonucleotides used are indicated in the oligonucleotide list in Table S1 in 
the supplemental material. DNA (10 nM) was incubated with purified PdeL-StrepII (0, 200, 400, or 600 
nM) for 10 min at room temperature in 10 µL buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10 mM 
MgCl2, 10% glycerol, 1 mM DTT, 0.01 % Triton X-100, 0.1 mg/mL bovine serum albumin [BSA], and 25 
µg/ml DNA). After electrophoresis on 8 % polyacrylamide gels, DNA-protein complexes were analyzed 
using a Typhoon FLA 7000 imager (GE Healthcare). 
 
b-galactosidase reporter assay 
Strains were grown in TB overnight at 37°C. The next day, cultures were diluted 1:1,000 in fresh medium 
and grown with shaking at 37°C to an OD600 of 0.8. An equivalent of 1 mL of culture at an OD600 of 1.0 
pGpG+AP⎯→⎯ PiGpG+Pi
P+PS KD 	PS← →⎯⎯ PiPS
RFU=RFU1+RFU2= sc×PS× sc×gain×PiPS
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was pelleted and resuspended in 1 mL Z-buffer (75 mM Na2HPO4, 40 mM NaH2PO4, 1 mM KCl, 1 mM 
MgSO4; pH 7.0). 100 µL of 0.1 % SDS was added together with 20 µL chloroform. The samples were 
vortexed for 20 sec and then left on the bench to sediment until samples cleared up. Two hundred 
microliters of each sample was transferred to a 96-well plate. Twenty-five microliters of a 4 mg/ml s-
nitrophenyl-b-D-galactopyranoside (sNPG) solution (dissolved in Z-buffer) was added as the substrate. 
The b-galactosidase activity was measured in a plate reader at 405 nm (20 reads; fastest interval) and 
determined as the initial slope of the curve in the linear range. Experiments were carried out as biological 
triplicates.  
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Strains, plasmids and oligonucleotides 
Table S1A 
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Abstract 
Bacteria preferentially colonize surfaces and air-liquid interfaces as matrix embedded communities 
called biofilms. Biofilms exhibit specific physiological properties, including general stress tolerance, 
increased antibiotic recalcitrance and tolerance against phagocytic clearance. Together this largely 
accounts for increased biofilm persistence, chronic infections and infection relapses. One of the principle 
regulators of biofilm formation is c-di-GMP, a bacterial second messenger controlling various cellular 
processes. Cellular levels of c-di-GMP are controlled by two antagonistic enzyme families, diguanylate 
cyclases and phosphodiesterases. But despite the identification and characterization of an increasing 
number of components of the c-di-GMP network in different bacterial model organisms, details of c-di-
GMP mediated decision-making have remained unclear. In particular, how cells shuttle between specific 
c-di-GMP regimes at the population and single cell level is largely unknown and moreover how these 
transitions are deterministically made in time and space, given that bacterial networks of diguanylate 
cyclases and phosphodiesterases show a high degree of complexity. 
Here we describe a novel mechanism regulating c-di-GMP mediated biofilm formation in E. coli. This 
mechanism relies on the bistable expression of a key phosphodiesterase that acts both as catalyst for c-
di-GMP degradation and as a transcription factor promoting its own production. Bistability results from 
two interconnected positive feedback loops operating on the catalytic and gene expression level. Based 
on genetic, structural and biochemical analyses we postulate a simple substrate-induced switch 
mechanism through which this enzyme can sense changing concentration of c-di-GMP and convert this 
information into a bistable c-di-GMP response. This mechanism may explain how cellular heterogeneity 
of small signaling molecules is generated in bacteria and used as a bet hedging strategy for important 
lifestyle transitions. 
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Introduction 
To maintain their own integrity and fitness, all living organisms need to be able to effectively change the 
cellular program in order to take over specialized functions or to respond to changes in the environment. 
To provide directionality to key cellular decisions such as changing cell shape and/or behavior, the 
respective regulatory networks need to be deterministic and robust. For example, stem cells need to 
stably maintain their replicative program but at the same time be capable to rapidly induce cell 
differentiation in response to external signals [215,216]. This is mainly achieved through positive 
feedback regulation and mutual cross-inhibition of master regulators activating downstream 
feedforward regulatory cascades [217]. Thus, although differentiation of cells is not terminal, reversion 
of this highly coordinated and robust process becomes harder, the more differentiation has proceeded 
[218]. 
In analogy, bacteria can transit between two different forms of behavior, a motile single cell and a sessile, 
community-based lifestyle called biofilm [161,162,219]. These two lifestyles are fundamentally different 
with respect to gene expression patterns and the overall physiological state of the cell [220-223]. 
Consequently, both the transition between and the stable maintenance of these two physiological states 
come with substantial costs. Thus, the decision to transit from single cell to community behavior requires 
fine-tuned regulatory processes that integrate environmental signals and – in response – establish robust 
and stable programs at the right time and space. While several aspects of cellular control mechanisms of 
this switch have been uncovered, it has remained unclear which factors contribute to the directionality 
and stability of this important bi- or multimodal program [224]. 
One of the central regulators of this physiological adaptation is the second messenger c-di-GMP. 
Discovered as a small signaling molecule stimulating cellulose production in Gluconacetoacter xylinus [1], 
c-di-GMP controls important behavioral processes such as motility [78], virulence [225], biofilm 
formation [110] or cell-cycle regulation [9]. Planktonic cells are associated with low intracellular c-di-
GMP concentrations [78,79], whereas sessile communities generally display high levels of c-di-GMP 
[128]. Most bacteria harbor large arrays of enzymes that synthesize (diguanylate-cyclases, DGC) or 
degrade c-di-GMP (phosphodiesterases PDE) to adjust their internal concentration of the second 
messenger in response to specific intrinsic or extrinsic signals [59,61,72-75]. The internal c-di-GMP 
concentration is then sensed by downstream effectors, which ultimately elicit a cellular function (see 
reviews [54,219]). The co-occurrence of multiple DGCs and PDEs, combined with hypersensitive 
downstream effectors (nM affinities) poses the problem of stochastic noise and network stability 
[161,162]. While in eukaryotic cells, compartmentalization can potentially shield cellular components 
from such effects, bacteria cannot rely on physical barriers. Thus, there is a necessity for systems that 
buffer stochastic fluctuations and establish precise threshold concentrations of c-di-GMP to initiate rapid 
program switch. We postulate that in order to install stable programs, cells harbor specialized enzymes 
with the ability to “sense” the prevailing c-di-GMP levels and are equipped with feedback control and 
		84 | 
non-linear behavior. In principle such a cellular component could generate populations with bistable c-
di-GMP steady states, where intermediate levels would be highly instable [226]. 
Here we characterize the c-di-GMP-specific phosphodiesterase and transcription factor PdeL from 
Escherichia coli K-12. We show that PdeL is feedback regulated both on the transcriptional and on the 
enzymatic level and that these properties install bistable c-di-GMP regimes in E. coli cells. PdeL 
transcription is under superordinate control by the central metabolic regulator Cra, which binds to the 
pdeL promoter region to recruit PdeL. PdeL stimulates its own expression in a c-di-GMP-dependent 
manner. This positive feedback loop on the transcriptional level is assisted by a double-negative feedback 
loop at the enzymatic level where c-di-GMP inhibits PdeL activity and PdeL itself negatively contributes 
to the c-di-GMP pool. As a consequence, PdeL shows high catalytic and transcription activity at low c-
di-GMP levels, while the protein is catalytically and transcriptionally inert when c-di-GMP levels are 
high. We present structural, biochemical and genetic evidence that PdeL catalysis and transcription are 
directly interlinked through a c-di-GMP-driven non-linear conformational switch of PdeL. This system 
generates bistable populations with a high degree of cellular memory that buffers against noise in c-di-
GMP distribution and establishes self-sustained heritable regimes of a potent small signaling molecule. 
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Results 
Cra and PdeL are activators of pdeL transcription 
To understand the determinants of pdeL auto-regulation, we set out to dissect the regulatory elements of 
the pdeL promoter region (Figure 1A). This region contains a s70-dependent promoter, 341 bp upstream 
of the pdeL start codon [227], a binding site for the central metabolic regulator Cra (catabolite repressor 
activator) [227,228], and a palindromic binding site for PdeL 675 bp upstream of the pdeL start codon [79]. 
We first confirmed that Cra binds with high affinity (KD = 49 nM) to a site 114 bp upstream of the pdeL 
promoter, which shows strong similarity to other Cra binding sites [228] (Figure 1A, B & S1A, B). EMSA 
experiments with different DNA fragments and oligonucleotides spanning the promoter region revealed 
an additional binding site for PdeL in the immediate vicinity of the Cra binding site (Figure 1A & B). 
PdeL binding to this site was dependent on the presence of Cra, indicating that Cra is able to recruit PdeL 
to this site upstream of the promoter. We thus termed this binding site Cra-dependent PdeL-box (CDB). 
Titration experiments revealed that PdeL binds to this DNA site with an affinity similar to Cra (KD = 76 
nM) (Figure S1C, D). In contrast, PdeL binds to the upstream Cra-independent binding site (CIB) with 
significantly lower affinity (KD = 573 nM) (Figure 1B & S1E, F). While c-di-GMP negatively impacts pdeL 
transcription [79], in vitro binding of PdeL to the CDB and CIB sites was not modulated by c-di-GMP 
(Figure 1B). 
Strains lacking Cra or PdeL showed strongly reduced pdeL promoter activity as compared to wild type 
(Figure 1C), arguing that both proteins help stimulating pdeL transcription. Scrambling of the Cra- or 
PdeL-boxes (Figure S1G, H), resulted in a similar reduction of pdeL promoter activity (Figure 1C). The 
observation that the cra deletion had a stronger effect as compared to the pdeL mutant, together with the 
observation that Cra is required for PdeL binding to the CDB site indicated that Cra acts upstream of 
PdeL in stimulating pdeL transcription. Scrambling one half-site of the CIB palindrome significantly 
reduced pdeL transcription 2.5-fold (Figure 1C).  
A previous study had shown that the histone-like protein H-NS binds to the intergenic region of pdeL 
[229]. After recognition of a specific nucleation consensus sequence [230-232], H-NS is described to 
polymerize across AT-rich DNA-stretches thus facilitating bending or bridging of DNA [233]. The pdeL 
promoter region has a relatively high AT content (66%) and contains several putative H-NS recognition 
sequences, one of which overlaps the 5’-palindrome half-site of the CIB (Figure 1A & S5). EMSA analyses 
showed that PdeL competes with H-NS for binding to the CIB (Figure 1D). In agreement with H-NS 
acting as a transcriptional silencer of pdeL [234], an hns mutant showed strong derepression of pdeL 
transcription (Figure 1C). 
Together these data indicated that Cra, PdeL and H-NS are critical regulatory elements of the pdeL 
promoter. The data suggested that H-NS acts as a transcriptional silencer, possibly by protecting large 
regions of the pdeL promoter region. 
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Figure 1 | Regulation of pdeL transcription. (A) Schematic representation of pdeL intergenic region (not to scale). Minimal 
binding regions for PdeL- and Cra-binding are shown in blue and green respectively. Palindromes or bases, which were 
identified to be crucial for transcription factor binding are highlighted in blue or green boxes respectively. Binding 
affinities for Cra and PdeL to respective binding boxes are shown as determined by EMSA (see Figure S1). H-NS 
recognition sequence is shown as web logo. Putative H-NS-recognition site overlapping with CIB is highlighted in orange. 
(B) Electrophoretic mobility shift assay (EMSA) of 5’ Cy3 labeled oligonucleotides, co-incubated with purified Cra-StrepII 
and PdeL-StrepII. (CDB = Cra-dependent PdeL-box; CB = Cra-box; CIB = Cra-independent PdeL-box). The position of the 
labeled oligonucleotides (4991-7 & 4695-6) within the intergenic region is depicted in (A). (C) b-galactosidase activity of 
merodiploid translational PpdeL-lacZ promoter fusion. Transcription factor recognition sequences were randomized to 
abolish binding. Mutations abolishing binding of PdeL to CIB were chosen to not affect H-NS recognition sequence. Inset 
shows domain architecture of PdeL. (D) Competition of PdeL and HN-S for CIB as determined by EMSA. Increasing H-
NS-StrepII concentrations were titrated to a fixed PdeL-StrepII concentration of 100 nM. (E) Effect of c-di-GMP on pdeL 
transcription. PdeL transcription was probed in strains with different c-di-GMP regimes (L = low c-di-GMP levels, which 
correspond to a ∆pdeH strain with 65 µM IPTG induction of plasmid-borne Plac-pdeH. H = high c-di-GMP levels, which 
correspond to a ∆pdeH strain with uninduced Plac-pdeH). Cellular PdeL protein levels – as determined by SRM LC-MS/MS 
– are shown above corresponding bars. c-di-GMP-dependent pdeL transcription is shown in CDB- and CIB- promoter 
mutation as well as in an hns mutant background. 
 
 
Cra and PdeL mediate c-di-GMP-dependent transcription of pdeL 
PdeL autoregulates transcription of the pdeL gene in response to the cellular levels of c-di-GMP [79] 
(Figure 1E). While pdeL transcription is maximal at low c-di-GMP concentration, it is strongly reduced at 
increased c-di-GMP levels. As a result, PdeL protein levels change roughly 6.7-fold from 201 nM ± 28 nM 
– 1352 ± 228 nM in strains with c-di-GMP levels ranging from 0 – ca. 7.6 µM (Figure S4). This c-di-GMP 
mediated response was not only dependent on PdeL itself, but was also impacted when the PdeL binding 
sites in the pdeL promoter region were mutated (Figure 1E). While scrambling the CDB site abolished 
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pdeL transcription, mutation of the CIB strongly diminished the dynamic range of pdeL promoter 
strength. These data suggested that the CDB is the primary control element of c-di-GMP-dependent pdeL 
transcription, while the distal CIB serves as an auxiliary site to enhance the dynamic range of c-di-GMP 
control. The c-di-GMP mediated control of pdeL transcription is completely abolished in an hns mutant 
(Figure 1E), arguing that H-NS acts as a silencer to gauge pdeL transcription to a range in which c-di-
GMP has the maximal dynamic range effect on pdeL transcription. 
 
 
Figure 2 | PdeL is a c-di-GMP sensor. PdeL transcription was 
measured via a chromosomal merodiploid translational 
PpdeL-lacZ reporter fusion in strains with different c-di-GMP 
regimes (L = low c-di-GMP levels, which correspond to a 
∆pdeH strain with 65 µM IPTG induction of plasmid-borne 
Plac-pdeH. H = high c-di-GMP levels, which correspond to a 
∆pdeH strain with uninduced Plac-pdeH, wt = wild type 
background with respective PdeL mutant variant and empty 
vector). This was performed for various mutant PdeL alleles: 
K60A = DNA-binding-deficient, S298F = dimerization-
deficient and E141A = c-di-GMP binding-deficient. For wild 
type, as well as variant E141A the binding affinity of 
fluorescein-labeled c-di-GMP (c-di-GMPfc) to PdeLEAL was 
determined in the presence of Mg2+. 
 
 
 
PdeL is a c-di-GMP sensor 
We previously showed that PdeL acts as a sensor for c-di-GMP by translating the intracellular c-di-GMP 
concentration into pdeL expression [79] (Figure 1E). To understand this link, we genetically dissected the 
properties of PdeL needed for c-di-GMP-dependent pdeL transcription. 
In our previous study [79], we introduced a DNA-blind PdeL mutant (K60A), which showed baseline 
pdeL expression, thus concluding that PdeL regulates its own expression. In line with these results a pdeL 
(K60A) allele remained transcriptionally insensitive to c-di-GMP (Figure 2). In agreement with our 
previously published data [79], this reinforces that PdeL itself is strictly required for c-di-GMP-
dependent pdeL autoregulation by binding to its own promoter region. 
In a previous study focusing on structural and biochemical characterization of the EAL-domain of PdeL 
it was shown that c-di-GMP drives PdeL dimerization [62]. Moreover, a crucial serine (S298) was 
identified as a key residue for dimerization. Mutation of this serine to a bulky aromatic amino acid fully 
abrogated dimerization and consequently enzyme activity [62]. Interestingly, mutation of S298 to 
phenylalanine (S298F) rendered the pdeL promoter irresponsive to c-di-GMP (Figure 2) arguing that c-
di-GMP-dependent transcription requires either the enzymatic activity of PdeL, its ability to dimerize or 
both. To further address this, we focused on the highly conserved glutamate as part of the name-giving 
EAL-motif, which was reported to be crucial for substrate binding [80]. Interestingly, alanine-substitution 
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of this particular glutamate (E141A) lead to derepressed and c-di-GMP-independent pdeL transcription 
(Figure 2). 
Given that – compared to the c-di-GMP blind E141A variant –  a dimerization deficient PdeL mutant 
shows wild-type-like substrate binding constants [62] these results suggest that absent c-di-GMP-
dependent pdeL transcription of a dimerization mutant is a consequence of impaired dimerization, rather 
that absent enzymatic activity. Form this we conclude that that c-di-GMP is sensed by binding to the 
active site of PdeL and thereby inducing dimerization to regulate pdeL transcription. 
 
 
 
 
Figure 3 | Characterization of PdeL dimer species. (A) Zoom of active site (green), loop 6 (loop itself shown in orange, 
region in magenta) and dimerization helices in canonical “open” dimer configuration (R-state) of PdeL EAL-domain as 
crystalized in apo in presence of Mg2+ (PDB: 4LYK). Dimerization helices a5 and b6’B are shown with electrostatic potential 
area. (B) Zoom of non-canonical “closed” dimer configuration, crystalized in presence of Ca2+ and c-di-GMP (PDB: 4LJ3). 
Coloring is analogous to (A), with loop 6 shown here in magenta. (C) Overlay of T-state dimer (blue hues) and protomer 
B of the R-state configuration (grey), depicting large quaternary rearrangements and positioning of loop 6. (D) c-di-GMP-
dependent pdeL Promoter activity of PdeL point mutations in the dimerization interface and loop 6. (L = low c-di-GMP 
levels, H = high c-di-GMP levels as introduced in Figure 1 & 2). Note that both D295N and T270A were isolated as a motile 
suppressor allele (see Figure S2). (E) In vitro cysteine-crosslink of PdeLEAL (Y268C)-StrepII with bismaleimidoethane 
(BMOE) (see Figure S3). Crosslinks were performed with Ca2+ to prevent c-di-GMP hydrolysis and in absence or presence 
of 50 µM c-di-GMP. As a negative control for Y268C-specific crosslink wild type PdeLEAL-StrepII was included. (F) 
Quantification of in vitro cysteine-crosslinks of PdeL mutant variants as described in (E). Graph shows ratio of band 
intensity between cysteine-crosslink in presence and absence of excess c-di-GMP, plotted as fold change. 
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Two dimer configurations of PdeL drive c-di-GMP-dependent pdeL transcription 
Given that both DNA-binding and dimerization of PdeL are prerequisites for pdeL transcription and that 
substrate binding induces dimerization, it is tempting to hypothesize that substrate-induced 
dimerization of the EAL-domain facilitates dimerization of the associated HTH-domains and therefore 
DNA binding. However, the observation that a dimerization-deficient mutant showed wild-type like 
binding to DNA (data not shown) lead us to test alternative hypotheses for how c-di-GMP-dependent 
PdeL autoregulation. Structural studies with the EAL-domain of PdeL revealed that PdeL can adopt two 
different dimer configurations [62]. In its apo form, PdeLEAL crystalized as a canonical “open” EAL-dimer 
(Figure 3A & C), whereas in its c-di-GMP-bound form, PdeL formed a non-canonical “closed” EAL-
dimer configuration (Figure 3B & C). For simplicity reason the canonical dimer configuration is termed 
R-state (relaxed) and the non-canonical configuration T-state (tight) throughout this study. Formation of 
the T-state requires the two dimerization helices a5A and a6’B to face each other via their positively 
charged N-termini. In order to enable this conformation, intercalation of the negatively charged D295B 
residue is strictly required (Figure 3A-C). Moreover formation of the two dimer configurations comes 
along with large structural movements in a highly conserved loop region, which connects strand b5 and 
a5 of the EAL TIM-barrel structure and is commonly termed loop 6 (Figure 3A-C) [62]. Loop 6 was shown 
to play a central role in PDE enzyme activity and to impact dimerization and the formation of higher 
oligomers [64]. In PdeL a striking feature of loop 6 is its ability to adopt two different conformations, 
which are attributed to the T- and R-state [62]. Alternative conformations of loop 6 are directed by (i) the 
dimer configuration, (ii) occupancy of the active site and (iii) E235, the so-called “anchoring glutamate”, 
which interacts either with active-site residue D263 (R-state) or with T270 (T-state), a central residue 
within loop 6 (Figure 3A & B). Thus, it appears that there is a loop 6-mediated bidirectional 
communication between the active site and the dimerization interface of PdeL. 
As a matter of fact, mutating the anchoring glutamate (E235A) lead to derepressed and c-di-GMP-
independent pdeL transcription (Figure 3D) arguing that destabilization of loop 6 favors a 
transcriptionally active species of PdeL. Based on the PdeLEAL structure, mutating the T-state interaction 
partner of the anchoring glutamate (T270) or the residue stabilizing the T-state conformation of 
dimerization helices a5 and a6’ (D295), should in principle phenocopy the effect of an E235A. This was 
confirmed by gain of function pdeL alleles (T270A & D295N), which were isolated in a selection screen 
for motile suppressors of a non-motile ∆pdeH strain (see [79] and Figure S2). Reassuringly, these 
mutations indeed fully abrogated c-di-GMP-dependent pdeL transcription control (Figure 3D). 
Thus, c-di-GMP seems to be sensed via the active site and this information translated via the conserved 
loop 6 to the dimerization interface in order to dictate the dimer configuration of PdeL, which in turn 
determines transcriptional activity of PdeL. 
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C-di-GMP determines PdeL dimer-species configuration 
The previous section suggested that PdeL can shuttle between a transcriptionally inert T-state and a 
transcriptionally active R-state dimer. Since pdeL transcription is a function of c-di-GMP levels, we 
postulated that c-di-GMP drives the switch between the two PdeL dimer configurations. In order to test 
this substrate-dependent regulation we performed cysteine cross-link assays with the catalytic domain 
of PdeL in presence and absence of c-di-GMP. These experiments were based on a cysteine substitution 
in residue Y268, which exclusively show close steric proximity to the R-state dimer (Figure S3). 
Bismaleimidoethane-mediated (BMOE) oxidation of Y268C revealed that in absence of c-di-GMP the R-
state variant is predominantly cross-linked (Figure 3E). Further, in line with our transcriptional data, 
mutations of crucial loop 6 residues or the aspartic acid intercalating between loop a5A and a6’B renders 
PdeL insensitive to a substrate-induced R- to T-state switch (Figure 3F). 
These data evoke a model where PdeL can adopt two alternative confirmations, the equilibrium of which 
is determined by the concentration of its substrate. While low c-di-GMP concentrations favor the 
transcriptionally active R-state, PdeL switches into the inert T-state at high substrate concentrations. 
 
 
PdeL enzyme activity scales with c-di-GMP concentrations 
The isolated motile-suppressor mutant alleles of PdeL were isolated in a strain background displaying 
high c-di-GMP levels (∆pdeH). Under such conditions, wild type PdeL does not show high enough 
activity to suppress this phenotype. Characterization of several motile suppressor alleles ([79] & Figure 
S2) showed enhanced enzymatic activity as well as derepressed pdeL transcription indicating that the 
suppressor mutations lock PdeL in a state in which c-di-GMP can no longer regulate PdeL and therefore 
display high activity even at high c-di-GMP levels. Together with the previous results we hypothesized 
that the c-di-GMP-driven equilibrium shift from the R-state to the T-state not only switches PdeL off as 
a transcription factor but also as an enzyme. 
To test this, we measured turnover rates of PdeL as a function of increasing substrate concentrations 
(Figure 4A). Indeed, we determined substrate concentration-dependent turnover rates that were nicely 
fitted with a substrate inhibition Michaelis-Menten model, thus confirming that PdeL activity negatively 
scales with increasing c-di-GMP levels. 
 
 
PdeL enzyme activity scales with PdeL concentrations 
In the previous sections, we showed that c-di-GMP drives pdeL transcription by determining the 
equilibrium between an enzymatically and transcriptionally inert T-state and highly active R-state 
configuration. As a consequence, within a c-di-GMP concentration range between 0 – 7.6 µM (Figure S4), 
PdeL protein levels inversely scale between 201 – 1352 nM (Figure 1E). Although this feature is 
commonly observed in transcription factors that regulate their own expression in response to a ligand 
[235] this autoregulation is particularly interesting given that PdeL is a bona fide c-di-GMP-specific 
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phosphdiesterase. Thus, increasing PdeL levels could in principle also impact PdeL enzyme activity and 
by that have substantial implications on the feedback loop itself as well as on general cell physiology. To 
address this question, we determined turnover rates of PdeL as a function of PdeL concentration. PdeL 
turnover rates showed a non-linear apparent kcat, with half-maximal activation at ca. 1.5 µM PdeL 
concentration (Figure 4B). From this we concluded that one reason for building up PdeL levels is a net 
increase in PdeL enzyme activity. 
Since our data reinforces the notion that there is bidirectional communication between the dimer 
configuration and the active site via loop 6, we hypothesized that – in addition to substrate controlled 
dimer-state equilibrium – PdeL itself can drive the equilibrium between the inert T-state and highly 
active R-state. To test this, we measured enzyme activity of the D295N R-lock variant as a function of 
protein concentrations. We could clearly show that – compared to wild type – an R-lock mutant shows a 
protein concentration-independent kcat, which is comparable to the highest kcat values measured for wild 
type PdeL (Figure 4B). 
This argues that in addition to substrate-regulated T- to R-state equilibrium, the dimer configurations of 
PdeL are a function of PdeL levels itself therefore possibly strongly enhancing the equilibrium shift from 
a transcriptionally and enzymatically inert T-state to a highly active R-state. 
 
 
PdeL controls the global c-di-GMP pool 
Determination of PdeL enzyme activity revealed that PdeL activity is a function of substrate 
concentration (Figure 4A) as well as the PdeL concentration itself (Figure 4B). Moreover, since PdeL 
levels are determined via the cellular c-di-GMP levels (Figure 1E), these properties allow PdeL to show 
maximal activity at low c-di-GMP concentrations. As a consequence, PdeL might be an important 
component to adjust the cellular c-di-GMP pool in response to c-di-GMP changes. To test this, we 
compared the cellular c-di-GMP levels of a ∆pdeH and a ∆pdeH ∆pdeL background in which we tuned 
the levels of c-di-GMP by expressing plasmid-borne Plac-pdeH. To assess the effect of PdeL on increasing 
and decreasing c-di-GMP levels, we pre-established initially low or initially high levels of c-di-GMP by 
either fully (Figure 4C) or not inducing (Figure 4D) Plac-pdeH over night. While PdeL did not seem to 
accelerate a decrease in c-di-GMP, PdeL showed a strong buffering effect at rising c-di-GMP levels, 
leading to a maximal difference in cellular c-di-GMP concentration of ca. 2 µM (Figure 4D). 
These data clearly show that – depending on the initial c-di-GMP concentration – PdeL significantly 
contributes to the global c-di-GMP pool. PdeL functions as a buffer for increasing c-di-GMP 
concentrations, while we could not observe a PdeL-driven boost when c-di-GMP levels decrease. It might 
nevertheless be that under the conditions tested such an effect is masked by the overriding PDE activity 
of PdeH. 
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Figure 4 | Properties of PdeL enzyme activity, effect of PdeL on global c-di-GMP pool and cooperativity of pdeL 
transcription. (A) Apparent kcat at 37°C of 500 nM PdeL-StrepII as a function of increasing substrate concentrations. 
Enzyme activity was measured with FPLC as published in [62]. Data points were fitted with a Michaelis-Menten substrate 
inhibition model. Green area depicts physiologically relevant c-di-GMP concentration range (see (B)). (B) Apparent kcat of 
PdeL-StrepII at 37°C as a function of PdeL concentration (wt = black, motile suppressor and R-lock mutant D295N = red). 
Enzyme activity was measured with phosphate sensor method as previously published in [79]. Data points were fitted 
with a simple Michaelis-Menten model. Green area depicts physiologically relevant PdeL concentration range (see Figure 
1E). Cellular c-di-GMP concentration were measured by nucleotide extraction from cell extracts and subsequent 
quantification by LC-MS/MS. Measurements were performed in a ∆pdeH strain expressing plasmid-borne Plac-pdeH. To 
establish a c-di-GMP history with initial high levels of c-di-GMP, plasmid was not induced during over night growth at 
37°C in TB medium (C), whereas plasmid was induced with 65 µM IPTG to generate initially low levels of c-di-GMP (D). 
Experiments were performed in a ∆pdeH strain (blue) and a ∆pdeH ∆pdeL strain (black). Before sampling, over night 
cultures were diluted back 1:500 and grown for 4.5 h in TB medium at 37°C (final OD600 of ca. 0.4). Experiments were 
performed as biological triplicates. Data points show mean of replicates and standard deviations are shown in grey and 
blue area. Curves show Michaelis-Menten fit with hill coefficient. (E) Schematic of feedback loops determining pdeL 
transcription. PdeL is in an equilibrium between T- and R-state. Upper loop = double-negative enzymatic feedback loop 
where high c-di-GMP levels shift the equilibrium towards the enzymatically and transcriptionally active R-state. 
Enzymatic feedback loop can be opened by a catalytically inactive PdeLEL- mutant (PdeL (D263N) (K283R)), which is still 
able to sense c-di-GMP. Lower loop = transcriptional feedback loop. Chromosomal construct of Ptet-driven pdeL (Ptet-pdeL) 
opens transcriptional feedback loop. (F) Cooperative behavior of PdeL-dependent pdeL transcription shown as fold change 
compared to lowest measured value (nFC). Experiment was performed in a ∆pdeH background with chromosomal Ptet-
pdeL or Para-pdeL (violet data points) and plasmid borne Plac-pdeH. Black curve = full induction of Plac-pdeH to generate 
background devoid of c-di-GMP. Stippled black curve = no induction of Plac-pdeH to generate high c-di-GMP levels. Red 
curve = PpdeL-lacZ reporter strain with mutated CIB measured in absence of c-di-GMP. Data points were fitted with a 
Michaelis-Menten fit with hill-coefficient. Data points of stippled black curve were fitted with horizontal line. Stippled 
grey line shows Khalf of Michaelis-Menten fits. Black curve Khalf = 317 nM, red curve Khalf = 693 nM). Green area depicts 
physiologically relevant cellular PdeL concentration (see Figure 1E). 
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PdeL expression is highly cooperative and requires the Cra-independent PdeL-box 
At his stage, the data allow us to place PdeL in the center of two interlinked positive feedback loops. (i) 
a double-negative enzymatic feedback where c-di-GMP inhibits PdeL enzyme activity and PdeL 
negatively affects the c-di-GMP pool and (ii) a positive transcriptional feedback loop where increasing 
PdeL levels enhance pdeL transcription (Figure 4E). When present in noisy systems, positive feedback 
loops can give rise to bistability [236-239], especially when these feedback loops show strong non-linear 
or cooperative behavior. The observation that pdeL transcription is driven by two intricate positive 
feedback loops suggests that pdeL transcription shows cooperative behavior. 
We tested whether the pdeL promoter responds in a cooperative manner to increasing PdeL levels. To do 
so we measured pdeL transcription as a function of PdeL levels by driving PdeL from a chromosomal 
tetracycline-inducible promoter (Ptet-pdeL). To exclude the c-di-GMP effect on pdeL transcription we 
performed this experiment in a strain devoid of c-di-GMP (full Plac-pdeH induction in a ∆pdeH 
background). We observed that pdeL transcription reacts in a highly cooperative manner (nh = 3.4) to 
increasing levels of PdeL, with a half-maximal activation constant of 368 nM PdeL (Figure 4F). 
To address the source of cooperativity we focused on the distal Cra-independent PdeL-box (CIB). We 
previously described and characterized the palindromic and Cra-independent low-affinity binding box 
for PdeL (CIB), which – when mutated – significantly reduced pdeL transcription (Figure 1C). The 
observation that a CIB- strain still responded to c-di-GMP but reduced the overall dynamic range of pdeL 
transcription (Figure 1E), argued that c-di-GMP control goes via the CDB and that the CIB serves as an 
enhancing auxiliary element. We therefore asked to what extend the CIB contributes to pdeL expression 
as a function of PdeL levels. Again, we expressed PdeL from our previously introduced Ptet-pdeL 
construct in a strain background devoid of c-di-GMP and measured the pdeL promoter response. 
Interestingly the pdeL CIB- promoter responded in a non-cooperative manner (nh = 1.1) with a half-
maximal activation constant (Khalf) of 693 nM (Figure 4F). Interestingly, the activation constant is 25-fold 
higher than the determined in vitro KD for PdeL binding to the CDB (Figure 1A & S1C, D) suggesting 
that other cellular factors such as H-NS might possibly occlude the CDB thus resulting in weaker binding 
in vivo. 
From this we concluded that the upstream PdeL binding-box serves as an auxiliary element to generate 
a cooperative, switch-like pdeL promoter activation in response to increasing PdeL levels. 
 
 
PdeL transcription is bistable 
In the previous section, we showed that the pdeL promoter reacts in a cooperative manner to PdeL levels. 
In the light of positive feedback regulation, this property might be the framework for bistable expression 
of pdeL. A hallmark of bistability is hysteresis, which describes the discrepancy in activation energies 
depending on the initial resting state of a system [239-241]. This feature ultimately endows a system with 
intrinsic memory and can lead to the establishment of bistable and bimodal populations [242]. 
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To test this, we performed hysteresis experiments in vivo. In order to modulate c-di-GMP levels we made 
use of the previously described Plac-pdeH expression system, which we introduced in a ∆pdeH 
background. Either not inducing or fully inducing the plasmid over-night allowed us to pre-establish a 
history with high or low levels of c-di-GMP respectively. In these two backgrounds, we finely tuned the 
c-di-GMP levels and measured pdeL transcription as a function of c-di-GMP in exponential growing cells. 
In this experiment, we saw a remarkable hysteresis window with a window size of ca. 5 log, within a c-
di-GMP concentration range of 0.1 nM and ca. 5 µM (Figure 5A). Interestingly, after 4.5 h growth, pdeL 
on-kinetics did not reach the maximal possible transcription level in absence of c-di-GMP. 
Although c-di-GMP-dependent pdeL regulation shows strong hysteresis it might nonetheless be that the 
memory quickly collapses over time, which would argue against a highly stable system. We thus re-
performed the hysteresis experiment after 8 h of continuous cultivation in exponential phase. The pdeL 
on-kinetics curve now reached maximal pdeL transcription levels at c-di-GMP concentrations as high as 
0.3 µM (Figure 5B), thus converging towards the off-kinetics curve, yet showing a still significantly 
present hysteresis window. 
This experiment reinforces that c-di-GMP-dependent pdeL transcription not only shows strong 
transcriptional memory but can maintain this memory over long timescales, thus confirming the strong 
bistable nature of pdeL transcription. 
 
 
Enzymatic feedback loop is not required for pdeL bistability 
At this point we aimed to dissect the requirements for bistable c-di-GMP-dependent pdeL transcription. 
As previously described, pdeL transcription depends on two intricate self-amplifying feedback loops 
(Figure 4E). We therefore asked, which of the two feedback loops has the greatest contribution or is even 
essential for the establishment of bistability. To open the enzymatic feedback loop we made use of a PdeL 
variant, which has a mutation in the conserved double-aspartic acid motif (D263N) as well as the 
conserved catalytic base (K283R), both residues which are essential for enzymatic activity (Figure S4). In 
fact, the individual mutations render PdeL catalytically inactive. Transcriptionally however the 
individual mutations show an inverse behavior. While both individual mutations abrogate c-di-GMP-
dependent pdeL transcription control, D263N shows basal and K283R derepressed pdeL transcription. 
Surprisingly, combination of both mutations fully restored c-di-GMP-dependent pdeL transcription 
control, while still being catalytically inactive. Although a mechanistic explanation is hard to reconcile, 
this particular mutant can be exploited to study c-di-GMP-dependent pdeL transcription in absence of 
PdeL catalytic activity, thus opening the enzymatic feedback loop (Figure 4E). For simplicity, the PdeL 
(D263N) (K283R) mutant will be termed PdeLEL- (EL- = enzymatic loop) throughout this study. Re-
performing the hysteresis experiment with PdeLEL- after 8 h continuous cultivation in exponential phase 
(Figure 5C), showed a hysteresis pattern resembling wild type (Figure 5C) with still significantly present 
hysteresis window. 
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From this we concluded that bistability of pdeL does not depend on the enzymatic feedback loop. Rather 
the enzymatic feedback loop adds a strong time component to the persistence of hysteresis by 
contributing to steady-state levels of c-di-GMP. 
 
 
 
 
Figure 5 | Bistability and bimodality of pdeL. Hysteresis experiment showing pdeL transcription as a function of cellular 
c-di-GMP levels. Strain background is ∆pdeH Plac-pdeH. black curve represents strain background grown over night with 
no induction of plasmid-borne pdeH = initial high c-di-GMP levels. Blue curve represents strain background grown over 
night with full induction of plasmid-borne pdeH = low initial c-di-GMP levels. Through gradual expression of pdeH, black 
curve shows pdeL on-kinetics due to reduction of c-di-GMP levels and blue curve shows pdeL off-kinetics due to increasing 
c-di-GMP levels. Curves were fitted with Michelis-Menten model with Hill-coefficient. (A) Experiment performed in a 
wild type strain after 4.5 h exponential growth and (B) 8 h continuous cultivation. Red area depicts c-di-GMP concentration 
range in which bimodality was observed on single-cell level. (C) Hysteresis experiment performed with enzymatic 
feedback loop-deficient PdeLEL- variant after 4.5 h exponential growth. (D) Experiment performed analogous to (A) with 
a strain with mutated CIB after 4.5 h exponential growth. (E-H) Quantification of single cell fluorescence of a pdeL-[RBS-
mCherry]2 reporter fusion in a ∆pdeH background. Hysteresis experiment was performed analogous to (A-D) by tuning 
Plac-pdeH in a strain where Plac-pdeH was previously fully induced (blue) or not induced (black) over night. Histograms 
shown as violin plots. Conditions where bimodality was observed on single cell level are outlined red. 
 
 
CIB is required for pdeL bistability 
The previous section showed that pdeL bistability is still present in absence of the enzymatic feedback 
loop. Moreover, considering that the transcriptional feedback loop reacts highly cooperative to 
increasing PdeL levels (Figure 4E) and cooperativity is often the basis for bistable systems, we focused 
on the contribution of the CIB on pdeL bistability. We previously showed that cooperative pdeL 
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transcription is dependent on the CIB (Figure 4F). Thus, we asked whether an intact CIB is a prerequisite 
for bistability. To test this, we performed a hysteresis experiment after 4.5 h exponential growth in a CIB- 
strain background. In addition to the previously observed overall lower pdeL transcription (Figure 1C & 
E), pdeL CIB- transcription showed no apparent hysteresis (Figure 5D), confirming that transcription 
hysteresis and thus establishment of bistability requires the auxiliary CIB. 
 
 
Bistable expression of pdeL generates bimodal populations 
The behavior of individuals within a clonal population will ultimately determine how a population will 
adapt to environmental changes, which in this particular case are changes in c-di-GMP levels. It is mostly 
observed that bistable systems also manifest in bimodality on the single-cell level [243]. These properties 
help to establish life-strategies such as bet-hedging and/or division of labor, which significantly 
contribute to the fitness of a whole population [236,243,244]. In the previous section, we observed strong 
and time-dependent bistability of pdeL expression on the population level. To address how this translates 
to individual cells we re-performed the hysteresis experiment on the single-cell level by measuring 
fluorescence of a transcriptional pdeL-[RBS-mCherry]2 fusion. 
Here we observed that while pdeL on-kinetics showed a unimodal – yet switch-like – behavior, down-
kinetics showed clear bimodal population split at c-di-GMP concentrations of ca. 2 µM (Figure 5E). In 
contrast, after 8 h pdeL transcription showed bimodal behavior during pdeL on-kinetics (Figure 5F) at a 
c-di-GMP concentration, which coincides with the hysteresis window seen at the population level 
(Figure 5B). In line with this observation, a pdeL CIB- promoter mutant that does not show bistability on 
population levels (Figure 5D) is monomodal on the single cell level (Figure 5H). 
Thus, c-di-GMP-dependent and bistable pdeL transcription establishes bimodality, which depends on 
time and the c-di-GMP history of the cells, both of which depend on a functional transcriptional feedback 
loop. 
 
 
The enzymatic feedback loop is required for pdeL bimodality 
On the population level, we clearly saw that the enzymatic feedback loop is not required to establish 
bistability (Figure 5C) but rather determines the half-life of the transcription memory by contributing to 
the global c-di-GMP pool (compare Figure 5B & C). In the light of PdeL being a candidate for the 
establishment of bimodal c-di-GMP regimes, we asked, whether the enzymatic feedback loop is required 
to establish bimodal pdeL expression and consequently bimodal c-di-GMP regimes. We therefore 
determined single cell pdeL expression after 8 h continuous cultivation in exponential phase of a PdeLEL- 
variant, which lost its ability to degrade c-di-GMP in response to the prevailing c-di-GMP levels. 
Strikingly we found that – although showing strong bistability on the population level (Figure 5C) – a 
PdeL variant with inactive enzymatic feedback loop fully loses its ability to establish bimodal 
populations (Figure 5G). 
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These data suggest that initial c-di-GMP heterogeneity is sensed by PdeLEL- and amplified into a bistable 
pdeL promoter response. As PdeLEL- is catalytically inactive, it cannot amplify the initial c-di-GMP 
heterogeneity into discrete bimodal c-di-GMP regimes within a population. Thus, within the two positive 
feedback loops that drive c-di-GMP-dependent pdeL transcription, PdeL enzyme activity is dedicated to 
establish bimodal c-di-GMP regimes. 
 
 
Figure 6 | Effect of PdeL on c-di-GMP-
dependent processes. (A) Crystal-Violet-
based staining of attached biomass during 
gradual expression of plasmid-borne Plac-
pdeH. Biofilm formation of a DpdeH 
background (blue) and ∆pdeH ∆pdeL 
background (black), both with constitutive 
chromosomal pgaA-D expression (Pconst-pgaA-
D). In order to start with low c-di-GMP levels 
strains were grown over night with full 
induction of plasmid-borne Plac-pdeH. (B) 
Quantification of planktonic cells escaping a 
pre-formed biofilm. A csrA- DpdeH (black) and 
csrA- DpdeH DpdeL (blue), equipped with 
plasmid-borne Plac-pdeH were incubated for 8 
h static at 30°C to form a biofilm. After 
washing, fresh medium supplemented with 
increasing amounts of IPTG was added to the 
pre-formed biofilm and incubated static at 
30°C for 3 h. Escaped planktonic cells were 
quantified by dot-spotting serial dilutions and 
determination of cfu/mL. Black bars represent 
median cfu/mL, error-bars show upper and 
lower quartile. (C) Schematic showing the 
effect of PdeL on global c-di-GMP and related 
phenotypes. A clonal populations experiences 
noise in the intracellular c-di-GMP levels. Large changes in the cellular c-di-GMP concentration are governed by the action 
of upstream cyclases (DGCs) and phosphodiesterases (PDEs) and either buffered or accelerated by PdeL the enzymatic 
action of PdeL itself. A strong net decrease in c-di-GMP levels leads to strong upregulation of PdeL (red cells) and 
concomitant contribution of PdeL to decreasing c-di-GMP levels. As a consequence, most cells will show phenotypes 
associated with low c-di-GMP levels (yellow) such as motility (= flagellated cells). Respectively a strong net increase in c-
di-GMP levels will inhibit both enzymatic and transcriptional activity of PdeL. This will generate a population with the 
majority of cells showing phenotypes associated with high c-di-GMP levels (purple) such as biofilm formation (depicted 
as thicker cell outline). In the case of noise-induced intermediate c-di-GMP levels, PdeL will act as a decision maker and 
establish a bimodal population. 
 
 
PdeL is a gatekeeper for motile-sessile lifestyle transcription 
The dissection of the feedback loops driving c-di-GMP-dependent pdeL transcription, showed that PdeL 
is in the center of two positive feedback loops, which sense c-di-GMP but at the same time affect the c-
di-GMP pool itself (Figure 4E). This suggests that within a certain c-di-GMP concentration window, PdeL 
can have a substantial impact on the global c-di-GMP pool and therefore on c-di-GMP-related cellular 
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processes. To test this, we looked at the effect of PdeL on the formation of biofilms and the escape from 
preformed biofilms, which both are processes known to be regulated by c-di-GMP [128]. To this end we 
chose to test the effect of PdeL on poly-GlcNAc-dependent (PGA) biofilm formation, since it was 
previously described that this system is post-translationally regulated by c-di-GMP with an activation 
constant of 62 nM [110]. In order to test the effect of PdeL on biofilm entry we took advantage of our Plac-
pdeH expression system to tune c-di-GMP in strain backgrounds, with initially low c-di-GMP levels. In 
order to uncouple the translation of the pga operon from the upstream BarA-UvrY/CsrA-cascade [245], 
we expressed the pga operon from a weak constitutive promoter. While the wild type strain showed a 
sharp and steep response to increasing c-di-GMP levels, the pdeL mutant prematurely increased biofilm 
formation at already much lower c-di-GMP levels compared to wild type (Figure 6A). Apparently, one 
role of PdeL is to buffer c-di-GMP noise and to prevent premature entry into biofilm mode. Since PdeL 
is a phosphodiesterase it could in principle also confer an advantage to cells trying to escape from an 
existing biofilm. We thus designed an experiment in which we compared the ability of a csrA- ∆pdeH and 
a csrA- ∆pdeH ∆pdeL to escape from a preformed biofilm upon reduction of c-di-GMP levels through 
induction of plasmid-borne PdeH. While escape rates remained low over a range of c-di-GMP levels 
(PdeH induction), a strain harboring pdeL displayed significantly higher escape rates even at relatively 
low PdeH induction (Figure 6B). 
Thus, PdeL not only buffers against premature entry into biofilms as c-di-GMP levels increase in 
response to DGC activity, but it also promotes cellular escape from biofilms as c-di-GMP levels drop in 
response to PDE activity. These results provide physiological relevance to PdeL as a cellular component 
facilitating rapid and robust lifestyle switches.
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Discussion 
Binary switches between alternative cellular programs are key features of natural systems contributing 
to cellular homeostasis or population fitness in fluctuating environments. The second messenger c-di-
GMP directs a series of important cellular processes in bacteria including motility, virulence and biofilm 
formation. But how are c-di-GMP dependent programs regulated considering that this cellular network 
might exhibit considerable internal noise and is highly sensitive and complex? Is the internal noise in 
this network a basis for “all-or-nothing” phenotypes? Are these decisive phenotypes beneficial in nature? 
And if so how are stochastic fluctuations amplified or buffered to drive deterministic and robust lifestyle-
decisions? Here we identify the phosphodiesterase PdeL as a central element of c-di-GMP homeostasis 
in E. coli. We demonstrated that PdeL activity and expression respond to c-di-GMP and by coupling 
enzymatic and transcriptional feedback provides bistable c-di-GMP regimes and rapid responses at c-di-
GMP threshold levels. 
Based on our genetic and biochemical data we propose the following working model: PdeL is recruited 
to the pdeL promoter region by the Cra regulator at metabolic conditions that favor gluconeogenesis [246]. 
When intracellular c-di-GMP levels are high, PdeL adopts the non-canonical T-state dimer configuration. 
In this static conformation, the active sites of both protomers are occupied with substrate thereby shifting 
PdeL into a conformation that is both catalytically and transcriptionally inert. When cellular levels of c-
di-GMP drop, the fully loaded and inert T-state is destabilized, thereby shifting the equilibrium to the 
canonical R-state dimer configuration, which is highly active both as an enzyme and as a transcription 
factor. This model is supported by the observations that mutations, which generally abolish either 
substrate binding such as E141A or the stabilization of loop 6 or the dimerization helices in the T-state 
conformation (E235A, T270A, D295N) lead to derepressed and c-di-GMP-irresponsive pdeL transcription 
(Figure 3D & F). 
We conclude that relieving the T-state through reduction of the c-di-GMP regime initiates an equilibrium 
shift from an inert to a catalytically and transcriptionally highly active PdeL species. This will have two 
effects: (i) derepression of the catalytic activity of PdeL enhanced decrease of c-di-GMP and (ii) 
substantially increase in PdeL levels. The latter is of great importance, since apart from the substrate-
mediated effect on pdeL transcription we observed that pdeL transcription and PdeL enzyme activity is a 
function of PdeL levels itself. Since it is not conceivable, how increasing PdeL levels might positively 
affect an equilibrium between to dimer species, we suggest that increasing PdeL levels will allow PdeL 
to bind to the upstream low affinity Cra-independent PdeL-box (CIB) therefore inducing tetramerization 
of PdeL with a PdeL dimer bound to the Cra-dependent PdeL-box (CDB). We suggest that 
tetramerization will further shift the equilibrium towards the R-state, resulting in maximal 
transcriptional and catalytic activity. This is corroborated by the observation that loss of the CIB impairs 
maximal promoter response. In addition, tetramerization might aid to displace the general gene silencer 
H-NS off the intergenic region of pdeL. In fact, the intergenic region of pdeL displays several regions 
strongly resembling the consensus recognition sequence of H-NS, one of which we showed overlaps with 
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the CIB and for which both H-NS and PdeL compete (Figure S5). Thus, occupation of the CIB at 
increasing PdeL levels likely induces tetramerization of PdeL, eventually facilitating a robust ON-state 
of pdeL transcription and catalytic activity. 
In this study, we show that placing an enzyme – which at the same time is a transcription factor – in the 
center of two interconnected positive feedback loops (Figure 4E), allows to sense the prevailing c-di-
GMP concentration and translate this information into autoregulation. As a c-di-GMP specific 
phosphodiesterase PdeL will feed back into the global c-di-GMP pool and concomitantly impose robust 
c-di-GMP regimes. While it is unclear whether the commitment of such a component is to generate 
stochasticity or to amplify already existing fluctuation, it appears that coupling of a transcription factor 
with an enzyme is a smart way to fulfill either of the two tasks (Figure 6C). This might have implication 
in both the establishment of environmental biofilm structures as well as survival in the host environment. 
The need to stably reside in either of the two states becomes evident when microscopically observing E. 
coli macrocolonies. These structures are highly organized displaying vegetative, flagellated cells at the 
nutrient-rich bottom and curli and cellulose expressing cells in the upper – nutrient limiting – layers 
[201]. Here, PdeL could be a key player to maintain low c-di-GMP levels in the lower nutrient rich areas. 
Moreover, it has been observed that these structures are not homogeneous. In fact, one can frequently 
find curli-ON and flagellated curli-OFF cells side-by-side even in the upper layers of such macrocolonies. 
This might have two implications: (i) According to the cross-sections of the macrocolonies it appears that 
flagella of cells trapped within these structures serve as a scaffold for secreted curli fibers and cellulose. 
(ii) Moreover, in line with our observations, that pdeL facilitates cell-dispersal from mature biofilms its 
bistable nature might be beneficial in order to maintain regions with flagellated cells at the surface of 
these structures to allow for occasional single-cell dispersal. 
We postulate that PdeL is a central module to allow for bet hedging and division of labor in fluctuating 
environments. Thus, during its voyage through the host, including the shedding into the non-host 
environment, E. coli encounters ever-changing environments to which the phenotypic heterogeneity 
within a population strongly contributes in terms of survival. Therefore, nature must have selected for 
modules that drive phenotypic heterogeneity such as PdeL. 
Thinking of PdeL as a transcription factor it is hard to reconcile that – with PdeL levels fluctuating 
between ca. 200 and 1000 molecules per cell – PdeL is solely required for c-di-GMP-dependent 
autoregulation. It is more likely that PdeL engages into two major tasks: (i) autoregulation according to 
the metabolic- and c-di-GMP-status, which eventually affects the global c-di-GMP pool to facilitate 
robust lifestyle transitions in a bistable and bimodal manner and (ii) c-di-GMP-dependent regulation of 
secondary genes involved in either of the two major lifestyles. These two properties could be inextricably 
linked, since full activation of PdeL activity to affect the global c-di-GMP pool, might need saturation of 
all PdeL binding sites on the E. coli chromosome. The use of ChIP-Seq and proteomics to unravel and 
characterize the complete PdeL-regulon will be the aim of future work. 
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Materials & Methods 
Bacterial strains and growth conditions 
The bacterial strains and plasmids used in this study are listed in Table S1. E. coli K-12 MG1655 from 
Blattner et al. [202] and its derivatives were grow as indicated in the dedicated methods sections. When 
needed antibiotics were present at following concentrations: 30 µg/mL chloramphenicol for plasmids 
and 20 µg/mL chloramphenicol for chromosomal chloramphenicol resistance cassettes, 50 µg/mL 
kanamycin, 100 µg/mL ampicillin for high copy plasmids and 30 µg/mL for low or single-copy plasmids. 
 
P1 phage lysate preparation and transduction 
P1 phage lysate preparation and transduction were carried out as described in [210]. 
 
Gene deletions and l-RED-mediated recombineering 
Chromosomal gene deletions and modifications: Gene deletions were essentially carried out either as 
described by Datsenko et al. [211] or with the use of a comprehensive mutant library (“Keio collection” 
[212]) and P1 mediated transduction. Chromosomal 3xflag-taging of genes was carried out according to 
the published method by Uzzau et al. [213]. For unmodified strains AB330 (see strain list Table S1) was 
used, whereas pKD46 was used for construction of strains already harboring chromosomal 
modifications. Selection markers were removed by site-specific recombination using pCP20 [211]. 
Construction of promoter-lacZ fusions: Construction of chromosomal promoter-lacZ fusions were carried 
out via λ-RED-mediated recombination as described above. AB989 (see strain list Table S1) was used as 
a recipient strain. The donor PCR fragment harboring the promoter of interest was designed to site-
specifically excide Prha-ccdB and integrate upstream of the native lacZ ORF to generate a merodiploid 
translational fusion. Successful integration events were selected through growth on rhamnose minimal 
plates. 
 
Electrophoretic mobility shift assay (EMSA) 
5’ Cy3-labeled input DNA was generated either via oligonucleotide annealing or PCR. For 
oligonucleotides used see Table S1. 10 nM of the input DNA and purified proteins were incubated for 
10 min at room temperature in buffer consisting of 50 mM Tris-HCl pH 8.0, 50 mM NaCl, 10 mM MgCl2, 
10 % glycerol, 1 mM DTT, 0.01 & Triton X-100, 0.1 mg/mL BSA and 25 µg/mL λ-DNA. As indicated in 
the figures, samples were incubated in the presence or absence of 2 mM CaCl2 and 50 µM c-di-GMP. 
Samples were run on 8 % polyacrylamide gel. DNA-protein complexes were analyzed using Typhoon 
FLA 7000 (GE healthcare). 
 
b-galactosidase reporter  
Strains were grown in TB medium o/n at 37°C. The next day cultures were diluted back 1:500 into fresh 
medium and grown at 37°C until desired OD600. 500 µL of the culture were mixed with 380 µL Z-buffer 
		 | 103 
(75 mM Na2HPO4, 40 mM NaH2PO4, 1 mM KCl, 1 mM MgSO4), 100 µL 0.1 % SDS and 20 µL chloroform. 
Samples were vortexed for 10 sec and left on the bench for 15 min. 200 µL sample were transferred into 
a clear 96-well plate (Falcon). As substrate 25 µL 4 mg/mL σ-nitrophenyl-b-D-galactopyranoside (σNPG) 
solution (dissolved in Z-buffer) were added. The initial velocity of the color reaction was determined at 
a wavelength of 420 nm. 
 
Protein purification 
All strepII-tagged proteins were purified using the same method. PdeLEAL variants were purified by a 
single StrepII-tag affinity purification, whereas for full-length PdeL and other transcription factors a 
heparin purification step was added.  
StrepII purification: All proteins were cloned into a pET28a vector (Novagen) between NcoI and NotI 
restriction sites. Proteins were overexpressed in BL21 (AI) cells grown at 30°C in 2 L LB medium. For 
overexpression of mutant protein variants, the corresponding wild type version of the gene was deleted 
in the overexpression strain. At an OD600 of 0.6 the culture was induced with 0.1 % L-arabinose. Cells 
were harvested 4 h post induction by centrifugation at 5000 rpm for 30 min at 4°C. The cell pellet was 
resuspended in 7 mL Buffer A (100 mM Tris-HCl pH 8.0, 250 mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 1 
mM DTT) including a tablet of c0mplete mini EDTA-free protease inhibitor (Roche) and a spatula tip of 
DNaseI (Roche). Cells were lysed by 4 passages of french press and the lysate cleared at 4°C in a table-
top centrifuge set at full-speed for 40 min. The cleared supernatant was loaded on 1 mL StrepTactin 
Superflow Plus resin (QIAGEN). The supernatant was reloaded another two times before washing with 
a total of 50 mL Buffer A. The column was washed with 10 mL Buffer B (100 mM Tris-HCl pH 8.0, 50 
mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 1 mM DTT). 500 µL aliquots of proteins were eluted with Buffer 
B supplemented with 2.5 mM d-Desthiobiotin. 
Heparin Purification: A 1 mL HiTrap Heparin HP column (GE healthcare) was washed with 10 mL H2Odest., 
followed by an equilibration with 10 mL Buffer B. The eluate from the StrepII-tag affinity purification 
was loaded three times. After loading the column was washed with 10 mL Buffer A followed by a 
washing step with 10 mL Buffer C (100 mM Tris-HCl pH 8.0, 350 mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 
1 mM DTT). The protein was eluted in 500 µL fractions with a total of 10 mL Buffer D (100 mM Tris-HCl 
pH 8.0, 2 M NaCl, 5 mM MgCl2, 0.5 mM EDTA, 1 mM DTT). The fractions containing the highest protein 
concentration were pooled and dialyzed o/n at 4°C against 1.5 L Dialysis Buffer (100 mM Tris-HCl pH 
8.0, 250 mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 1 mM DTT). PdeLEAL variants used for cysteine crosslink 
assays were dialyzed against CXA Buffer (100 mM Tris-HCl pH 7.2, 250 mM NaCl, 2 mM EDTA). The 
final protein concentration was recorded at 280 nm and the content of co-purified nucleotide 
contaminants determined as a ration of 260/280 nm. 
 
Immunoblotting 
Cells were grown in TB medium at 37°C until desired OD600. An equivalent of 1 mL of an OD600 of 1.0 
was pelleted and resuspended in 100 µL SDS Laemmli buffer. Cells were lysed by boiling the sample at 
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98°C for 10 min. 8 µL of the total cell extract were loaded onto a 12.5 % SDS-polyacrylamide gel and 
proteins transferred using a BioRad® wet blot system. Proteins with 3xflag-tag were detected with a 
1:10.000 dilution of monoclonal mouse α-Flag monoclonal antibody (Sigma) and a 1:10.000 dilution of 
polyclonal rabbit α-mouse horseradish-peroxidase (HRP) secondary antibody (DakoCytomation, DK). 
Proteins were visualized with enhanced chemiluminescence (ECL) detection reagent (Perkin Elmer Life 
Science) and imaged in a gel imager (GE ImageQuant LAS 4000). 
 
C-di-GMP hydrolysis assay 
Phosphate Sensor assay: Phosphate sensor assay was essentially performed as described in [79]. Briefly: 
Conversion of c-di-GMP into pGpG was measured indirectly by a coupled alkaline phosphatase 
(AP)/phosphate sensor online assay. The terminal phosphate of the pGpG product is cleaved by the 
coupling enzyme AP (20 U/µl, Roche), and the phosphate concentration is determined from the 
fluorescence increase through binding of phosphate to the phosphate sensor (0.5 µM; Life Technologies). 
PdeL and c-di-GMP concentrations were used as shown in the individual experiments. Fluorescence 
increase was detected by excitation at 430 nm end emission at 468 nm. 
FPLC assay: Assay was performed as described in [62]. Enzymatic activity was assayed offline by FPLC-
based steady-state nucleotide quantification following incubation for varying durations. Enzymatic 
reactions were carried out at 20°C in 100 mM Tris-HCl pH 8.0, 250 mM NaCl, 5 mM MgCl2, 0.5 mM 
EDTA, 1 mM DTT and 50 M thiamine pyrophosphate as FPLC standard. PdeL and c-di-GMP 
concentrations were used as described in the result section. The reaction was started by addition of 
enzyme to a total reaction volume of 600 µl. Samples volumes of 100 µl were withdrawn and the reaction 
was stopped at different time points by addition of 10 µl of 100 mM and subsequent heating at 98°C for 
10 min. 
The samples were then analyzed using ion-exchange chromatography (1-mL- Resource-Q column) after 
addition of 890 µL of 5 mM ammonium bicarbonate (NH4 CO3) to increase the volume to 1 mL. 500 µL 
of this was then loaded onto the column. The column was washed thoroughly and the bound nucleotides 
were eluted with a linear NH4CO3 gradient (5 mM to 1 M) over 17 column volumes. The amount of pGpG 
product was determined by integration of the corresponding absorption (253 nm) peak after 
normalization of the data with respect to the internal thiamine pyrophosphate standard. 
 
Cysteine crosslink assay 
10 µM PdeLEAL-3xFlag-StrepII variants purified in CXA Buffer (100 mM Tris-HCl pH 7.2, 250 mM NaCl, 
2 mM EDTA) were incubated for 10 min at room temperature in presence of 10 mM CaCl2 either in 
presence or absence of 50 µM c-di-GMP. Proteins were crosslinked for 1 h at room temperature with an 
8-fold molar excess (80 µM) of bismaleimidoethane (BMOE) (ThermoFisher Scientific). Crosslink reaction 
was quenched for 15 min at room temperature by addition of 50 mM DTT. Samples were supplemented 
with SDS Laemmli buffer and proteins denature by heating at 98°C for 5 min. Samples were loaded on a 
12.5 % SDS-polyacrylamide gel and detected by staining with Coomassie Brilliant Blue. 
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Microscopy 
Fluorescence and differential interference contrast (DIC) microscopy was performed on a DeltaVision 
Core (Applied Prescision, USA) microscope equipped with an Olympus 100X/1.30 Oil objective and an 
EDGE/sCMOS CCD camera. Cells were placed on a PBS pad solidified with 1% agarose. Exposure time 
for microscopy picture was 0.05 sec for bright field (POL) and 0.3 s for mCherry. For both settings, the 
ND filter was set to 100% transmission. 
 
Analysis of microscopy images 
Cell outlines of images were determined by open source software-package Oufti [247]. Outlines were 
used to compute mean single cell fluorescence by our custom made program WHISIT [248]. 
 
C-di-GMP measurements 
C-di-GMP measurements were performed according to the published procedure by Spangler at al. [99]. 
In brief: E. coli cells were grown in 24 mL TB medium at 37°C until an OD600 of 0.5. Cells were pelleted 
and washed in 300 µL ice-cold H2Odest.. After washing the cell pellet was resuspended in 300 µL ice-cold 
extraction solvent (acetonitrile/methanol/H2Odest., 40/20/20 v/v/v). After pelleting, the supernatant was 
transferred into a 2 mL safe-lock tube and the extraction procedure repeated twice with 200 µL extraction 
solvent. Biological triplicates were performed. Measurements were performed in collaboration with the 
group of Prof. Volkhard Kaever (Institute of Pharmacology, Hannover) via HPLC-MS/MS. Measured 
values were mathematically converted into cellular c-di-GMP concentration. Constants of E. coli cell 
volume and cfu/mL needed for calculation were experimentally determined. 
 
Absolute protein concentration determination via selected reaction-monitoring (SRM) LC-MS 
analysis 
600 µL of an E. coli culture grown in TB to an OD600 of ca. 0.5 were pelleted and washed twice with 1 mL 
ice-cold PBS. Cells were lysed in 1 % sodium deoxycholate (SDC), 100 mM Tris pH 8.5 by sonication. 
Proteins were denatured by heating at 95°C for 10 min. Protein alkylation was performed with 
chloracetamide. Protein digestion was performed by subsequent treatment with Lys-C (enzyme/protein 
ratio 1:200) and trypsin (enzyme/protein ratio 1:50). Peptides were acidified with TFA and desalted using 
PreOmics (ThermoFisher) cartridges. 
To each peptide samples an aliquot of a heavy reference peptide mix was spiked into each sample at a 
concentration of 20 fmol of heavy reference peptides per 1µg of total endogenous protein mass. The 
heavy peptide mix contained 10 chemically synthesized proteotypic peptides (JPT Peptide Technologies 
GmbH) of the two target proteins (5 peptides each) that showed the highest MS1 responses in a previous 
large-scale study [249]. In a first step, selected reaction-monitoring (SRM) assays [250] were generated 
from a mixture containing 500 fmol of each reference peptide and shotgun LC-MS/MS analysis on a Q-
Exactive HF platform. The setup of the µRPLC-MS system was as described previously 
[251].Chromatographic separation of peptides was carried out using an EASY nano-LC 1000 system 
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(Thermo Fisher Scientific), equipped with a heated RP-HPLC column (75 µm x 37 cm) packed in-house 
with 1.9 µm C18 resin (Reprosil-AQ Pur, Dr. Maisch). Peptides were analyzed per LC-MS/MS run using 
a linear gradient ranging from 95% solvent A (0.1% formic acid) and 5% solvent B (99.9% acetonitrile, 
0.1% formic acid) to 45% solvent B over 60 minutes at a flow rate of 200 nL/min. Mass spectrometry 
analysis was performed on Q-Exactive HF mass spectrometer equipped with a nanoelectrospray ion 
source (both Thermo Fisher Scientific). Each MS1 scan was followed by high-collision-dissociation (HCD) 
of the 10 most abundant precursor ions with dynamic exclusion for 20 seconds. Total cycle time was 
approximately 1 sec. For MS1, 3e6 ions were accumulated in the Orbitrap cell over a maximum time of 
100 ms and scanned at a resolution of 120,000 FWHM (at 200 m/z). MS2 scans were acquired at a target 
setting of 1e5 ions, accumulation time of 50 ms and a resolution of 30,000 FWHM (at 200 m/z). Singly 
charged ions and ions with unassigned charge state were excluded from triggering MS2 events. The 
normalized collision energy was set to 27%, the mass isolation window was set to 1.4 m/z and one 
microscan was acquired for each spectrum.  
The acquired raw-files were searched against a decoy database using the MaxQuant software (Version 
1.0.13.13) containing normal and reverse sequences of the predicted SwissProt entries of E. coli 
(www.ebi.ac.uk, release date 2016/05/02), retention time standard peptides and commonly observed 
contaminants (in total 10402 sequences) generated using the SequenceReverser tool from the MaxQuant 
software (Version 1.0.13.13). The precursor ion tolerance was set to 10 ppm and fragment ion tolerance 
was set to 0.02 Da. The search criteria were set as follows: full tryptic specificity was required (cleavage 
after lysine or arginine residues unless followed by proline), 3 missed cleavages were allowed, 
carbamidomethylation (C) was set as fixed modification and arginine (+10 Da), lysine (+8 Da) and 
oxidation (M) were set as a variable modification. The resulting msms.txt file was converted to a spectral 
library panel with the 5 to 10 best transitions for each peptide using an in-house software tool. This was 
then imported into the SpectroDive program (Version 7.5, Biognosys, Schlieren, Switzerland) and a 
transition list for quantitative SRM analysis was generated. Here, all samples were analyzed on a TSQ-
Vantage triple-quadrupole mass spectrometer coupled to an Easy-nLC (Thermo Fisher, Scientific). In 
each injection, an equivalent of 1.5 µg of peptides including heavy peptide references was loaded onto a 
custom-made main column (Reprosil C18 AQ, 3 µm diameter, 100 Å pore, 0.75 × 300 mm) and separated 
using the same gradient mentioned above. The mass spectrometer was operated in the positive ion mode 
using ESI with a capillary temperature of 275 °C, a spray voltage of +2200 V. All of the measurements 
were performed in an unscheduled mode and a cycle time of 2 sec. A 0.7 FWHM resolution window for 
both Q1 and Q3 was set for parent- and product-ion isolation. Fragmentation of parent-ions was 
performed in Q2 at 1.2 mTorr, using collision energies calculated with the SpectroDive software (version 
7.5). Each condition was analyzed in biological quadruplicates. All raw-files were imported into 
SpectroDive for absolute peptide and protein quantification.  
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Attachment assay 
Attachment assays were carried out as described by Böhm et al [214]. Briefly: 200 µL TB medium 
provided in a clear 96-well microtiter plate (Falcon) were inoculated 1:40 with an o/n culture grown at 
37°C. The plate was incubated statically at 37°C for 24 h unless indicated differently. After recording the 
OD600 of the total biomass, the planktonic phase of the culture was discarded and the wells washed with 
H2Odest. from a hose. The remaining attached biomass was stained with 200 µL 0.3 % crystal violet (0.3 % 
(w/v) in 5 % (v/v) 2-propanol, 5 % (v/v) methanol) for 20 min. The plate was washed with H2Odest. from a 
hose and the stained biofilm dissolved in 20 % acetic acid for 20 min. Intensity of crystal violet stain was 
quantified at 600 nm and normalized to the initially measured total biomass. 
 
Biofilm escape assay 
Cells harboring pAR81 (see plasmid list Table S2) were given 7 h time at 30°C to attach to 96-well 
microtiter plate supplemented with TB medium supplemented with ampicillin. Plate was gently washed 
with deionized water from a hose and dried for 20 min. Fresh medium supplemented with IPTG to 
induce plasmid-borne Plac-pdeH was added to the wells and incubated for 3 h at 30°C. After incubation, 
10 µL of the planktonic phase were isolated to determine cfu/mL by spotting serial dilutions in LA plates 
supplemented with ampicillin. 
 
Motility assay 
A single colony was picked onto a TB swarmer plate (0.3 % agar). Plates were incubated at 37°C for 3-4 
h. Swarm halos were recorded with a NIKON Coolpix990 and swarm radius quantified via ImageJ (NIH, 
USA). 
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Strains, plasmids and oligonucleotides 
Table S1 
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Table S2 
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Chapter 5 | SUPPLEMENTALS 
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Figure S1 | Specificity and DNA-binding affinities of Cra and Pde to pdeL intergenic region 
 
 
 
(A) Binding of purified Cra-StrepII to pdeL intergenic region as tested by electrophoretic mobility shift assay (EMSA). 
Binding is assayed using 5’ Cy3-labeled oligonucleotides spanning the Cra-box (CB) as well as the Cra-dependent PdeL-
box (CDB). DNA concentration is kept constant at 10 nM, while Cra protein titration concentration is shown. (B)  Saturation 
binding fit of quantified band intensities. (C) EMSA and (D) binding affinity of purified PdeL-StrepII in presence of co-
factor Cra using the same DNA region as indicated in (A). Cra-StrepII concentration was kept constant at 40 nM. In (D), 
the band intensities of the supershift (Cra-PdeL-DNA-complex) were quantified to obtain binding constant. (E) Binding 
of purified PdeL-StrepII to distal Cra-independent PdeL-box (CIB). DNA region containing 10 bp upstream and 33 bp 
downstream of the CIB was used. (F) Saturation binding fit of PdeL-DNA-bands (E) to determine binding constant. (G) 
Confirmation of abrogated binding of transcription factors by introducing point mutation in the recognition sequences. 
Left panel: binding of Cra and/or PdeL was tested at 40 nM Cra and 400 nM PdeL concentration. Right panel: binding of 
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PdeL to the CIB and to the mutated CIB (CIB-) was tested at 200 - 600 nM PdeL concentration. (H) Recognition sequence 
of Cra and PdeL to corresponding binding boxes. Upper sequence shows recognition sequence whereas lower sequence 
highlighted in bold and red shows mutations introduced to abrogate binging Note that mutations abolishing binding of 
PdeL to the CIB were chosen to not affect the putative H-NS consensus sequence. 
 
 
Figure S2 | Location and properties of PdeL motile suppressor alleles 
 
 
 
(A) Swarm plate showing restoration of non-motile phenotype of ∆pdeH strain when combined with a selection of motile 
suppressor allele in PdeL. (B) Domain architecture of PdeL protein. Location of isolated motile suppressor alleles are 
shown as black dots. Red dot indicates aspartic acid responsible for stabilization of repulsive macro-dipole, which is 
generated by the N-termini of helices !5A and !6’B facing each other. Green dots show position of motile suppressor alleles 
located within highly conserved loop 6. Secondary structural elements in EAL-domain are shown as follows (alpha-helices 
= rounded grey bars, b-sheets = blank rectangles = line, unstructured regions). Amino acid conservation of neighborhood 
of motile suppressor mutations is shown as web logo of an alignment of 500 non-redundant EAL-domain proteins. (C) 
Crystal structure of monomer of non-conventional T-state PdeLEAL dimer in presence of Ca2+ (orange spheres) and c-di-
GMP as published in [62]. Conserved loop 6 is shown in purple. Residues, which resulted in motile suppressor phenotype 
are shown as sticks. Their position within the crystal structure is highlighted in yellow. (D) c-di-GMP-dependent pdeL 
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transcription of selection of motile suppressor alleles in PdeL. Wild-type PdeL is shown in grey. Note that – with exception 
of G299S – all tested alleles render the pdeL promoter irresponsive to different c-di-GMP regimes. 
 
 
Figure S3 | R-state-specific cysteine-crosslink of PdeL (Y268C) 
 
 
 
(A) Close-up of loop 6 (orange) and dimerization helices region of R-state dimer configuration of the EAL-domain of PdeL. 
Individual protomers are colored in marine or grey. Distance between Y268C of two protomers is shown as stippled black 
lines in Å. (B) Loop 6 (magenta) and dimerization helices region of T-state dimer configuration. Protomers here shown in 
marine and light-teal. Note the almost 5-fold higher distance of the Y268C substitutions compared to (A). 
Bismaleimidoethane (BMOE) is capable of crosslinking cysteines over a distance of maximal 8 Å. 
 
 
Figure S4 | Characterization of enzymatic feedback loop-deficient PdeLEL- variant 
 
Effect of wild type and mutant PdeL variants on c-di-GMP-
dependent pdeL transcription measured via a chromosomal 
translational PpdeL-lacZ reporter fusion. PdeL transcription was 
measured in in different c-di-GMP regimes: (L = ∆pdeH strain 
with low c-di-GMP levels generated by 65 µM induction of 
plasmid-borne Plac-pdeH; H = ∆pdeH strain with high c-di-
GMP levels generated by not inducing plasmid). D263N = 
mutation of second aspartic acid from highly conserved DD 
motif (see Figure S2B) responsible for coordination of 
catalytic metals. K283R = mutation of conserved catalytic base. 
Combination of both mutations = PdeLEL- (enzyme loop-
deficient). C-di-GMP levels are from experiment in Figure 4D 
(black curve) Enzymatic activity was measured via Phosphate 
Sensor assay (see Materials & Methods & [79]. Enzymatically 
inactive PdeL variants are shown in red. 
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Figure S5 | Putative H-NS binding boxes within pdeL intergenic region 
 
 
 
 
PdeL intergenic region shown with promoter (grey), PdeL binding boxes (blue) and Cra-binding box (green). Putative H-
NS binding boxes, which were identified using the Virtual Footprint website http://www.prodoric.de/vfp/ [252] are shown 
in orange. Individual regions are highlighted in base-pair resolution. Note that red box was not predicted in silico but was 
experimentally identified and characterized H-NS binding box (see Figure 1A & D). Graph below shows AT- and GC-
content of pdeL intergenic region with a binning of 5 bp. 
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To this end we applied structure-function based approaches to unravel how c-di-GMP affects both the 
enzymatic as well as the transcriptional activity of PdeL. In the discussion, we proposed a model in which 
binding of PdeL to the upstream Cra-independent PdeL-box induces PdeL tetramerization, which 
stabilizes PdeL in the highly active R-state. This model emerges from previous evidences in which EAL-
domain proteins were shown to form higher oligomers, and also from initial MALLS experiments that 
suggest a c-di-GMP and PdeL concentration-dependent oligomerization of PdeL. In collaboration with 
the structural group of Prof. Tilman Schirmer one major task will be to confirm these initial findings, 
structurally and biochemically characterize the tetrameric state of PdeL and unravel its implication in 
vivo. 
 
In this study, we have acquired precise quantitative data regarding the enzymatic and transcriptional 
properties of PdeL and how PdeL contributes to the homeostasis of the global c-di-GMP pool on the 
population and on single-cell level. We suggested that PdeL is a module that responds to noise in the c-
di-GMP concentration to either buffer or amplify these fluctuations, which ultimately leads to the 
establishment of bimodal c-di-GMP regimes. However, measuring noise in the c-di-GMP levels is a 
challenging endeavor experimentally. Given that the complexity of this multifactorial system easily 
exceeds simple two-dimensional problems, it will be paramount to apply mathematical modeling in the 
future. Not only can mathematical simulations of the pdeL regulation circuit strengthen the integrity of 
our proposed model but also serve to make predictions about the degree in c-di-GMP noise, which PdeL 
can amplify to generate bistable c-di-GMP regimes. 
  
The fact that the central carbon metabolic regulator Cra binds to the pdeL promoter and growth on 
various carbon sources seems to affect pdeL transcription (data not shown), implied that the metabolic 
and c-di-GMP status of the cell are integrated to drive pdeL transcription and ultimately affect c-di-GMP 
levels. Combination of genetic and metabolomics will be subject to future work as an approach to 
understand the metabolic impact on c-di-GMP levels, and whether – in return – c-di-GMP itself might 
signal back into metabolism. 
 
As a transcription factor, PdeL is likely to be involved in the regulation of more than just its own 
expression. It is hard to reconcile that a cell invests a high degree of energy and applies such a complex 
circuit to tune PdeL levels between roughly 200 and 1000 molecules per cell, although – if we neglect 
DNA-binding affinities – only 4 molecules are in principle required for the regulation of pdeL 
transcription. Rather it is conceivable that PdeL engages in further downstream signaling by binding and 
regulating secondary promoters. Initial proteomics analyses in which we compared the proteome of wild 
type and pdeL mutant in different c-di-GMP regimes already revealed several promising candidates 
involved in metabolism, biofilm formation and most interestingly c-di-GMP signaling itself. Future 
ChIP-Seq experiments will be complementary to the already performed proteomics approach and 
moreover will unravel direct PdeL targets
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